Processing 00000000.tx.1: Journal of Histochemistry and Cytochemistry, Vol. 

Phrase: "Journal of Histochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "and"

Phrase: "Cytochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010741:Cytochemistry [Biomedical Occupation or Discipline]

Phrase: "Vol."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0449468:VOL [Quantitative Concept]
  1000   C0560268:vol% [Quantitative Concept]
  1000   C1690016:% vol [Qualitative Concept]
Processing 00000000.tx.2: 50, 463-472, April 2002, Copyright  2002, The Histochemical Society, Inc. 

Phrase: "50,"

Phrase: "463-472,"

Phrase: "April 2002,"

Phrase: "Copyright  2002,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0009993:Copyright [Intellectual Product]
   861   C1552856:copyright [Idea or Concept]

Phrase: "The Histochemical Society,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037455:society [Organization]

Phrase: "Inc."
Processing 00000000.tx.3: ARTICLE Comparative Analysis of an Improved Thioflavin-S Stain, Gallyas Silver Stain, and Immunohistochemistry for Neurofibrillary Tangle Demonstration on the Same Sections Anyang Suna, Xuan V. 

Phrase: "ARTICLE Comparative Analysis of an Improved Thioflavin-S Stain,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C0683941:comparative analysis [Research Activity]
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]

Phrase: "Gallyas Silver Stain,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   901   C1318876:Silver stain [Indicator, Reagent, or Diagnostic Aid]
           Silver
   827   C0037125:Silver [Element, Ion, or Isotope]
   827   C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   827   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   827   C1305285:Silver [Qualitative Concept]
   743 E C0079853:Moon [Geographic Area]
   734 E C0003782:Argyria [Injury or Poisoning]
   734 E C3463959:Argyria [Eukaryote]

Phrase: "and"

Phrase: "Immunohistochemistry for Neurofibrillary Tangle Demonstration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0021044:Immunohistochemistry [Laboratory Procedure]

Phrase: "on the Same Sections Anyang Suna,"

Phrase: "Xuan V."
Processing 00000000.tx.4: Nguyena, and Guoying Binga a Department of Anatomy & Neurobiology, University of Kentucky Medical Center, Lexington, Kentucky Correspondence to: Guoying Bing, 310 Davis Mills Building, Dept. of Anatomy & Neurobiology, University of Kentucky Medical Center, Lexington, KY 40536-0098. 

Phrase: "Nguyena,"

Phrase: "and"

Phrase: "Guoying Binga"

Phrase: "a Department of Anatomy & Neurobiology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704729:Department [Organization]

Phrase: "University of Kentucky Medical Center,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   911   C0000872:University Medical Center [Health Care Related Organization,Manufactured Object]
   840   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   840   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   804   C0022557:Kentucky [Geographic Area]
   804   C0041740:University [Manufactured Object,Organization]
   804   C0205099:Center [Spatial Concept]
   804   C0205476:Medical [Functional Concept]

Phrase: "Lexington,"

Phrase: "Kentucky Correspondence to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0282413:Correspondence [Intellectual Product]

Phrase: ":"

Phrase: "Guoying Bing,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596170:bing [Mental or Behavioral Dysfunction]

Phrase: "310 Davis Mills Building,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1547706:Building [Functional Concept]
   812   C1999269:Building [Manufactured Object]

Phrase: "Dept."

Phrase: "of Anatomy & Neurobiology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027817:Neurobiology [Biomedical Occupation or Discipline]

Phrase: "University of Kentucky Medical Center,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   911   C0000872:University Medical Center [Health Care Related Organization,Manufactured Object]
   840   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   840   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   804   C0022557:Kentucky [Geographic Area]
   804   C0041740:University [Manufactured Object,Organization]
   804   C0205099:Center [Spatial Concept]
   804   C0205476:Medical [Functional Concept]

Phrase: "Lexington,"

Phrase: "KY 40536-0098."
Processing 00000000.tx.5: E-mail: gbing@pop.uky.edu Summary Top Summary Introduction Materials and Methods Results Discussion Literature Cited An improved thioflavin-S stain, Gallyas silver stain, and two immunostainings were quantitatively compared for demonstration of neurofibrillary tangles (NFTs) on the same sections. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "gbing@pop.uky.edu Summary Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion Literature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0023866:Literature [Intellectual Product]
   812   C0034036:LITERATURE [Intellectual Product,Manufactured Object]

Phrase: "Cited"

Phrase: "An improved thioflavin-S stain,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "Gallyas silver stain,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   901   C1318876:Silver stain [Indicator, Reagent, or Diagnostic Aid]
           Silver
   827   C0037125:Silver [Element, Ion, or Isotope]
   827   C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   827   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   827   C1305285:Silver [Qualitative Concept]
   743 E C0079853:Moon [Geographic Area]
   734 E C0003782:Argyria [Injury or Poisoning]
   734 E C3463959:Argyria [Eukaryote]

Phrase: "and"

Phrase: "two immunostainings"

Phrase: "were"

Phrase: "quantitatively"

Phrase: "compared for demonstration of neurofibrillary tangles (NFTs)"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   756 E C3543859:neurofibrillary tangle [Cell Component]
   753   C1707455:Compared [Activity]

Phrase: "on the same sections."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]
Processing 00000000.tx.6: Sections of hippocampal formation from seven cases of Alzheimer's disease (AD) were immunofluorescently stained with a commercially available polyclonal NFT antibody or a PHF-1 monoclonal antibody, followed by an improved thioflavin-S stain, and finally by Gallyas silver staining. 

Phrase: "Sections of hippocampal formation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   737   C0205155:Section [Spatial Concept]
   737   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   737   C1522472:Section [Substance]
   737   C1552923:Section [Quantitative Concept]
   737   C1705191:Section [Physical Object]

Phrase: "from seven cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "of Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(AD)"

Phrase: "were"

Phrase: "immunofluorescently"

Phrase: "stained with a commercially available polyclonal NFT antibody"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   767   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0085400:NFT [Acquired Abnormality]
   744   C0470187:Available [Functional Concept]
   744   C2986582:Stained [Qualitative Concept]
   711 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "or"

Phrase: "a PHF-1 monoclonal antibody,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0250876:PHF-1 monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   812   C0746619:monoclonal [Finding]

Phrase: "followed by an improved thioflavin-S stain,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   778   C0332283:Followed by [Temporal Concept]
           followed
   748   C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   748   C0184511:Improved [Qualitative Concept]
   748   C0332272:Improved [Qualitative Concept]
   748   C0950261:thioflavine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C1561611:Improved [Intellectual Product]
   714 E C1719822:Follow [Intellectual Product]

Phrase: "and"

Phrase: "finally by Gallyas silver staining."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C1293950:Silver Staining [Laboratory Procedure]
   790 E C1318876:Silver stain [Indicator, Reagent, or Diagnostic Aid]
           Silver
   760   C0037125:Silver [Element, Ion, or Isotope]
   760   C0487602:Staining [Laboratory Procedure]
   760   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   760   C1305285:Silver [Qualitative Concept]
   760   C1704680:Staining [Finding]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.7: The thioflavin-S method was improved by using a combination quenching method that removes background autofluorescence without remarkable tissue damage and by post-treatment with concentrated phosphate buffer, which minimizes photobleaching. 

Phrase: "The thioflavin-S method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025663:Method [Intellectual Product]
   827   C0449851:Method [Functional Concept]
   827   C0871511:METHOD [Intellectual Product]

Phrase: "was"

Phrase: "improved by"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0184511:Improved [Qualitative Concept]
   833   C0332272:Improved [Qualitative Concept]
   833   C1561611:Improved [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a combination quenching method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025663:Method [Intellectual Product]
   827   C0449851:Method [Functional Concept]
   827   C0871511:METHOD [Intellectual Product]

Phrase: "that"

Phrase: "removes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "background autofluorescence without remarkable tissue damage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0544711:Autofluorescence [Finding]

Phrase: "and by post-treatment"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C2709088:post treatment [Temporal Concept]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C0687676:Post [Temporal Concept]
   770   C1515981:And [Idea or Concept]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1704687:Post [Manufactured Object]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "with concentrated phosphate buffer,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "which"

Phrase: "minimizes"

Phrase: "photobleaching."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1138417:Photobleaching [Natural Phenomenon or Process]
Processing 00000000.tx.8: PHF-1 or NFT immunostaining is much less sensitive than the improved thioflavin-S staining and Gallyas silver staining, particularly in the transentorhinal region. 

Phrase: "PHF-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597162:PHF [Cell or Molecular Dysfunction]

Phrase: "or"

Phrase: "NFT immunostaining"

Phrase: "is"

Phrase: "much less sensitive than the improved thioflavin-S staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0332324:Sensitive [Functional Concept]
   742   C1550474:sensitive [Idea or Concept]

Phrase: "and"

Phrase: "Gallyas silver staining,"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   901   C1293950:Silver Staining [Laboratory Procedure]
   884 E C1318876:Silver stain [Indicator, Reagent, or Diagnostic Aid]
           Silver
   827   C0037125:Silver [Element, Ion, or Isotope]
   827   C0487602:Staining [Laboratory Procedure]
   827   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   827   C1305285:Silver [Qualitative Concept]
   827   C1704680:Staining [Finding]
   793 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   743 E C0079853:Moon [Geographic Area]
   734 E C0003782:Argyria [Injury or Poisoning]
   734 E C3463959:Argyria [Eukaryote]

Phrase: "particularly in the transentorhinal region."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0017446:Region [Geographic Area]
   760   C0205147:Region [Spatial Concept]
Processing 00000000.tx.9: Moreover PHF-1 immunoreactivity varied greatly among AD individuals. 

Phrase: "Moreover PHF-1 immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0597879:immunoreactivity [Molecular Function]

Phrase: "varied"

Phrase: "greatly among AD individuals."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0027361:Individual [Population Group]
   737   C0237401:Individual [Human]
Processing 00000000.tx.10: Thioflavin-S staining and Gallyas silver staining show almost the same sensitivity in NFT demonstration, but only the former depends on the secondary protein structure of NFTs. 

Phrase: "Thioflavin-S staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]

Phrase: "and"

Phrase: "Gallyas silver staining"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   901   C1293950:Silver Staining [Laboratory Procedure]
   884 E C1318876:Silver stain [Indicator, Reagent, or Diagnostic Aid]
           Silver
   827   C0037125:Silver [Element, Ion, or Isotope]
   827   C0487602:Staining [Laboratory Procedure]
   827   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   827   C1305285:Silver [Qualitative Concept]
   827   C1704680:Staining [Finding]
   793 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   743 E C0079853:Moon [Geographic Area]
   734 E C0003782:Argyria [Injury or Poisoning]
   734 E C3463959:Argyria [Eukaryote]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "almost"

Phrase: "the same sensitivity in NFT demonstration,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0036667:Sensitivity [Quantitative Concept]
   753   C0312418:Sensitivity [Mental Process]
   753   C0427965:Sensitivity [Finding]
   753   C1511883:Sensitivity [Quantitative Concept]
   753   C1522640:Sensitivity [Qualitative Concept]
   753   C2346484:SENSITIVITY [Phenomenon or Process]
   753   C2349185:Sensitivity [Qualitative Concept]

Phrase: "but"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "the former"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205156:Former [Temporal Concept]
  1000   C0750523:FORMER [Idea or Concept]

Phrase: "depends on the secondary protein structure of NFTs."
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   790   C0162807:Protein Structure, Secondary [Spatial Concept]
           Secondary Structure
   767   C2700455:Neurofibrillary Tangle Protein [Amino Acid, Peptide, or Protein]
   764   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   764   C0175168:protein structure [Amino Acid, Peptide, or Protein]
   764   C1510464:Protein Structure [Amino Acid, Peptide, or Protein]
   742   C0027627:secondary [Neoplastic Process]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0175668:Secondary [Temporal Concept]
   742   C0205436:Secondary [Quantitative Concept]
   742   C0678594:Structure [Spatial Concept]
   742   C0725813:depend [Medical Device]
   731 E C3543859:neurofibrillary tangle [Cell Component]
   726 E C0582263:Structural protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.11: This study suggests that the improved thioflavin-S staining is a simple, sensitive, and consistent method for demonstration of neurofibrillary pathology. 

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the improved thioflavin-S staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0487602:Staining [Laboratory Procedure]
   812   C1704680:Staining [Finding]

Phrase: "is"

Phrase: "a simple, sensitive,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332324:Sensitive [Functional Concept]
   861   C1550474:sensitive [Idea or Concept]

Phrase: "and"

Phrase: "consistent method for demonstration of neurofibrillary pathology."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0025663:Method [Intellectual Product]
   748   C0449851:Method [Functional Concept]
   748   C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.12: (J Histochem Cytochem 50:463472, 2002) Key Words: Alzheimer's disease, neurofibrillary tangles, transentorhinal cortex, thioflavin S, silver staining, immunohistochemistry Introduction Top Summary Introduction Materials and Methods Results Discussion Literature Cited Neurofibrillary tangles (NFTs) are a major defining neuropathological feature of Alzheimer's disease (AD) and other tangle-bearing disorders. 

Phrase: "(J Histochem Cytochem 50"

Phrase: ":"

Phrase: "463472,"

Phrase: "2002"

Phrase: ")"

Phrase: "Key Words"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1705313:Word [Idea or Concept]
   789 E C0439824:Verbal [Qualitative Concept]
   761 E C0871946:verb [Intellectual Product]

Phrase: ":"

Phrase: "Alzheimer's disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "neurofibrillary tangles,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "transentorhinal cortex,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "thioflavin S,"

Phrase: "silver staining,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1293950:Silver Staining [Laboratory Procedure]
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "immunohistochemistry Introduction Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion Literature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0023866:Literature [Intellectual Product]
   812   C0034036:LITERATURE [Intellectual Product,Manufactured Object]

Phrase: "Cited"

Phrase: "Neurofibrillary tangles"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "(NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: ")"

Phrase: "are"

Phrase: "a major defining neuropathological feature of Alzheimer's disease"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C1521970:Feature [Qualitative Concept]
   744   C1706388:Feature [Conceptual Entity]
   744   C2346469:Feature [Qualitative Concept]
   744   C2348519:Feature [Qualitative Concept]

Phrase: "(AD)"

Phrase: "and"

Phrase: "other tangle-bearing disorders."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012634:Disorders [Disease or Syndrome]
Processing 00000000.tx.13: Because postmortem diagnosis of AD relies in part on the accurate detection of NFTs in the brain, a number of methods have been developed to visualize these neurofibrillary lesions in brain sections. 

Phrase: "Because"

Phrase: "postmortem diagnosis of AD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0332145:Postmortem Diagnosis [Finding]
   770   C0011900:Diagnosis [Finding]
   770   C1704338:diagnosis [Qualitative Concept]
   770   C1704656:DIAGNOSIS [Research Activity]

Phrase: "relies in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "on the accurate detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "of NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "in the brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "a number of methods"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "developed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "visualize"

Phrase: "these neurofibrillary lesions in brain sections."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   783   C0221505:brain lesions [Disease or Syndrome]
   753   C0221198:lesions [Finding]
   719 E C1546698:Lesion [Intellectual Product]
Processing 00000000.tx.14: NFTs consist of bundles of paired helical filaments (PHFs) and straight filaments (Goedert et al. 1995 ), and their main constituent is the hyperphosphorylated microtubule-associated protein, tau (Iqbal et al. 1989 ; Lee et al. 1991 ). 

Phrase: "NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "consist of bundles of paired helical filaments (PHFs)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   780   C0597162:paired helical filament [Cell or Molecular Dysfunction]
   748   C0332529:CONSIST [Qualitative Concept]
   748   C1709450:Paired [Qualitative Concept]
   714   C0010851:Filament [Cell Component]

Phrase: "and"

Phrase: "straight filaments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0010851:Filament [Cell Component]
   777 E C1979891:Filamentous [Qualitative Concept]

Phrase: "(Goedert et al. 1995"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "their main constituent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0729650:constituent [Substance]

Phrase: "is"

Phrase: "the hyperphosphorylated microtubule-associated protein,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   923   C0026045:Microtubule-associated protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026046:Micro-tubule [Cell Component]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0332281:Associated [Qualitative Concept]
   779 E C0750490:Associate [Idea or Concept]
   779 E C1706221:Associate [Professional or Occupational Group]

Phrase: "tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "(Iqbal et al. 1989"

Phrase: "; Lee et al. 1991"

Phrase: ")."
Processing 00000000.tx.15: The specific structural and biochemical properties of NFTs enable them to be differentiated from normal cellular elements using conventional methods, such as silver, thioflavin-S, and immunohistochemical staining. 

Phrase: "The specific structural"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structural [Spatial Concept]

Phrase: "and"

Phrase: "biochemical properties of NFTs"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0871161:properties [Qualitative Concept]
   760   C1292721:properties [Functional Concept]
   726 E C1882134:Property [Conceptual Entity]
   726 E C2347695:Property [Entity]

Phrase: "enable"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562342:enable [Mental Process]
  1000   C1171285:enable [Mental Process]

Phrase: "them to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "differentiated from normal cellular elements"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   760   C0007589:Differentiated [Cell Function]
   760   C0007634:Cellular [Cell]
   760   C0013879:Elements [Element, Ion, or Isotope]
   760   C0178539:Cellular [Functional Concept]
   760   C0205307:Normal [Qualitative Concept]
   760   C0205615:Differentiated [Qualitative Concept]
   760   C0439166:% normal [Quantitative Concept]
   760   C2347086:% Normal [Quantitative Concept]
   726 E C1705248:Element [Conceptual Entity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "conventional methods,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]

Phrase: "such as silver,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0037125:Silver [Element, Ion, or Isotope]
  1000   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
  1000   C1305285:Silver [Qualitative Concept]
  1000   C1318876:Silver [Indicator, Reagent, or Diagnostic Aid]
   916 E C0079853:Moon [Geographic Area]
   907 E C0003782:Argyria [Injury or Poisoning]
   907 E C3463959:Argyria [Eukaryote]

Phrase: "thioflavin-S,"

Phrase: "and"

Phrase: "immunohistochemical staining."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1441616:Immunohistochemical [Laboratory Procedure]
   861   C1704680:Staining [Finding]
   827 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.16: Comparisons of the various staining methods for NFT demonstration had been reported in several earlier studies (Lamy et al. 1989 ; Vallet et al. 1992 ; Cullen et al. 1996 ). 

Phrase: "Comparisons of the various staining methods"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1707455:Comparison [Activity]

Phrase: "for NFT demonstration"

Phrase: "had"

Phrase: "been"

Phrase: "reported in several earlier studies"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   764   C1317750:Study report [Intellectual Product]
   764   C1831145:Study report [Clinical Attribute]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C0947630:studies [Laboratory Procedure]
   760   C3496591:Reported [Clinical Attribute]
   726 E C0557651:Study [Manufactured Object]
   726   C1279919:Early [Temporal Concept]
   726 E C2603343:Study [Research Activity]
   726 E C3273238:Report [Intellectual Product]

Phrase: "(Lamy et al. 1989"

Phrase: "; Vallet et al. 1992"

Phrase: "; Cullen et al. 1996"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1051267:Cullen [Plant]

Phrase: ")."
Processing 00000000.tx.17: The commonly reported drawbacks associated with the available methods include nonspecificity, stain variability, tissue damage, and amount of time required. 

Phrase: "The commonly reported drawbacks"

Phrase: "associated with the available methods"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0025663:Methods [Intellectual Product]
   760   C0025664:methods [Intellectual Product]
   760   C0449851:Methods [Functional Concept]
   760   C0470187:Available [Functional Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C0871511:METHOD [Intellectual Product]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "nonspecificity,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   928   C0205370:Non-specific [Qualitative Concept]
   928   C0750540:Nonspecific [Idea or Concept]

Phrase: "stain variability,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C2827666:Variability [Conceptual Entity]
   789 E C0439828:Variable [Qualitative Concept]

Phrase: "tissue damage,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0010957:Tissue damage [Injury or Poisoning]
           Damage
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]
   861   C1883709:Damage [Functional Concept]

Phrase: "and"

Phrase: "amount of time"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1265611:Amount [Quantitative Concept]

Phrase: "required."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]
Processing 00000000.tx.18: In this study we introduce a modification of the thioflavin-S histochemical technique that addresses many of these practical concerns. 

Phrase: "In this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "introduce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292748:introduce [Functional Concept]

Phrase: "a modification of the thioflavin-S histochemical technique"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0392747:Modification [Functional Concept]
   744   C1554963:modification [Qualitative Concept]

Phrase: "that"

Phrase: "addresses"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "many of these practical concerns."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439064:Many [Quantitative Concept]
   760   C0747726:many [Conceptual Entity]
   760   C2699424:Concerns [Idea or Concept]
Processing 00000000.tx.19: The present study compares the modified thioflavin-S staining to conventional thioflavin-S staining, Gallyas silver staining, and anti-NFT or anti-tau immunofluorescence. 

Phrase: "The present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "compares"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "the modified thioflavin-S staining to conventional thioflavin-S staining,"

Phrase: "Gallyas silver staining,"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   901   C1293950:Silver Staining [Laboratory Procedure]
   884 E C1318876:Silver stain [Indicator, Reagent, or Diagnostic Aid]
           Silver
   827   C0037125:Silver [Element, Ion, or Isotope]
   827   C0487602:Staining [Laboratory Procedure]
   827   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   827   C1305285:Silver [Qualitative Concept]
   827   C1704680:Staining [Finding]
   793 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   743 E C0079853:Moon [Geographic Area]
   734 E C0003782:Argyria [Injury or Poisoning]
   734 E C3463959:Argyria [Eukaryote]

Phrase: "and"

Phrase: "anti-NFT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0085400:NFT [Acquired Abnormality]

Phrase: "or"

Phrase: "anti-tau immunofluorescence."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0016318:Immunofluorescence [Laboratory Procedure]
   827   C0079603:Immunofluorescence [Laboratory Procedure]
   771 E C0282648:Direct immunofluorescence [Laboratory Procedure]
   755 E C0183489:Immunofluorescent [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.20: Gallyas silver staining was chosen as a representative of the available silver staining techniques because it shows much less nonspecific staining on normal cellular elements and is generally considered a relatively specific stain for neurofibrillary pathology. 

Phrase: "Gallyas silver staining"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   901   C1293950:Silver Staining [Laboratory Procedure]
   884 E C1318876:Silver stain [Indicator, Reagent, or Diagnostic Aid]
           Silver
   827   C0037125:Silver [Element, Ion, or Isotope]
   827   C0487602:Staining [Laboratory Procedure]
   827   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   827   C1305285:Silver [Qualitative Concept]
   827   C1704680:Staining [Finding]
   793 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   743 E C0079853:Moon [Geographic Area]
   734 E C0003782:Argyria [Injury or Poisoning]
   734 E C3463959:Argyria [Eukaryote]

Phrase: "was"

Phrase: "chosen as a representative of the available silver staining techniques"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   760   C1293950:Silver Staining [Laboratory Procedure]
   743 E C1318876:Silver stain [Indicator, Reagent, or Diagnostic Aid]
           Silver
   739   C0025664:techniques [Intellectual Product]
   739   C0037125:Silver [Element, Ion, or Isotope]
   739   C0449851:Techniques [Functional Concept]
   739   C0470187:Available [Functional Concept]
           Availability of
   739   C0487602:Staining [Laboratory Procedure]
   739   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   739   C1305285:Silver [Qualitative Concept]
   739   C1704680:Staining [Finding]
   739   C1707391:Chosen [Activity]
   739   C1882932:Representative [Activity]
   706 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "because"

Phrase: "it"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "much less nonspecific staining on normal cellular elements"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0487602:Staining [Laboratory Procedure]
   744   C1704680:Staining [Finding]

Phrase: "and"

Phrase: "is"

Phrase: "generally"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "a relatively specific stain for neurofibrillary pathology."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.21: Because the past methodological comparison studies had been performed on different sections, the present study may permit a more accurate comparison of sensitivity and selectivity by testing three staining methods on the same sections. 

Phrase: "Because"

Phrase: "the past methodological comparison studies"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   875   C0025662:Studies, Methodological [Occupational Activity]
   827   C0489479:Comparison.study [Clinical Attribute]
   827   C1579762:comparison study [Research Activity]
   812   C0947630:studies [Laboratory Procedure]
   812   C1707455:Comparison [Activity]
   779 E C0557651:Study [Manufactured Object]
   779 E C2603343:Study [Research Activity]

Phrase: "had"

Phrase: "been"

Phrase: "performed on different sections,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0884358:Performed [Functional Concept]
   770   C1705242:Different [Qualitative Concept]
   737   C0205155:Section [Spatial Concept]
   737   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   737   C1522472:Section [Substance]
   737   C1552923:Section [Quantitative Concept]
   737   C1705191:Section [Physical Object]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "the present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "may"

Phrase: "permit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0023636:Permit [Regulation or Law]
  1000   C0329040:Permit [Fish]

Phrase: "a more accurate comparison of sensitivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1707455:Comparison [Activity]

Phrase: "and"

Phrase: "selectivity by testing three staining methods"

Phrase: "on the same sections."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]
Processing 00000000.tx.22: Materials and Methods Top Summary Introduction Materials and Methods Results Discussion Literature Cited Tissues Postmortem brain tissues were obtained from 7 AD patients autopsied at the University of Kentucky Alzheimer's Disease Research Center (ADRC). 

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion Literature Cited Tissues Postmortem brain tissues"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   807   C0440746:brain tissues [Tissue]
   791   C0006104:Brain [Body Part, Organ, or Organ Component]
   791   C1269537:Brain [Body Part, Organ, or Organ Component]
   774 E C0459385:Brain tissue [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "obtained from 7 AD patients"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0030705:Patients [Patient or Disabled Group]
   760   C1301820:Obtained [Functional Concept]
   726 E C1706701:Obtain [Activity]

Phrase: "autopsied at the University of Kentucky Alzheimer's Disease Research Center"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0002395:Alzheimer's Disease [Disease or Syndrome]
   760   C0683939:research center [Manufactured Object,Organization]
   760   C1521724:Alzheimer's Disease [Pathologic Function]
   739   C0012634:Disease [Disease or Syndrome]
   739   C0022557:Kentucky [Geographic Area]
   739   C0035168:research [Research Activity]
   739   C0041740:University [Manufactured Object,Organization]
   739   C0205099:Center [Spatial Concept]
   739   C0242481:Research [Research Activity]
   706   C0004398:Autopsy [Diagnostic Procedure]

Phrase: "(ADRC"

Phrase: ")."
Processing 00000000.tx.23: Age at death of AD patients was 79.2  8.7 years (range 6591) and that of controls was 79.9  9.1 years (range 6695). 

Phrase: "Age at death of AD patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1543138:Age at death [Clinical Attribute]
   833   C1546180:Age at death [Clinical Attribute]
   783   C0742983:age death [Finding]
   753   C0001779:Age [Organism Attribute]

Phrase: "was"

Phrase: "79.2  8.7 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0439234:years [Temporal Concept]
   771 E C0439508:/year [Temporal Concept]

Phrase: "(range 6591"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1514721:Range [Quantitative Concept]
   861   C2348147:Range [Quantitative Concept]
   861   C3542016:Range [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "that of controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "was"

Phrase: "79.9  9.1 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0439234:years [Temporal Concept]
   771 E C0439508:/year [Temporal Concept]

Phrase: "(range 6695"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1514721:Range [Quantitative Concept]
   861   C2348147:Range [Quantitative Concept]
   861   C3542016:Range [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.24: The mean postmortem intervals were 2.8 hr (range 2.73 hr) for AD brains and 2.9 hr (range 1.84.5 hr) for controls. 

Phrase: "The mean postmortem intervals"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0004398:postmortem [Diagnostic Procedure]
   827   C0580205:Postmortem [Temporal Concept]
   827   C0848632:post mortem [Finding]
   827   C1272706:intervals [Temporal Concept]
   793 E C1552654:Interval [Idea or Concept]
   793 E C1552713:Interval [Intellectual Product]

Phrase: "were"

Phrase: "2.8 hr (range 2.73 hr) for AD brains"

Phrase: "and"

Phrase: "2.9 hr (range 1.84.5 hr)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C0450346:2 5 [Quantitative Concept]

Phrase: "for controls."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.25: All AD subjects met the clinical and neuropathological criteria for the diagnosis of AD. 

Phrase: "All AD subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "met"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550543:Meet [Idea or Concept]

Phrase: "the clinical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205210:Clinical [Qualitative Concept]

Phrase: "and"

Phrase: "neuropathological criteria for the diagnosis of AD."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0243161:criteria [Intellectual Product]
Processing 00000000.tx.26: Control subjects were individuals without evidence of neurological disorders who had been followed longitudinally as part of the normal volunteer control group at the University of Kentucky ADRC. 

Phrase: "Control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "were"

Phrase: "individuals without evidence of neurological disorders"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0027361:Individual [Population Group]
   719   C0237401:Individual [Human]

Phrase: "who"

Phrase: "had"

Phrase: "been"

Phrase: "followed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332283:followed [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "longitudinally"

Phrase: "as"

Phrase: "part of the normal volunteer control group"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1292711:Part of [Spatial Concept]
   748   C0449719:Part [Spatial Concept]
   748   C1709471:Part [Quantitative Concept]

Phrase: "at the University of Kentucky ADRC."
Processing 00000000.tx.27: Paraffin-embedded blocks were prepared by sequential dehydration in graded ethanol and vacuum-infiltration in paraffin before embedding and serial sectioning to a thickness of 8 m. 

Phrase: "Paraffin-embedded blocks"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0028778:blocks [Pathologic Function]
   827   C0332206:Blocks [Functional Concept]
   827   C1533157:Blocks [Substance]
   793 E C1706084:Block [Geographic Area]
   793 E C2828370:Block [Quantitative Concept]
   743 E C2983591:BLOCKED [Research Activity]

Phrase: "were"

Phrase: "prepared by sequential dehydration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0011175:Dehydration [Disease or Syndrome]
   770   C1548958:Sequential [Idea or Concept]
   770   C1705294:Sequential [Qualitative Concept]
   737   C1521827:Prepare [Functional Concept]

Phrase: "in graded ethanol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001962:Ethanol [Organic Chemical]

Phrase: "and"

Phrase: "vacuum-infiltration in paraffin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332448:Infiltration [Pathologic Function]
   770   C0702249:Infiltration [Therapeutic or Preventive Procedure]
   770   C1523986:Infiltration [Functional Concept]

Phrase: "before embedding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707903:Embedding [Laboratory Procedure]

Phrase: "and"

Phrase: "serial sectioning to a thickness of 8 m."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   744   C0700320:sectioning [Laboratory Procedure]
   711 E C0205155:Section [Spatial Concept]
   711 E C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   711 E C1522472:Section [Substance]
   711 E C1552923:Section [Quantitative Concept]
   711 E C1705191:Section [Physical Object]
Processing 00000000.tx.28: Antigen Retrieval and Quenching Autofluorescence Deparaffinized brain sections were rehydrated in distilled water and placed in a stainless steel pressure cooker containing a boiling dilution (1:100) of Antigen Unmasking Solution (#H-3300; Vector Laboratories, Burlingame, CA) according to the manufacturer's protocol. 

Phrase: "Antigen Retrieval"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0003320:Antigen [Immunologic Factor]
   861   C1514918:Retrieval [Health Care Activity]
   761 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "and"

Phrase: "Quenching Autofluorescence Deparaffinized brain sections"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   804   C0006104:Brain [Body Part, Organ, or Organ Component]
   804   C1269537:Brain [Body Part, Organ, or Organ Component]
   771   C0205155:Section [Spatial Concept]
   771   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   771   C1522472:Section [Substance]
   771   C1552923:Section [Quantitative Concept]
   771   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "rehydrated in distilled water"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0790233:Distilled water [Inorganic Chemical,Pharmacologic Substance]
   770   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   770   C0599638:WATER [Substance]
   770   C0681549:distilled [Occupational Activity]
   770   C1550678:Water [Inorganic Chemical]

Phrase: "and"

Phrase: "placed in a stainless steel pressure cooker"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0038126:Stainless Steel [Biomedical or Dental Material,Inorganic Chemical]
   748   C0033095:Pressure [Phenomenon or Process]
   748   C0038239:Steel [Biomedical or Dental Material,Inorganic Chemical]
   748   C0441035:Cooker [Manufactured Object]
   748   C0460139:Pressure [Finding]
   748   C1306345:Pressure [Functional Concept]
   714   C0442504:Place [Spatial Concept]
   714   C1704765:Place [Functional Concept]
   714   C1882509:Place [Activity]
   714   C3496241:place [Disease or Syndrome]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "a boiling dilution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079240:Dilution [Laboratory Procedure]
   861   C1948037:Dilution [Functional Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "100"

Phrase: ")"

Phrase: "of Antigen Unmasking Solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037633:Solution [Substance]
   827   C0525069:Solution [Biomedical or Dental Material]

Phrase: "(#H-3300"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "; Vector Laboratories,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022877:Laboratories [Manufactured Object,Organization]
   861   C1619828:Laboratories [Intellectual Product]
   827 E C3244292:laboratory [Functional Concept]

Phrase: "Burlingame,"

Phrase: "CA) according to the manufacturer's protocol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   783   C0050385:CA protocol [Therapeutic or Preventive Procedure]
Processing 00000000.tx.29: After heating under pressure for 1 min, samples were removed, placed briefly in a room-temperature (RT) water bath, and washed in PBS pH 7.2, for 5 min. 

Phrase: "After heating under pressure"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0033095:Pressure [Phenomenon or Process]
   827   C0460139:Pressure [Finding]
   827   C1306345:Pressure [Functional Concept]

Phrase: "for 1 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: ","

Phrase: "placed"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0442504:Place [Spatial Concept]
   966   C1704765:Place [Functional Concept]
   966   C1882509:Place [Activity]
   966   C3496241:place [Disease or Syndrome]

Phrase: "briefly in a room-temperature (RT) water bath,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   774   C0179245:bath water [Medical Device]
   748   C0005903:temperature [Organism Attribute]
   748   C0039476:*Temperature [Quantitative Concept]
   748   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   748   C0150141:Bath [Therapeutic or Preventive Procedure]
   748   C0599638:WATER [Substance]
   748   C1547703:Room [Spatial Concept]
   748   C1550678:Water [Inorganic Chemical]

Phrase: "and"

Phrase: "washed in PBS pH 7.2,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   790   C1882074:pH 7 [Qualitative Concept]
   753   C0020283:[pH] [Quantitative Concept]
   753   C0450407:ph+ [Finding]
   753   C0450408:ph++ [Finding]
   753   C0450409:ph+++ [Finding]
   753   C1548982:Washed [Idea or Concept]
   753   C1720830:PBS [Disease or Syndrome]
   753   C1823521:PBS [Gene or Genome]
   719 E C0441648:Wash [Activity]

Phrase: "for 5 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.30: Because the human brain sections showed considerable autofluorescence at FITC and Cy3 channels because of the abundance of highly fluorescent lipofuscin granules, a combination quenching procedure was used to reduce background autofluorescence (Sun et al. 2001 ). 

Phrase: "Because"

Phrase: "the human brain sections"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   793   C0205155:Section [Spatial Concept]
   793   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   793   C1522472:Section [Substance]
   793   C1552923:Section [Quantitative Concept]
   793   C1705191:Section [Physical Object]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "considerable autofluorescence at FITC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0544711:Autofluorescence [Finding]

Phrase: "and"

Phrase: "Cy3"

Phrase: "channels because of the abundance of highly fluorescent lipofuscin granules,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   743   C0230820:Lipofuscin granule [Cell Component]
   739   C0010837:Granules [Cell Component]
   739   C0023789:Lipofuscin [Biologically Active Substance,Lipid]
   739   C0205250:Highly [Qualitative Concept]
   739   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   739   C0439799:Channel [Spatial Concept]
   739   C0993609:Granules [Biomedical or Dental Material]
   739   C1706095:Channel [Conceptual Entity]
   739   C2346714:Abundance [Qualitative Concept]

Phrase: "a combination quenching procedure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   827   C1948041:Procedure [Therapeutic or Preventive Procedure]
   827   C2700391:Procedure [Activity]
   827   C3274430:PROCEDURE [Health Care Activity]
   827   C3538935:Procedure [Idea or Concept]
   827   C3539779:Procedure [Intellectual Product]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reduce"

Phrase: "background autofluorescence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0544711:Autofluorescence [Finding]

Phrase: "(Sun et al. 2001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0038817:Sun [Natural Phenomenon or Process]
   812   C0376223:Sun [Geographic Area]

Phrase: ")."
Processing 00000000.tx.31: First, slides were incubated in 0.3% KMnO4 for 35 min, washed with water, then treated with a solution of 1% K2S2O5 and 1% oxalic acid until the brown color was removed from the tissue (typically 2040 sec). 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "slides"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0444330:slides [Research Device]
   966 E C1705201:Slide [Manufactured Object]

Phrase: "were"

Phrase: "incubated in 0.3% KMnO4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 35 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "washed with water,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   790   C0599638:WATER [Substance]
   790   C1548982:Washed [Idea or Concept]
   790   C1550678:Water [Inorganic Chemical]
   756 E C0441648:Wash [Activity]
   718 E C0443350:Watery [Qualitative Concept]

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "treated with a solution of 1% K2S2O5"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   778   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   748   C0037633:Solution [Substance]
   748   C0525069:Solution [Biomedical or Dental Material]
   748   C1522326:Treated [Functional Concept]
   714 E C1292734:TREAT [Functional Concept]

Phrase: "and"

Phrase: "1% oxalic acid until the brown color"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0069715:Oxalic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   778   C0600422:oxalic acid [Organic Chemical]
   778   C1144584:oxalic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C0001128:Acid [Chemical]
   748   C0202406:Acid [Laboratory Procedure]

Phrase: "was"

Phrase: "removed from the tissue"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0040300:Tissue [Tissue]
   770   C0849355:Removed [Qualitative Concept]
   770   C1547928:Tissue [Intellectual Product]
   737 E C1883720:Remove [Activity]
   737 E C3244314:remove [Functional Concept]

Phrase: "(typically 2040 sec"

Phrase: ")."
Processing 00000000.tx.32: After a second wash with water, 1% sodium borohydride (NaBH4), which was prepared 2 hr before use, was applied for 5 min. 

Phrase: "After a second wash"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441648:Wash [Activity]

Phrase: "with water,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
  1000   C0599638:WATER [Substance]
  1000   C1550678:Water [Inorganic Chemical]
   928 E C0443350:Watery [Qualitative Concept]

Phrase: "1% sodium borohydride"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0074728:sodium borohydride [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   827   C0006029:borohydride [Chemical Viewed Structurally]
   827   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "(NaBH4"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "was"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "2 hr before use,"

Phrase: "was"

Phrase: "applied for 5 min."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0185125:Applied [Health Care Activity]
   770   C0702093:/min [Temporal Concept]
   737 E C1632850:Apply [Functional Concept]
   737 E C1879355:Apply [Functional Concept]
Processing 00000000.tx.33: Samples were then washed three times with distilled water and returned to PBS. 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "three times with distilled water"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0040223:times [Temporal Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "returned to PBS."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   866   C0332156:Return to [Qualitative Concept]
           Return
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
Processing 00000000.tx.34: Immunofluorescent Staining After antigen retrieval and quenching treatment, the deparaffinized sections were subjected to conventional immunofluorescence staining using either rabbit anti-NFT polyclonal antibody (#AB1518; Chemicon, Temecula, CA) or mouse PHF-1 monoclonal antibody, which recognizes the dually phosphorylated Ser396 and Ser404 epitope of tau peptides (Otvos et al. 1994 ). 

Phrase: "Immunofluorescent Staining After antigen retrieval"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0183489:Immunofluorescent stain [Indicator, Reagent, or Diagnostic Aid]
           Immunofluorescent
   760   C0487602:Staining [Laboratory Procedure]
   760   C1704680:Staining [Finding]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "quenching treatment,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "the deparaffinized sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "subjected to conventional immunofluorescence staining"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   760   C0016318:Immunofluorescence [Laboratory Procedure]
   760   C0079603:Immunofluorescence [Laboratory Procedure]
   760   C0439858:Conventional [Qualitative Concept]
   760   C0487602:Staining [Laboratory Procedure]
   760   C1704680:Staining [Finding]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]
   704 E C0282648:Direct immunofluorescence [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "either rabbit anti-NFT polyclonal antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   876   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   858   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   799   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(#AB1518"

Phrase: "; Chemicon,"

Phrase: "Temecula,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555271:Temecula [Population Group]

Phrase: "CA)"

Phrase: "or"

Phrase: "mouse PHF-1 monoclonal antibody,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   937   C0250876:PHF-1 monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   911   C0359168:Mouse monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   840   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   804   C0746619:monoclonal [Finding]

Phrase: "which"

Phrase: "recognizes"

Phrase: "the dually phosphorylated Ser396"

Phrase: "and"

Phrase: "Ser404 epitope of tau peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0003316:Epitope [Immunologic Factor]

Phrase: "(Otvos et al. 1994"

Phrase: ")."
Processing 00000000.tx.35: The PHF-1 antibody was kindly provided by Dr. 

Phrase: "The PHF-1 antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "kindly"

Phrase: "provided by Dr."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0031831:DR [Professional or Occupational Group]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C1999230:Provided [Activity]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
Processing 00000000.tx.36: Peter Davies (Albert Einstein College of Medicine; Bronx, NY). 

Phrase: "Peter Davies"

Phrase: "(Albert Einstein College of Medicine"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0013227:Medicine, NOS [Pharmacologic Substance]
   804   C0025118:Medicine [Biomedical Occupation or Discipline]
   804   C0557806:College [Manufactured Object]

Phrase: "; Bronx,"

Phrase: "NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.37: Incubation with anti-NFT antibody (1:400) or PHF-1 antibody (1:60) took place overnight at 4C, followed by 1 hr at room temperature (RT). 

Phrase: "Incubation with anti-NFT antibody"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "400"

Phrase: ")"

Phrase: "or"

Phrase: "PHF-1 antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "60"

Phrase: ")"

Phrase: "took"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1515187:Take [Health Care Activity]

Phrase: "place"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442504:Place [Spatial Concept]
  1000   C1704765:Place [Functional Concept]
  1000   C1882509:Place [Activity]
  1000   C3496241:place [Disease or Syndrome]

Phrase: "overnight at 4C,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439583:Overnight [Temporal Concept]
   790   C0450376:4c [Intellectual Product]

Phrase: "followed by 1 hr"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0332283:Followed by [Temporal Concept]
           followed
   737 E C1719822:Follow [Intellectual Product]

Phrase: "at room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "(RT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.38: One control section was processed identically except that the primary antibody was omitted from the incubation buffer. 

Phrase: "One control section"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "was"

Phrase: "processed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522240:Processed [Phenomenon or Process]
   966 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "identically"

Phrase: "except"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332300:except [Functional Concept]

Phrase: "that"

Phrase: "the primary antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "omitted from the incubation buffer."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0750563:omitted [Idea or Concept]
Processing 00000000.tx.39: After rinsing, sections were incubated in the presence of Cy3-conjugated goat, anti-rabbit secondary antibody (1:200) or goat anti-mouse antibody (1:100) (Sigma; St. Louis, MO) for 3 hr at RT. 

Phrase: "After rinsing,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882955:Rinsing [Activity]

Phrase: "sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "incubated in the presence of Cy3-conjugated goat,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0018019:goat [Mammal]
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   744   C0522529:Conjugated [Spatial Concept]
   744   C1265549:goat [Mammal]
   744   C1439852:Incubated [Laboratory Procedure]
   744   C1510458:Goat [Mammal]

Phrase: "anti-rabbit secondary antibody"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   902   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   812   C0027627:secondary [Neoplastic Process]
   812   C0034493:Rabbit [Mammal]
   812   C0175668:Secondary [Temporal Concept]
   812   C0205436:Secondary [Quantitative Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "200"

Phrase: ")"

Phrase: "or"

Phrase: "goat anti-mouse antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "100"

Phrase: ")"

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: "; St. Louis,"

Phrase: "MO) for 3 hr"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C3538743:MO [Idea or Concept]

Phrase: "at RT."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.40: Sections were then thoroughly rinsed in PBS. 

Phrase: "Sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "then thoroughly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883708:Then [Temporal Concept]

Phrase: "rinsed in PBS."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   756   C1701810:Rinse [Functional Concept]
   756   C1882955:Rinse [Activity]
Processing 00000000.tx.41: For the same-section comparisons in this study, this step was immediately followed by the thioflavin-S staining procedure. 

Phrase: "For the same-section comparisons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1707455:Comparison [Activity]

Phrase: "in this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "this step"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1261552:Step [Conceptual Entity]
  1000   C1704379:Step [Functional Concept]
  1000   C1705117:Step [Quantitative Concept]
  1000   C2825408:Step [Manufactured Object]

Phrase: "was"

Phrase: "immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "followed by the thioflavin-S"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C0950261:thioflavine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "staining"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "procedure."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
  1000   C1948041:Procedure [Therapeutic or Preventive Procedure]
  1000   C2700391:Procedure [Activity]
  1000   C3274430:PROCEDURE [Health Care Activity]
  1000   C3538935:Procedure [Idea or Concept]
  1000   C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.42: Improved Thioflavin-S Staining Traditional thioflavin-S staining was previously modified by Guntern et al. 

Phrase: "Improved Thioflavin-S"

Phrase: "Staining"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "Traditional thioflavin-S staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0487602:Staining [Laboratory Procedure]
   812   C1704680:Staining [Finding]

Phrase: "was"

Phrase: "previously"

Phrase: "modified by Guntern et al."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0205349:Modified By [Qualitative Concept]
   760   C0392747:Modified [Functional Concept]
Processing 00000000.tx.43: 1992 by adding pretreatments with KMnO4 for 20 min followed by NaOH plus H2O2 treatment. 

Phrase: "1992 by adding pretreatments"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   737   C1550147:Pretreatment [Substance]
   737   C1883712:Add [Functional Concept]
   737   C3539075:Pretreatment [Temporal Concept]
   737   C3539076:Pretreatment [Activity]

Phrase: "with KMnO4"

Phrase: "for 20 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "followed by NaOH plus H2O2 treatment."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   790   C0332283:Followed by [Temporal Concept]
           followed
   753   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C0332287:Plus [Qualitative Concept]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]
   719 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.44: However, NaOH treatment causes tissue damage in some cases, as reported by others (Cullen et al. 1996 ) and in our preliminary study. 

Phrase: "However,"

Phrase: "NaOH treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "tissue damage in some cases,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0010957:Tissue damage [Injury or Poisoning]
           Damage
   760   C0040300:Tissue [Tissue]
   760   C1547928:Tissue [Intellectual Product]
   760   C1883709:Damage [Functional Concept]

Phrase: "as"

Phrase: "reported by others"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   882   C1709908:Reported By [Group]
   790   C0684224:Reported [Intellectual Product]
   790   C0700287:Reported [Health Care Activity]
   790   C1955473:Others [Finding]
   790   C3496591:Reported [Clinical Attribute]
   756 E C3273238:Report [Intellectual Product]

Phrase: "(Cullen et al. 1996"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1051267:Cullen [Plant]

Phrase: ")"

Phrase: "and in our preliminary study."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439611:Preliminary [Temporal Concept]
   760   C0557651:Study [Manufactured Object]
   760   C1515981:And [Idea or Concept]
   760   C2603343:Study [Research Activity]
Processing 00000000.tx.45: Photobleaching is also encountered in the modified method above (Vallet et al. 1992 ), possibly due to the quenching treatment or/and the low thioflavin-S concentration used. 

Phrase: "Photobleaching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1138417:Photobleaching [Natural Phenomenon or Process]

Phrase: "is"

Phrase: "also"

Phrase: "encountered in the modified method"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0025663:Method [Intellectual Product]
   760   C0392747:Modified [Functional Concept]
   760   C0449851:Method [Functional Concept]
   760   C0871511:METHOD [Intellectual Product]
   726   C0545082:Encounter [Behavior]
   726   C1512346:encounter [Health Care Activity]
   726   C1947978:Encounter [Behavior]

Phrase: "above"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]

Phrase: "(Vallet et al. 1992"

Phrase: ")"

Phrase: ","

Phrase: "possibly due to the quenching treatment"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0678226:Due to [Functional Concept]
           due
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C2362652:Possibly [Qualitative Concept]
   753   C3146286:Due [Idea or Concept]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "or/"

Phrase: "and"

Phrase: "the low thioflavin-S concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0086045:Concentration [Mental Process]
   812   C1446561:Concentration [Quantitative Concept]
   741 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.46: In this study we introduce two modifications to the thioflavin-S staining method based on our empirical observations of staining quality. 

Phrase: "In this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "introduce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292748:introduce [Functional Concept]

Phrase: "two modifications to the thioflavin-S"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0392747:Modification [Functional Concept]
   719   C1554963:modification [Qualitative Concept]

Phrase: "staining"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "based on our empirical observations of staining quality."
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   744   C0302523:observations [Research Activity]
   744   C0332306:Quality [Qualitative Concept]
   744   C0487602:Staining [Laboratory Procedure]
   744   C0700325:observations [Health Care Activity]
   744   C1527178:Based [Functional Concept]
   744   C1704680:Staining [Finding]
   744   C1705938:Based [Idea or Concept]
   744   C1880496:Empirical [Qualitative Concept]
   744   C3244290:observations [Functional Concept]
   711 E C0002055:base [Inorganic Chemical]
   711 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   711 E C0178499:Base [Chemical Viewed Functionally]
   711 E C1880279:Base [Biomedical or Dental Material]
   711 E C1964257:Observation [Diagnostic Procedure]
Processing 00000000.tx.47: First, the quenching method was improved, as described above, by reducing the duration of potassium permanganate oxidation from 20 min (Vallet et al. 1992 ) to 4 min, followed by 1% sodium borohydride. 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "the quenching method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025663:Method [Intellectual Product]
   861   C0449851:Method [Functional Concept]
   861   C0871511:METHOD [Intellectual Product]

Phrase: "was"

Phrase: "improved"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0184511:Improved [Qualitative Concept]
  1000   C0332272:Improved [Qualitative Concept]
  1000   C1561611:Improved [Intellectual Product]

Phrase: ","

Phrase: "as"

Phrase: "described above,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1552738:described [Idea or Concept]

Phrase: "by reducing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reducing [Qualitative Concept]

Phrase: "the duration of potassium permanganate oxidation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449238:Duration [Temporal Concept]
   753   C2926735:Duration [Pharmacologic Substance]

Phrase: "from 20 min (Vallet et al. 1992"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0702093:/min [Temporal Concept]

Phrase: ")"

Phrase: "to 4 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "followed by 1% sodium borohydride."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0074728:sodium borohydride [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   806   C0332283:Followed by [Temporal Concept]
           followed
   797   C0597484:Sodium 1+ [Element, Ion, or Isotope,Pharmacologic Substance]
           Sodium+
   760   C0006029:borohydride [Chemical Viewed Structurally]
   760   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   726 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.48: Treatments with NaOH, H2O2, and acetic acid were abolished. 

Phrase: "Treatments with NaOH,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   790   C0087111:Treatments [Therapeutic or Preventive Procedure]
   756 E C0039798:treatment [Functional Concept]
   756 E C1522326:Treatment [Functional Concept]
   756 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   756 E C1705169:Treatment [Conceptual Entity]
   756 E C3538994:TREATMENT [Research Activity]

Phrase: "H2O2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "and"

Phrase: "acetic acid"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0000983:Acetic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
  1000   C0000985:Acetic acid [Organic Chemical]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]
   861   C0981805:ACETIC [Organic Chemical,Pharmacologic Substance]
   805 E C0148405:Vinegar [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "abolished."
Processing 00000000.tx.49: Second, sections were post-treated with a high concentration of phosphate buffer for 30 min at 4C, which was found to alleviate photobleaching. 

Phrase: "Second, sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "post-"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0687676:Post [Temporal Concept]
  1000   C1704687:Post [Manufactured Object]
   928 E C1514253:Postal [Functional Concept]

Phrase: "treated with a high concentration of phosphate buffer"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   770   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   767   C0860988:high phosphate [Finding]
   744   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   744   C0031701:phosphate [Organophosphorus Compound]
   744   C0086045:Concentration [Mental Process]
   744   C0205250:High [Qualitative Concept]
   744   C1299351:High [Qualitative Concept]
   744   C1446561:Concentration [Quantitative Concept]
   744   C1522326:Treated [Functional Concept]
   744   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   744   C2700149:HIGH [Intellectual Product]
   711 E C1292734:TREAT [Functional Concept]

Phrase: "for 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "at 4C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "which"

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "alleviate"

Phrase: "photobleaching."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1138417:Photobleaching [Natural Phenomenon or Process]
Processing 00000000.tx.50: In addition, because of the high background associated with the intrinsic blue fluorescence from tissue proteins under the DAPI filter set, we used in this study the FITC filter set (ex 470  20 nm, em >515 nm). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "because of the high background"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1706907:Background [Conceptual Entity]

Phrase: "associated with the intrinsic blue fluorescence"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0016315:Fluorescence [Natural Phenomenon or Process]
   753   C0205102:Intrinsic [Spatial Concept]
   753   C0439674:Intrinsic [Functional Concept]
   753   C1260957:Blue [Qualitative Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "from tissue proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "under the DAPI filter set,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0036849:Set [Mental Process]
   827   C1442518:Set [Functional Concept]
   827   C1705195:Set [Conceptual Entity]

Phrase: "we"

Phrase: "used in this"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the FITC filter set (ex 470  20 nm,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0312860:NM [Cell Function]

Phrase: "em >515 nm)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0312860:NM [Cell Function]
Processing 00000000.tx.51: In our same-section comparison study of multiple staining methods, the thioflavin-S staining was preceded by the combination quenching steps (described above) and conventional immunofluorescent staining on deparaffinized sections. 

Phrase: "In our same-section comparison study"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0489479:Comparison.study [Clinical Attribute]
   861   C1579762:comparison study [Research Activity]
   812   C0557651:Study [Manufactured Object]
   812   C1707455:Comparison [Activity]
   812   C2603343:Study [Research Activity]

Phrase: "of multiple staining methods,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   884   C0487602:Staining method [Laboratory Procedure]
   827   C0025663:Methods [Intellectual Product]
   827   C0025664:methods [Intellectual Product]
   827   C0449851:Methods [Functional Concept]
   793 E C0871511:METHOD [Intellectual Product]

Phrase: "the thioflavin-S staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]

Phrase: "was"

Phrase: "preceded by the combination quenching steps"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   753   C0205195:Combination [Qualitative Concept]
   753   C0332152:preceded [Temporal Concept]
   753   C1261552:steps [Conceptual Entity]
   753   C1947911:Combination [Physical Object]
   719 E C1704379:Step [Functional Concept]
   719 E C1705117:Step [Quantitative Concept]
   719 E C2825408:Step [Manufactured Object]

Phrase: "(described above"

Phrase: ")"

Phrase: "and"

Phrase: "conventional immunofluorescent staining on deparaffinized sections."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   773   C0183489:Immunofluorescent stain [Indicator, Reagent, or Diagnostic Aid]
           Immunofluorescent
   753   C0487602:Staining [Laboratory Procedure]
   753   C1704680:Staining [Finding]
   719 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.52: Sections were then stained with 0.05% thioflavin-S in 50% ethanol in the dark for 8 min. 

Phrase: "Sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "stained with 0.05% thioflavin-S"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0950261:thioflavine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C2986582:Stained [Qualitative Concept]
   719 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "in 50% ethanol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001962:Ethanol [Organic Chemical]

Phrase: "in the dark"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332582:Dark [Qualitative Concept]

Phrase: "for 8 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.53: In preliminary optimization trials, dilutions of 0.01%, 0.05%, 0.1%, and 1% thioflavin-S solutions were tested for optimal staining quality at 8 min. 

Phrase: "In preliminary optimization trials,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0008976:Trial [Research Activity]

Phrase: "dilutions of 0.01%,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0079240:dilutions [Laboratory Procedure]
   737 E C1948037:Dilution [Functional Concept]

Phrase: "0.05%,"

Phrase: "0.1%,"

Phrase: "and"

Phrase: "1% thioflavin-S solutions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0037633:Solutions [Substance]
   779 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "were"

Phrase: "tested for optimal staining quality"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0332306:Quality [Qualitative Concept]
   760   C0392366:tested [Intellectual Product]
   760   C0487602:Staining [Laboratory Procedure]
   760   C1704680:Staining [Finding]
   760   C2698651:Optimal [Qualitative Concept]
   726 E C0022885:Test [Laboratory Procedure]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   726 E C0039593:Test [Functional Concept]

Phrase: "at 8 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.54: A thioflavin-S concentration of 0.05% was found to be optimal and was used for the remainder of the study. 

Phrase: "A thioflavin-S concentration of 0.05%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0086045:Concentration [Mental Process]
   748   C1446561:Concentration [Quantitative Concept]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "optimal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2698651:Optimal [Qualitative Concept]

Phrase: "and"

Phrase: "was"

Phrase: "used for the remainder of the study."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   757   C0869040:study use [Research Activity]
   757   C1524063:Use of [Functional Concept]
   748   C0557651:Study [Manufactured Object]
   748   C1273517:used [Finding]
   748   C2603343:Study [Research Activity]
   714 E C0042153:use [Functional Concept]
   714 E C0457083:Use [Functional Concept]
   714 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.55: This step was followed by differentiation in two changes of 80% ethanol for 10 sec each and three washes in large volumes of distilled water. 

Phrase: "This step"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1261552:Step [Conceptual Entity]
  1000   C1704379:Step [Functional Concept]
  1000   C1705117:Step [Quantitative Concept]
  1000   C2825408:Step [Manufactured Object]

Phrase: "was"

Phrase: "followed by differentiation"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0007589:Differentiation [Cell Function]
   790   C1511938:Differentiation [Clinical Attribute]
   790   C2945687:Differentiation [Functional Concept]
   756 E C1719822:Follow [Intellectual Product]
   718 E C0205615:Differentiated [Qualitative Concept]

Phrase: "in two changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "of 80% ethanol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001962:Ethanol [Organic Chemical]

Phrase: "for 10 sec"

Phrase: "each"

Phrase: "and"

Phrase: "three washes in large volumes of distilled water."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C0441648:Wash [Activity]
Processing 00000000.tx.56: Slides were then incubated in a high concentration of phosphate buffer (411 mM NaCl, 8.1 mM KCl, 30 mM Na2HPO4, 5.2 mM KH2PO4, pH 7.2) at 4C for 30 min or more, then briefly rinsed with distilled water and coverslipped using water. 

Phrase: "Slides"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0444330:slides [Research Device]
   966 E C1705201:Slide [Manufactured Object]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated in a high concentration of phosphate buffer"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   770   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   767   C0860988:high phosphate [Finding]
   744   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   744   C0031701:phosphate [Organophosphorus Compound]
   744   C0086045:Concentration [Mental Process]
   744   C0205250:High [Qualitative Concept]
   744   C1299351:High [Qualitative Concept]
   744   C1439852:Incubated [Laboratory Procedure]
   744   C1446561:Concentration [Quantitative Concept]
   744   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   744   C2700149:HIGH [Intellectual Product]

Phrase: "(411 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "8.1 mM KCl,"

Phrase: "30 mM Na2HPO4,"

Phrase: "5.2 mM KH2PO4,"

Phrase: "pH 7.2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "for 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "or"

Phrase: "more,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "then briefly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883708:Then [Temporal Concept]

Phrase: "rinsed with distilled water"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0790233:Distilled water [Inorganic Chemical,Pharmacologic Substance]
   770   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   770   C0599638:WATER [Substance]
   770   C0681549:distilled [Occupational Activity]
   770   C1550678:Water [Inorganic Chemical]
   737   C1701810:Rinse [Functional Concept]
   737   C1882955:Rinse [Activity]

Phrase: "and"

Phrase: "coverslipped"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "water."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
  1000   C0599638:WATER [Substance]
  1000   C1550678:Water [Inorganic Chemical]
   928 E C0443350:Watery [Qualitative Concept]
Processing 00000000.tx.57: No mounting resin was used so as to facilitate re-use of the same sections for subsequent stains. 

Phrase: "No mounting resin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035191:Resin [Biomedical or Dental Material]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "so as to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0037640:SO [Geographic Area]

Phrase: "facilitate"

Phrase: "re-use of the same sections"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C1524063:Use of [Functional Concept]
   753   C0042153:use [Functional Concept]
   753   C0445247:Same [Qualitative Concept]
   753   C0457083:Use [Functional Concept]
   753   C1947944:Use [Intellectual Product]
   753   C2986904:RE [Idea or Concept]
   719   C0205155:Section [Spatial Concept]
   719   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   719   C1522472:Section [Substance]
   719   C1552923:Section [Quantitative Concept]
   719   C1705191:Section [Physical Object]

Phrase: "for subsequent stains."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038128:Stains [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.58: Images at different subregions were captured with a digital camera, and NFTs were counted (see below) before any subsequent silver staining procedure. 

Phrase: "Images at different subregions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1704254:Image [Intellectual Product]
   737   C1704922:Image [Entity]
   737   C3542466:Image [Intellectual Product]

Phrase: "were"

Phrase: "captured with a digital camera,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0179533:Camera [Medical Device]
   760   C0442015:Digital [Intellectual Product]
   760   C1654607:Camera [Eukaryote]
   760   C1706254:CAMERA [Medical Device]
   760   C1883674:Digital [Qualitative Concept]
   704 E C0016129:Finger [Body Location or Region]
   704 E C0549188:fingers [Quantitative Concept]
   704 E C1281584:Finger [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "were"

Phrase: "counted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0750480:Count [Activity]
   966   C1705566:Count [Quantitative Concept]

Phrase: "("

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: ")"

Phrase: "before any subsequent silver staining procedure."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   812   C1948041:Procedure [Therapeutic or Preventive Procedure]
   812   C2700391:Procedure [Activity]
   812   C3274430:PROCEDURE [Health Care Activity]
   812   C3538935:Procedure [Idea or Concept]
   812   C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.59: Fluorescence Microscopy The induced fluorescence, silver staining, and immunostaining were viewed using an Axioplan 2 imaging microscope (Zeiss; Oberkochen, Germany). 

Phrase: "Fluorescence Microscopy"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0026022:Microscopy, Fluorescence [Laboratory Procedure]
   861   C0016315:Fluorescence [Natural Phenomenon or Process]
   861   C0026018:Microscopy [Laboratory Procedure]
   789 E C0205288:Microscopic [Qualitative Concept]
   789 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "The induced fluorescence,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0016315:Fluorescence [Natural Phenomenon or Process]
   789 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "silver staining,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1293950:Silver Staining [Laboratory Procedure]
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "and"

Phrase: "immunostaining"

Phrase: "were"

Phrase: "viewed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0449911:View [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an Axioplan 2 imaging microscope"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0181839:Microscope [Medical Device]
   812   C1706379:Microscope [Medical Device]

Phrase: "(Zeiss"

Phrase: "; Oberkochen,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")."
Processing 00000000.tx.60: For fluorescence, the filters used were as follows: rhodamine (ex 546  6 nm, em > 570 nm); 

Phrase: "For fluorescence,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016315:Fluorescence [Natural Phenomenon or Process]
   928 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "the filters"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0180860:Filters [Manufactured Object]
   966 E C0581406:Filter [Medical Device]
   966 E C1522664:Filter [Intellectual Product]
   966 E C1704449:Filter [Conceptual Entity]
   966 E C1704684:Filter [Medical Device]
   966 E C1875155:FILTER [Medical Device]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "were"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "rhodamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600322:Rhodamine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(ex 546  6 nm,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0312860:NM [Cell Function]

Phrase: "em > 570 nm)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0312860:NM [Cell Function]

Phrase: ";"
Processing 00000000.tx.61: FITC (ex 470  20 nm, em >515 nm); 

Phrase: "FITC (ex 470  20 nm,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0312860:NM [Cell Function]

Phrase: "em >515 nm)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0312860:NM [Cell Function]

Phrase: ";"
Processing 00000000.tx.62: DAPI (ex 365  6 nm, em >397 nm). 

Phrase: "DAPI (ex 365  6 nm,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0312860:NM [Cell Function]

Phrase: "em >397 nm)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0312860:NM [Cell Function]
Processing 00000000.tx.63: Images were captured using an Axiocam digital camera interfaced with a computer containing Axiovision 3.0 software (Zeiss). 

Phrase: "Images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1704254:Image [Intellectual Product]
   966   C1704922:Image [Entity]
   966   C3542466:Image [Intellectual Product]

Phrase: "were"

Phrase: "captured"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an Axiocam digital camera"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0179533:Camera [Medical Device]
   827   C1654607:Camera [Eukaryote]
   827   C1706254:CAMERA [Medical Device]

Phrase: "interfaced with a computer containing Axiovision 3.0 software"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   762   C0037585:Computer software [Intellectual Product,Manufactured Object]
           Software
   742   C0009622:Computer [Manufactured Object]
   742   C0332256:Containing [Functional Concept]
   742   C2700400:Containing [Activity]
   708   C1708533:Interface [Manufactured Object]
   708   C2698172:Interface [Intellectual Product]

Phrase: "(Zeiss"

Phrase: ")."
Processing 00000000.tx.64: Inputs from rhodamine and FITC channels were superimposed to facilitate comparison. 

Phrase: "Inputs from rhodamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1708517:Input [Conceptual Entity]

Phrase: "and"

Phrase: "FITC channels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]

Phrase: "were"

Phrase: "superimposed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "facilitate"

Phrase: "comparison."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Comparison [Activity]
Processing 00000000.tx.65: Gallyas Silver Staining Gallyas silver staining (Gallyas 1971 ) was performed on the same sections as described previously. 

Phrase: "Gallyas Silver Staining Gallyas silver staining"

Phrase: "(Gallyas 1971"

Phrase: ")"

Phrase: "was"

Phrase: "performed on the same sections"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0445247:Same [Qualitative Concept]
   760   C0884358:Performed [Functional Concept]
   726   C0205155:Section [Spatial Concept]
   726   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   726   C1522472:Section [Substance]
   726   C1552923:Section [Quantitative Concept]
   726   C1705191:Section [Physical Object]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously."
Processing 00000000.tx.66: For purposes of same-section comparisons in this study, the Gallyas silver staining was performed after micrographs and NFT quantitation results had been obtained for the immunohistochemical and thioflavin-S stains. 

Phrase: "For purposes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1285529:purposes [Functional Concept]

Phrase: "of same-section comparisons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1707455:Comparison [Activity]

Phrase: "in this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the Gallyas silver staining"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   901   C1293950:Silver Staining [Laboratory Procedure]
   884 E C1318876:Silver stain [Indicator, Reagent, or Diagnostic Aid]
           Silver
   827   C0037125:Silver [Element, Ion, or Isotope]
   827   C0487602:Staining [Laboratory Procedure]
   827   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   827   C1305285:Silver [Qualitative Concept]
   827   C1704680:Staining [Finding]
   793 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   743 E C0079853:Moon [Geographic Area]
   734 E C0003782:Argyria [Injury or Poisoning]
   734 E C3463959:Argyria [Eukaryote]

Phrase: "was"

Phrase: "performed after micrographs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and"

Phrase: "NFT quantitation results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1274040:Result [Functional Concept]
   793   C1546471:Result [Idea or Concept]
   793   C2825142:Result [Finding]

Phrase: "had"

Phrase: "been"

Phrase: "obtained for the immunohistochemical"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C1301820:Obtained [Functional Concept]
   770   C1441616:Immunohistochemical [Laboratory Procedure]
   737 E C1706701:Obtain [Activity]

Phrase: "and"

Phrase: "thioflavin-S stains."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0038128:Stains [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.67: NFT Density Typical fields containing high tangle densities were chosen for comparison at three representative regions (CA1, subiculum/presubiculum, and transentorhinal cortex). 

Phrase: "NFT Density Typical fields"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   779   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   779   C1521738:Field [Conceptual Entity]
   779   C2346620:Field [Conceptual Entity]
   779   C2349184:Field [Conceptual Entity]
   779   C3539073:FIELD [Spatial Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "high tangle densities"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0178587:densities [Quantitative Concept]
   743 E C0439794:Dense [Qualitative Concept]

Phrase: "were"

Phrase: "chosen for comparison"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1707391:Chosen [Activity]
   790   C1707455:Comparison [Activity]

Phrase: "at three representative regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   793   C0017446:Region [Geographic Area]
   793   C0205147:Region [Spatial Concept]
   743 E C0205276:Regional [Spatial Concept]
   743 E C1947913:Regional [Spatial Concept]

Phrase: "(CA1,"

Phrase: "subiculum/presubiculum,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0175194:Presubiculum [Body Location or Region]

Phrase: "and"

Phrase: "transentorhinal cortex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: ")."
Processing 00000000.tx.68: The numbers of NFTs were counted within the frame of captured images (1340 x 1060 m2) at x200 magnification. 

Phrase: "The numbers of NFTs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "were"

Phrase: "counted within the frame of captured images"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0080089:Frame [Nucleotide Sequence]
   748   C0180979:Frame [Medical Device]
   748   C1705858:Frame [Manufactured Object]
   714   C0750480:Count [Activity]
   714   C1704254:Image [Intellectual Product]
   714   C1704922:Image [Entity]
   714   C1705566:Count [Quantitative Concept]
   714   C3542466:Image [Intellectual Product]

Phrase: "(1340 x 1060 m2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0457242:m2 [Quantitative Concept]

Phrase: ")"

Phrase: "at x200 magnification."
Processing 00000000.tx.69: Histological cues within a section were used to facilitate selection of identical fields so that the counting frame was set at the same positions for the comparison of the three methods. 

Phrase: "Histological cues within a section"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0010439:Cues [Idea or Concept]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "facilitate"

Phrase: "selection of identical fields"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0036576:selection [Genetic Function]

Phrase: "so"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "that"

Phrase: "the counting frame"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0080089:Frame [Nucleotide Sequence]
   861   C0180979:Frame [Medical Device]
   861   C1705858:Frame [Manufactured Object]

Phrase: "was"

Phrase: "set at the same positions"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0036849:Set [Mental Process]
   760   C0445247:Same [Qualitative Concept]
   760   C0733755:positions [Spatial Concept]
   760   C1442518:Set [Functional Concept]
   760   C1705195:Set [Conceptual Entity]

Phrase: "for the comparison"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Comparison [Activity]

Phrase: "of the three methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.70: NFT density was calculated as the number of NFTs in the frame divided by the area of the frame. 

Phrase: "NFT density"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0178587:density [Quantitative Concept]
   789 E C0439794:Dense [Qualitative Concept]

Phrase: "was"

Phrase: "calculated as the number of NFTs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   778   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   748   C0237753:*Number [Quantitative Concept]
   748   C0444686:Calculated [Functional Concept]
   748   C0449788:Number [Quantitative Concept]
   748   C1441506:Calculated [Activity]
   748   C1443182:Calculated [Laboratory Procedure]
   745 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "in the frame"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0080089:Frame [Nucleotide Sequence]
  1000   C0180979:Frame [Medical Device]
  1000   C1705858:Frame [Manufactured Object]

Phrase: "divided by the area of the frame."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0017446:Area [Geographic Area]
   748   C0080089:Frame [Nucleotide Sequence]
   748   C0180979:Frame [Medical Device]
   748   C0205146:Area [Spatial Concept]
   748   C0332849:Divided [Functional Concept]
   748   C1705858:Frame [Manufactured Object]
Processing 00000000.tx.71: In the transentorhinal region, we followed the pattern of lamination described by Braak and Braak 1992 . Formic Acid Treatment Formic acid destroys the secondary structure of proteins immediately without cleaving or removing the protein (Cammarata et al. 1990 ). 

Phrase: "In the transentorhinal region,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "we"

Phrase: "followed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332283:followed [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the pattern of lamination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0449774:Pattern [Spatial Concept]

Phrase: "described by Braak"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Braak 1992 . Formic Acid Treatment Formic acid"

Phrase: "destroys"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0681205:Destroy [Idea or Concept]

Phrase: "the secondary structure of proteins immediately"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   803   C0162807:Protein Structure, Secondary [Spatial Concept]
           Secondary Structure
   767   C0175168:protein structure [Amino Acid, Peptide, or Protein]
   767   C1510464:Protein Structure [Amino Acid, Peptide, or Protein]
   753   C0027627:secondary [Neoplastic Process]
   753   C0175668:Secondary [Temporal Concept]
   753   C0205436:Secondary [Quantitative Concept]
   753   C0678594:Structure [Spatial Concept]
   748 E C0582263:structural proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "without cleaving"

Phrase: "or"

Phrase: "removing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0849355:remove [Qualitative Concept]
   966   C1883720:Remove [Activity]
   966   C3244314:remove [Functional Concept]

Phrase: "the protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Cammarata et al. 1990"

Phrase: ")."
Processing 00000000.tx.72: Sections were treated with 99% formic acid for 2 min and washed thoroughly with PBS. 

Phrase: "Sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "treated with 99% formic acid"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   806   C0885348:formic acid [Organic Chemical]
   760   C0001128:Acid [Chemical]
   760   C0202406:Acid [Laboratory Procedure]
   760   C1522326:Treated [Functional Concept]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "for 2 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "thoroughly with PBS."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
Processing 00000000.tx.73: This step was performed either before or after thioflavin-S staining to test the effects of secondary structure on induction or maintenance, respectively, of thioflavin-S-associated staining. 

Phrase: "This step"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1261552:Step [Conceptual Entity]
  1000   C1704379:Step [Functional Concept]
  1000   C1705117:Step [Quantitative Concept]
  1000   C2825408:Step [Manufactured Object]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "either before"

Phrase: "or after thioflavin-S"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0950261:thioflavine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "staining"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "the effects of secondary structure"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205263:Induction [Functional Concept]
  1000   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "maintenance,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024501:Maintenance [Activity]

Phrase: "respectively,"

Phrase: "of thioflavin-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0950261:thioflavine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "S-"

Phrase: "associated staining."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]
Processing 00000000.tx.74: Statistics NFT densities are expressed as mean  SE. 

Phrase: "Statistics NFT densities"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0178587:densities [Quantitative Concept]
   743 E C0439794:Dense [Qualitative Concept]

Phrase: "are"

Phrase: "expressed as mean  SE."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0444504:Mean [Quantitative Concept]
   770   C2347634:Mean [Quantitative Concept]
   770   C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.75: ANOVA was used to test the significance of difference in NFT densities detected by the three methods. 

Phrase: "ANOVA"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "the significance of difference"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237881:Significance [Quantitative Concept]
   770   C0750502:Significance [Idea or Concept]

Phrase: "in NFT densities"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0178587:densities [Quantitative Concept]
   777 E C0439794:Dense [Qualitative Concept]

Phrase: "detected by the three methods."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0025663:Methods [Intellectual Product]
   760   C0025664:methods [Intellectual Product]
   760   C0205449:Three [Quantitative Concept]
   760   C0442726:Detected [Finding]
   760   C0449851:Methods [Functional Concept]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   726 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.76: Results Top Summary Introduction Materials and Methods Results Discussion Literature Cited Improvement of the Thioflavin-S Staining Method We report a substantial improvement of the thioflavin-S technique that eliminates background cellular autofluorescence, minimizes photobleaching effects, and reduces tissue damage associated with NaOH and acetic acid pretreatment in deparaffinized sections. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion Literature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0023866:Literature [Intellectual Product]
   812   C0034036:LITERATURE [Intellectual Product,Manufactured Object]

Phrase: "Cited"

Phrase: "Improvement of the Thioflavin-S"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2986411:Improvement [Conceptual Entity]

Phrase: "Staining"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "Method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "We"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "a substantial improvement of the thioflavin-S technique"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2986411:Improvement [Conceptual Entity]

Phrase: "that"

Phrase: "eliminates"

Phrase: "background cellular autofluorescence,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0544711:Autofluorescence [Finding]

Phrase: "minimizes"

Phrase: "photobleaching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1138417:Photobleaching [Natural Phenomenon or Process]

Phrase: "effects,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "reduces"

Phrase: "tissue damage"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0010957:Tissue damage [Injury or Poisoning]
           Damage
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]
   861   C1883709:Damage [Functional Concept]

Phrase: "associated with NaOH"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "acetic acid pretreatment in deparaffinized sections."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C1550147:Pretreatment [Substance]
   753   C2709094:pre treatment [Temporal Concept]
   753   C3539075:Pretreatment [Temporal Concept]
   753   C3539076:Pretreatment [Activity]
Processing 00000000.tx.77: In the conventional thioflavin-S method, as modified by Vallet et al. 

Phrase: "In the conventional thioflavin-S method,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025663:Method [Intellectual Product]
   812   C0449851:Method [Functional Concept]
   812   C0871511:METHOD [Intellectual Product]

Phrase: "as"

Phrase: "modified by Vallet et al."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0205349:Modified By [Qualitative Concept]
   760   C0392747:Modified [Functional Concept]
Processing 00000000.tx.78: 1992 , the quenching pretreatment step, consisting of a 20-min KMnO4 incubation followed by NaOH plus H2O2, and finally acetic acid, sometimes causes tissue damage and partial detachment, as demonstrated by local variations in the focal plane (Fig 1A, arrows and arrowheads). 

Phrase: "1992 ,"

Phrase: "the quenching pretreatment step,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1261552:Step [Conceptual Entity]
   827   C1704379:Step [Functional Concept]
   827   C1705117:Step [Quantitative Concept]
   827   C2825408:Step [Manufactured Object]

Phrase: "consisting of a 20-min KMnO4 incubation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0702093:/min [Temporal Concept]
   714   C0332529:CONSIST [Qualitative Concept]

Phrase: "followed by NaOH plus H2O2,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0332287:Plus [Qualitative Concept]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "and"

Phrase: "finally acetic acid,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0000983:Acetic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   901   C0000985:Acetic acid [Organic Chemical]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]
   827   C0981805:ACETIC [Organic Chemical,Pharmacologic Substance]
   771 E C0148405:Vinegar [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "sometimes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1998882:Sometimes [Temporal Concept]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "tissue damage"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0010957:Tissue damage [Injury or Poisoning]
           Damage
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]
   861   C1883709:Damage [Functional Concept]

Phrase: "and"

Phrase: "partial detachment,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0541879:detachment [Mental Process]
   861   C0595950:Detachment [Pathologic Function]
   789 E C0687118:Detached [Functional Concept]
   789 E C1561504:detached [Idea or Concept]

Phrase: "as"

Phrase: "demonstrated by local variations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205276:Local [Spatial Concept]
   770   C0205419:variations [Qualitative Concept]

Phrase: "in the focal plane"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0205234:Focal [Spatial Concept]
   861   C0444660:Plane [Spatial Concept]
   789 E C1883677:Focality [Qualitative Concept]

Phrase: "(Fig 1A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: "and"

Phrase: "arrowheads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1080898:Arrowheads [Plant]
   966 E C0453107:Arrowhead [Food]

Phrase: ")."
Processing 00000000.tx.79: In contrast, minimal tissue destruction is encountered in the newly modified procedure (Fig 1B), which involves a shortened 5-min KMnO4 oxidation followed by 1% NaBH4, as described in Materials and Methods. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "minimal tissue destruction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1261381:Destruction [Therapeutic or Preventive Procedure]
   827   C1948029:Destruction [Activity]

Phrase: "is"

Phrase: "encountered in the newly modified procedure"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   753   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   753   C0392747:Modified [Functional Concept]
   753   C0750546:newly [Idea or Concept]
   753   C1948041:Procedure [Therapeutic or Preventive Procedure]
   753   C2700391:Procedure [Activity]
   753   C3274430:PROCEDURE [Health Care Activity]
   753   C3538935:Procedure [Idea or Concept]
   753   C3539779:Procedure [Intellectual Product]
   719   C0545082:Encounter [Behavior]
   719   C1512346:encounter [Health Care Activity]
   719   C1947978:Encounter [Behavior]

Phrase: "(Fig 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "involves"

Phrase: "a shortened 5-min KMnO4 oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0030011:Oxidation [Molecular Function]

Phrase: "followed by 1% NaBH4,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0332283:Followed by [Temporal Concept]
           followed
   737 E C1719822:Follow [Intellectual Product]

Phrase: "as"

Phrase: "described in Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.80: In addition, tangles can be clearly delineated with very little background. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "tangles"

Phrase: "can"

Phrase: "be"

Phrase: "clearly"

Phrase: "delineated with very little background."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
   760   C0442824:Very [Qualitative Concept]
   760   C0700321:Little [Quantitative Concept]
   760   C1706907:Background [Conceptual Entity]
   760   C2700395:Little [Quantitative Concept]
Processing 00000000.tx.81: A second drawback of the former thioflavin-S staining method is rapid fading of fluorescence intensity, with extensive photobleaching encountered after 1 min of illumination in a fluorescent microscope (Fig 1C). 

Phrase: "A second drawback of the former thioflavin-S"

Phrase: "staining"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "is"

Phrase: "rapid fading of fluorescence intensity,"

Phrase: "with extensive photobleaching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1138417:Photobleaching [Natural Phenomenon or Process]

Phrase: "encountered after 1 min of illumination"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   783   C1301862:Min 1 [Temporal Concept]
   753   C0023693:Illumination [Natural Phenomenon or Process]
   753   C0023700:Illumination [Human-caused Phenomenon or Process]
   753   C0684292:illumination [Laboratory Procedure]
   753   C0702093:/min [Temporal Concept]
   753   C1964256:Illumination [Diagnostic Procedure]
   719   C0545082:Encounter [Behavior]
   719   C1512346:encounter [Health Care Activity]
   719   C1947978:Encounter [Behavior]

Phrase: "in a fluorescent microscope"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0181839:Microscope [Medical Device]
   861   C1706379:Microscope [Medical Device]

Phrase: "(Fig 1C"

Phrase: ")."
Processing 00000000.tx.82: Post-treatment with concentrated phosphate buffer at 4C substantially enhances photostability when tested under otherwise identical conditions (Fig 1D). 

Phrase: "Post-treatment with concentrated phosphate buffer"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C2709088:post treatment [Temporal Concept]
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C0687676:Post [Temporal Concept]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1704687:Post [Manufactured Object]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "at 4C substantially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "photostability"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272552:Photostability [Intellectual Product]

Phrase: "when"

Phrase: "tested under otherwise identical conditions"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   781   C0449910:Test conditions [Qualitative Concept]
   760   C0205280:Identical [Qualitative Concept]
   760   C0392366:tested [Intellectual Product]
   726   C0012634:condition [Disease or Syndrome]
   726 E C0022885:Test [Laboratory Procedure]
   726 E C0039593:Test [Functional Concept]
   726   C0348080:Condition [Qualitative Concept]
   726   C1705253:Condition [Conceptual Entity]

Phrase: "(Fig"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]

Phrase: "1D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416886:1D [Gene or Genome]
  1000   C1442449:1D [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.83: The post-treatment step also appears to reduce the yellow content of the green signal visible under FITC filters. 

Phrase: "The post-treatment"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C2709088:post treatment [Temporal Concept]
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C0687676:Post [Temporal Concept]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1704687:Post [Manufactured Object]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]
   789 E C1514253:Postal [Functional Concept]

Phrase: "step"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1261552:Step [Conceptual Entity]
  1000   C1704379:Step [Functional Concept]
  1000   C1705117:Step [Quantitative Concept]
  1000   C2825408:Step [Manufactured Object]

Phrase: "also"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reduce"

Phrase: "the yellow content of the green signal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0423896:Content [Mental Process]
   748   C0456205:Content [Conceptual Entity]

Phrase: "visible under FITC filters."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205379:Visible [Qualitative Concept]
Processing 00000000.tx.84: The use of a DAPI filter set, as recommended by previous protocols, results in a high blue background (Fig 1E) attributable to the intrinsic autofluorescence of tissue proteins. 

Phrase: "The use of a DAPI filter set,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C1524063:Use of [Functional Concept]
   748   C0042153:use [Functional Concept]
   748   C0457083:Use [Functional Concept]
   748   C1947944:Use [Intellectual Product]

Phrase: "as"

Phrase: "recommended by previous protocols,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0034866:Recommended [Idea or Concept]
   770   C0205156:Previous [Temporal Concept]
   770   C0442711:Protocols [Intellectual Product]
   770   C1552607:previous [Temporal Concept]
   737 E C1507394:Protocol [Intellectual Product]
   737 E C1522729:Protocol [Intellectual Product]
   737 E C2348563:Protocol [Intellectual Product]

Phrase: "results in a high blue background"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0205250:High [Qualitative Concept]
   753   C1260957:Blue [Qualitative Concept]
   753   C1274040:Result [Functional Concept]
   753   C1299351:High [Qualitative Concept]
   753   C1546471:Result [Idea or Concept]
   753   C1706907:Background [Conceptual Entity]
   753   C2700149:HIGH [Intellectual Product]
   753   C2825142:Result [Finding]

Phrase: "(Fig 1E"

Phrase: ")"

Phrase: "attributable to the intrinsic autofluorescence of tissue proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0596130:Attributable [Mental Process]
Processing 00000000.tx.85: This background is effectively eliminated when viewed under the FITC filter (Fig 1F), with no change in the type or number of pathological entities visible. 

Phrase: "This background"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706907:Background [Conceptual Entity]

Phrase: "is"

Phrase: "effectively"

Phrase: "eliminated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0849355:Eliminated [Qualitative Concept]

Phrase: "when"

Phrase: "viewed under the FITC filter"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0085216:FITC [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0180860:Filter [Manufactured Object]
   760   C0581406:Filter [Medical Device]
   760   C1522664:Filter [Intellectual Product]
   760   C1704449:Filter [Conceptual Entity]
   760   C1704684:Filter [Medical Device]
   760   C1875155:FILTER [Medical Device]
   726   C0449911:View [Spatial Concept]

Phrase: "(Fig 1F"

Phrase: ")"

Phrase: ","

Phrase: "with no change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "in the type"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332307:Type [Qualitative Concept]
  1000   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "number of pathological entities"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   881   C0487262:Number of entities [Quantitative Concept]
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "visible."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205379:Visible [Qualitative Concept]
Processing 00000000.tx.86: An optimization of thioflavin-S concentration has determined that 0.050.1% thioflavin-S produces an acceptable compromise between signal strength and specificity. 

Phrase: "An optimization of thioflavin-S concentration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2698650:Optimization [Activity]

Phrase: "has"

Phrase: "determined"

Phrase: "that 0.050.1% thioflavin-S"

Phrase: "produces"

Phrase: "an acceptable compromise between signal strength"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2945640:compromise [Finding]

Phrase: "and"

Phrase: "specificity."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0037791:Specificity [Quantitative Concept]
  1000   C1511884:Specificity [Quantitative Concept]
   928 E C0205369:Specific [Qualitative Concept]
   928 E C1552740:specific [Intellectual Product]
Processing 00000000.tx.87: The use of 1% thioflavin-S yields strong signal intensity but causes strong nonspecific staining of blood vessels (Fig 1G), whereas 0.01% thioflavin-S stains NFTs with very little nonspecificity but only minimally stains plaques. 

Phrase: "The use of 1% thioflavin-S"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1524063:Use of [Functional Concept]
   753   C0042153:use [Functional Concept]
   753   C0457083:Use [Functional Concept]
   753   C1947944:Use [Intellectual Product]

Phrase: "yields"

Phrase: "strong signal intensity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0871362:signal intensity [Quantitative Concept]
   827   C0522510:Intensity [Qualitative Concept]
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "but"

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "strong nonspecific staining of blood vessels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0005835:blood staining [Body Substance]
   753   C0487602:Staining [Laboratory Procedure]
   753   C1704680:Staining [Finding]

Phrase: "(Fig 1G"

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "0.01% thioflavin-S"

Phrase: "stains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "NFTs with very little nonspecificity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   756 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "but"

Phrase: "only minimally"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205171:Only [Quantitative Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "stains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "plaques."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]
Processing 00000000.tx.88: In the latter case, post-treatment is required to prevent photobleaching. 

Phrase: "In the latter case,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0868928:Case [Functional Concept]
   861   C1706255:CASE [Medical Device]
   861   C1706256:Case [Conceptual Entity]

Phrase: "post-treatment"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C2709088:post treatment [Temporal Concept]
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C0687676:Post [Temporal Concept]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1704687:Post [Manufactured Object]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]
   789 E C1514253:Postal [Functional Concept]

Phrase: "is"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "photobleaching."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1138417:Photobleaching [Natural Phenomenon or Process]
Processing 00000000.tx.89: View larger version (33K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(33K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.90: Comparison of the classical thioflavin-S method (left column) and the improved method (right column) on tissue damage (A,B), photobleaching (C,D), autofluorescence background (E,F), and specificity (G,H). 

Phrase: "Comparison of the classical thioflavin-S method"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1707455:Comparison [Activity]

Phrase: "(left column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185738:Column [Body Part, Organ, or Organ Component]
   861   C1706132:Column [Idea or Concept]

Phrase: ")"

Phrase: "and"

Phrase: "the improved method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025663:Method [Intellectual Product]
   861   C0449851:Method [Functional Concept]
   861   C0871511:METHOD [Intellectual Product]

Phrase: "(right column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185738:Column [Body Part, Organ, or Organ Component]
   861   C1706132:Column [Idea or Concept]

Phrase: ")"

Phrase: "on tissue damage"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0010957:Tissue damage [Injury or Poisoning]
           Damage
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]
   861   C1883709:Damage [Functional Concept]

Phrase: "(A,B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1440044:A,B [Immunologic Factor]

Phrase: ")"

Phrase: ","

Phrase: "photobleaching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1138417:Photobleaching [Natural Phenomenon or Process]

Phrase: "(C,D),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0012358:c d [Therapeutic or Preventive Procedure]
   861   C1553033:[c] [Quantitative Concept]

Phrase: "autofluorescence background"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1706907:Background [Conceptual Entity]

Phrase: "(E,F),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "specificity"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0037791:Specificity [Quantitative Concept]
  1000   C1511884:Specificity [Quantitative Concept]
   928 E C0205369:Specific [Qualitative Concept]
   928 E C1552740:specific [Intellectual Product]

Phrase: "(G,H"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0560020:g h [Quantitative Concept]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.91: Tissue damage during pretreatment in the classical method resulted in local variations in the focal plane (A, arrows and arrowheads). 

Phrase: "Tissue damage during pretreatment"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0010957:Tissue damage [Injury or Poisoning]
           Damage
   770   C0040300:Tissue [Tissue]
   770   C1547928:Tissue [Intellectual Product]
   770   C1883709:Damage [Functional Concept]

Phrase: "in the classical method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025663:Method [Intellectual Product]
   861   C0449851:Method [Functional Concept]
   861   C0871511:METHOD [Intellectual Product]

Phrase: "resulted in local variations"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205276:Local [Spatial Concept]
   770   C0205419:variations [Qualitative Concept]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "in the focal plane"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0205234:Focal [Spatial Concept]
   861   C0444660:Plane [Spatial Concept]
   789 E C1883677:Focality [Qualitative Concept]

Phrase: "(A,"

Phrase: "arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: "and"

Phrase: "arrowheads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1080898:Arrowheads [Plant]
   966 E C0453107:Arrowhead [Food]

Phrase: ")."
Processing 00000000.tx.92: Photobleaching encountered with the former thioflavin-S staining method after illumination for 1 min (C) can be prevented by post-treatment with concentrated phosphate buffer (D). 

Phrase: "Photobleaching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1138417:Photobleaching [Natural Phenomenon or Process]

Phrase: "encountered with the former thioflavin-S"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0205156:Former [Temporal Concept]
   753   C0750523:FORMER [Idea or Concept]
   753   C0950261:thioflavine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   719   C0545082:Encounter [Behavior]
   719   C1512346:encounter [Health Care Activity]
   719   C1947978:Encounter [Behavior]

Phrase: "staining"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "method after illumination"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0025663:Method [Intellectual Product]
   790   C0449851:Method [Functional Concept]
   790   C0871511:METHOD [Intellectual Product]

Phrase: "for 1 min ("
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "can"

Phrase: "be"

Phrase: "prevented by post-treatment"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C2709088:post treatment [Temporal Concept]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C0687676:Post [Temporal Concept]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1704687:Post [Manufactured Object]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]
   737   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "with concentrated phosphate buffer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "("

Phrase: "D)."
Processing 00000000.tx.93: Higher blue background was seen under the DAPI filter (E) but not under the FITC filter used in the present study (F). 

Phrase: "Higher blue background"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1706907:Background [Conceptual Entity]

Phrase: "was"

Phrase: "seen under the DAPI filter"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   760   C0057142:DAPI [Organic Chemical,Pharmacologic Substance]
   760   C0180860:Filter [Manufactured Object]
   760   C0205397:Seen [Qualitative Concept]
   760   C0581406:Filter [Medical Device]
   760   C1522664:Filter [Intellectual Product]
   760   C1704449:Filter [Conceptual Entity]
   760   C1704684:Filter [Medical Device]
   760   C1875155:FILTER [Medical Device]
   726 E C0042789:see [Organism Function]
   726 E C1947903:See [Activity]

Phrase: "(E)"

Phrase: "but"

Phrase: "not under the FITC filter"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0085216:FITC [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0180860:Filter [Manufactured Object]
   760   C0581406:Filter [Medical Device]
   760   C1518422:Not [Functional Concept]
   760   C1522664:Filter [Intellectual Product]
   760   C1704449:Filter [Conceptual Entity]
   760   C1704684:Filter [Medical Device]
   760   C1875155:FILTER [Medical Device]

Phrase: "used in the present study"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   781   C0869040:study use [Research Activity]
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0557651:Study [Manufactured Object]
   760   C1273517:used [Finding]
   760   C2603343:Study [Research Activity]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "(F)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.94: Thioflavin-S 1% also strongly stained blood vessels (G), whereas 0.01% thioflavin-S stained NFTs but minimally stained plaques. 

Phrase: "Thioflavin-S 1% also strongly stained blood vessels"
Meta Candidates (Total=13; Excluded=11; Pruned=0; Remaining=2)
   812   C0005847:Blood Vessels [Body Part, Organ, or Organ Component]
           Vessels
   779 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   779 E C1511228:VESSEL, BLOOD [Tissue]
       E   Vessel
   741 E C1558950:VASCULAR [Finding]
   741 E C1801960:Vascular [Qualitative Concept]
   721 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]
   719 E C0005767:Blood [Tissue]
   719 E C0005768:blood [Body Substance]
   719 E C0229664:Blood [Body Substance]
   719 E C0392895:Bloods [Population Group]
   701 E C0333275:Bloody [Qualitative Concept]

Phrase: "(G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "0.01% thioflavin-S"

Phrase: "stained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2986582:Stained [Qualitative Concept]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "but"

Phrase: "minimally stained plaques."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0333463:plaques [Acquired Abnormality]
   793 E C0011389:Plaque [Disease or Syndrome]
   793 E C0332461:Plaque [Finding]
Processing 00000000.tx.95: All panel pairs except F and G represent stains on the same sections. 

Phrase: "All panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "pairs except F"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   790   C0439133:(f) [Intellectual Product]
   790   C1553038:[f] [Quantitative Concept]
   790   C1709450:Pair [Qualitative Concept]

Phrase: "and"

Phrase: "G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "stains on the same sections."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0038128:Stains [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.96: No post-treatment step was performed for B and F so as to restrict comparisons to the specific component of the procedure examined. 

Phrase: "No post-treatment step"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C1704379:Treatment Step [Functional Concept]
           Step
   827   C1261552:Step [Conceptual Entity]
   827   C1705117:Step [Quantitative Concept]
   827   C2825408:Step [Manufactured Object]
   734   C2709088:post treatment [Temporal Concept]

Phrase: "was"

Phrase: "performed for B"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and"

Phrase: "F so as to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   770   C0439133:(f) [Intellectual Product]
   770   C1553038:[f] [Quantitative Concept]

Phrase: "restrict"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443288:restrict [Functional Concept]

Phrase: "comparisons to the specific component of the procedure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C1707455:Comparison [Activity]

Phrase: "examined."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]
Processing 00000000.tx.97: Bars = 100 m. 

Phrase: "Bars"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1707156:BARS [Gene or Genome]
  1000   C3274014:BARS [Intellectual Product]
  1000   C3541345:BARS [Intellectual Product]
   966 E C0687760:bar [Manufactured Object]
   966 E C1551065:bar [Quantitative Concept]

Phrase: "= 100 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.98: Comparison of Immunostaining, Thioflavin-S Staining, and Gallyas Silver Staining on the Same Sections In this study we compared NFT immunostaining, thioflavin-S staining, and Gallyas silver staining in paraffin-embedded sections of various regions of the AD brain. 

Phrase: "Comparison of Immunostaining,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Comparison [Activity]

Phrase: "Thioflavin-S Staining,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]

Phrase: "and"

Phrase: "Gallyas Silver Staining on the Same Sections"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   778   C1293950:Silver Staining [Laboratory Procedure]
   762 E C1318876:Silver stain [Indicator, Reagent, or Diagnostic Aid]
           Silver
   748   C0037125:Silver [Element, Ion, or Isotope]
   748   C0487602:Staining [Laboratory Procedure]
   748   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   748   C1305285:Silver [Qualitative Concept]
   748   C1704680:Staining [Finding]
   714 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "In this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "NFT immunostaining,"

Phrase: "thioflavin-S staining,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]

Phrase: "and"

Phrase: "Gallyas silver staining in paraffin-embedded sections of various regions"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   760   C1293950:Silver Staining [Laboratory Procedure]
   743 E C1318876:Silver stain [Indicator, Reagent, or Diagnostic Aid]
           Silver
   739   C0037125:Silver [Element, Ion, or Isotope]
   739   C0487602:Staining [Laboratory Procedure]
   739   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   739   C1305285:Silver [Qualitative Concept]
   739   C1704680:Staining [Finding]
   706 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "of the AD brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.99: Comparisons were made on the same sections to avoid possible misinterpretations caused by differences among sections and to permit detection of more subtle differences in specificity or sensitivity. 

Phrase: "Comparisons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707455:Comparison [Activity]

Phrase: "were"

Phrase: "made on the same sections to"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0445247:Same [Qualitative Concept]
   719   C0205155:Section [Spatial Concept]
   719   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   719   C1522472:Section [Substance]
   719   C1552923:Section [Quantitative Concept]
   719   C1705191:Section [Physical Object]
   719   C1881534:Make [Functional Concept]

Phrase: "avoid"

Phrase: "possible misinterpretations"

Phrase: "caused by differences"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   756   C0015127:cause [Functional Concept]
   756   C1524003:Cause [Conceptual Entity]
   756   C1705241:*Difference [Quantitative Concept]
   756   C1705242:Difference [Qualitative Concept]
   706 E C0443199:Differential [Qualitative Concept]

Phrase: "among sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "permit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0023636:Permit [Regulation or Law]
  1000   C0329040:Permit [Fish]

Phrase: "detection of more subtle differences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "in specificity"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0037791:Specificity [Quantitative Concept]
  1000   C1511884:Specificity [Quantitative Concept]
   928 E C0205369:Specific [Qualitative Concept]
   928 E C1552740:specific [Intellectual Product]

Phrase: "or"

Phrase: "sensitivity."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0036667:Sensitivity [Quantitative Concept]
  1000   C0312418:Sensitivity [Mental Process]
  1000   C0427965:Sensitivity [Finding]
  1000   C1511883:Sensitivity [Quantitative Concept]
  1000   C1522640:Sensitivity [Qualitative Concept]
  1000   C2346484:SENSITIVITY [Phenomenon or Process]
  1000   C2349185:Sensitivity [Qualitative Concept]
   928 E C0332324:Sensitive [Functional Concept]
   928 E C1550474:sensitive [Idea or Concept]
Processing 00000000.tx.100: Sequential application of anti-NFT immunohistochemistry, our improved thioflavin-S staining, and the Gallyas silver staining revealed co-detection of some tangles in hippocampal CA1 (Fig 2A12A4, arrows) and subiculum/presubiculum (Fig 2B12B4, arrows). 

Phrase: "Sequential application of anti-NFT immunohistochemistry,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0185125:Application [Health Care Activity]
   753   C1947919:Application [Intellectual Product]
   753   C2347934:Application [Intellectual Product]
   753   C3539080:APPLICATION [Quantitative Concept]

Phrase: "our improved thioflavin-S staining,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0487602:Staining [Laboratory Procedure]
   812   C1704680:Staining [Finding]

Phrase: "and"

Phrase: "the Gallyas silver staining revealed co-detection of some tangles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "in hippocampal CA1"

Phrase: "(Fig 2A12A4,"

Phrase: "arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: ")"

Phrase: "and"

Phrase: "subiculum/presubiculum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0175194:Presubiculum [Body Location or Region]

Phrase: "(Fig 2B12B4,"

Phrase: "arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.101: However, the polyclonal anti-NFT antibody rarely detected NFTs in the pri- layer of transentorhinal cortex (Fig 2C12C4), where most NFTs appear early in AD (Braak and Braak 1991 ), despite the application of antigen retrieval in all cases. 

Phrase: "However,"

Phrase: "the polyclonal anti-NFT antibody rarely"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   853   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "NFTs in the pri- layer of transentorhinal cortex"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   764   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   731 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "(Fig 2C12C4"

Phrase: ")"

Phrase: ","

Phrase: "where most NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   827 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "early in AD (Braak"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1279919:Early [Temporal Concept]

Phrase: "and"

Phrase: "Braak 1991"

Phrase: ")"

Phrase: ","

Phrase: "despite the application"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0185125:Application [Health Care Activity]
  1000   C1947919:Application [Intellectual Product]
  1000   C2347934:Application [Intellectual Product]
  1000   C3539080:APPLICATION [Quantitative Concept]

Phrase: "of antigen retrieval"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0003320:Antigen [Immunologic Factor]
   861   C1514918:Retrieval [Health Care Activity]
   761 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "in all cases."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]
Processing 00000000.tx.102: On the contrary, this NFT antibody appears to stain plaques only slightly. 

Phrase: "On the contrary,"

Phrase: "this NFT antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "stain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "plaques only slightly."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0205171:Only [Quantitative Concept]
   827   C0333463:plaques [Acquired Abnormality]
   827   C0750482:Slightly [Idea or Concept]
   827   C1720467:Only [Intellectual Product]
   793 E C0011389:Plaque [Disease or Syndrome]
   793 E C0332461:Plaque [Finding]
Processing 00000000.tx.103: The lower sensitivity of the anti-NFT immunohistochemical method is demonstrated by a large number of NFTs that were detected by thioflavin-S or Gallyas silver staining but not by NFT immunostaining (Fig 2, arrowheads). 

Phrase: "The lower sensitivity of the anti-NFT immunohistochemical method"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   742   C0036667:Sensitivity [Quantitative Concept]
   742   C0312418:Sensitivity [Mental Process]
   742   C0427965:Sensitivity [Finding]
   742   C1511883:Sensitivity [Quantitative Concept]
   742   C1522640:Sensitivity [Qualitative Concept]
   742   C2346484:SENSITIVITY [Phenomenon or Process]
   742   C2349185:Sensitivity [Qualitative Concept]

Phrase: "is"

Phrase: "demonstrated by a large number of NFTs"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   744   C0237753:*Number [Quantitative Concept]
   744   C0449788:Number [Quantitative Concept]
   744   C0549177:Large [Quantitative Concept]
   737 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "that"

Phrase: "were"

Phrase: "detected by thioflavin-S"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0442726:Detected [Finding]
   770   C0950261:thioflavine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "Gallyas silver staining"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   901   C1293950:Silver Staining [Laboratory Procedure]
   884 E C1318876:Silver stain [Indicator, Reagent, or Diagnostic Aid]
           Silver
   827   C0037125:Silver [Element, Ion, or Isotope]
   827   C0487602:Staining [Laboratory Procedure]
   827   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   827   C1305285:Silver [Qualitative Concept]
   827   C1704680:Staining [Finding]
   793 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   743 E C0079853:Moon [Geographic Area]
   734 E C0003782:Argyria [Injury or Poisoning]
   734 E C3463959:Argyria [Eukaryote]

Phrase: "but"

Phrase: "not by NFT immunostaining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0085400:NFT [Acquired Abnormality]
   770   C1518422:Not [Functional Concept]

Phrase: "(Fig 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "arrowheads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1080898:Arrowheads [Plant]
   966 E C0453107:Arrowhead [Food]

Phrase: ")."
Processing 00000000.tx.104: View larger version (69K): [in this window] [in a new window]  Figure 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(69K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.105: Comparison of representative NFT immunostaining, thioflavin-S staining, and Gallyas silver staining on the same sections from AD hippocampal formation. 

Phrase: "Comparison of representative NFT immunostaining,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707455:Comparison [Activity]

Phrase: "thioflavin-S staining,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]

Phrase: "and"

Phrase: "Gallyas silver staining on the same sections"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   778   C1293950:Silver Staining [Laboratory Procedure]
   762 E C1318876:Silver stain [Indicator, Reagent, or Diagnostic Aid]
           Silver
   748   C0037125:Silver [Element, Ion, or Isotope]
   748   C0487602:Staining [Laboratory Procedure]
   748   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   748   C1305285:Silver [Qualitative Concept]
   748   C1704680:Staining [Finding]
   714 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "from AD hippocampal formation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0175202:Hippocampal Formation [Body Part, Organ, or Organ Component]
   827   C0019564:Hippocampal [Body Part, Organ, or Organ Component]
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]
Processing 00000000.tx.106: NFT immunofluorescent staining (A1,B1,C1), thioflavin-S staining (A2,B2,C2), and Gallyas silver staining (A4,B4,C4) were sequentially applied to the same sections, and the same fields at CA1 (A1A4), subiculum/presubiculum (B1B4), and the pri- layer of the transentorhinal cortex (C1C4) were compared. 

Phrase: "NFT immunofluorescent staining"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   884   C0183489:Immunofluorescent stain [Indicator, Reagent, or Diagnostic Aid]
           Immunofluorescent
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]
   793 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   755 E C0016318:Immunofluorescence [Laboratory Procedure]
   755 E C0079603:Immunofluorescence [Laboratory Procedure]
   734 E C0282648:Direct immunofluorescence [Laboratory Procedure]

Phrase: "(A1,"

Phrase: "B1,"

Phrase: "C1"

Phrase: ")"

Phrase: ","

Phrase: "thioflavin-S staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]

Phrase: "(A2,B2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0507114:B2 [Body Part, Organ, or Organ Component]
   861   C1416271:B2 [Gene or Genome]

Phrase: "C2"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "Gallyas silver staining"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   901   C1293950:Silver Staining [Laboratory Procedure]
   884 E C1318876:Silver stain [Indicator, Reagent, or Diagnostic Aid]
           Silver
   827   C0037125:Silver [Element, Ion, or Isotope]
   827   C0487602:Staining [Laboratory Procedure]
   827   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   827   C1305285:Silver [Qualitative Concept]
   827   C1704680:Staining [Finding]
   793 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   743 E C0079853:Moon [Geographic Area]
   734 E C0003782:Argyria [Injury or Poisoning]
   734 E C3463959:Argyria [Eukaryote]

Phrase: "(A4,"

Phrase: "B4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0108748:B4 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1705085:B4 [Gene or Genome]

Phrase: "C4)"

Phrase: "were"

Phrase: "sequentially"

Phrase: "applied to the same sections,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   760   C0185125:Applied [Health Care Activity]
   760   C0445247:Same [Qualitative Concept]
   726   C0205155:Section [Spatial Concept]
   726   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   726   C1522472:Section [Substance]
   726   C1552923:Section [Quantitative Concept]
   726 E C1632850:Apply [Functional Concept]
   726   C1705191:Section [Physical Object]
   726 E C1879355:Apply [Functional Concept]

Phrase: "and"

Phrase: "the same fields at CA1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   781   C0694598:CA1 field [Body Location or Region]
   726   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   726   C1521738:Field [Conceptual Entity]
   726   C2346620:Field [Conceptual Entity]
   726   C2349184:Field [Conceptual Entity]
   726   C3539073:FIELD [Spatial Concept]

Phrase: "(A1A4"

Phrase: ")"

Phrase: ","

Phrase: "subiculum/presubiculum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0175194:Presubiculum [Body Location or Region]

Phrase: "(B1B4"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the pri- layer of the transentorhinal cortex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0934502:Layer [Body Part, Organ, or Organ Component]
   748   C1522408:Layer [Qualitative Concept]
   748   C1561599:Layer [Intellectual Product]

Phrase: "(C1C4"

Phrase: ")"

Phrase: "were"

Phrase: "compared."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]
Processing 00000000.tx.107: NFTs co-detected by anti-NFT immunostaining and thioflavin-S staining exhibited a yellow color in the superimposed images (A3,B3,C3). 

Phrase: "NFTs co-"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   734   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   701 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "detected by anti-NFT immunostaining"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0085400:NFT [Acquired Abnormality]
   760   C0442726:Detected [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "thioflavin-S staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "a yellow color in the superimposed images"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0221205:Yellow color [Qualitative Concept]
   778   C0863146:Yellow color [Qualitative Concept]
   748   C0009393:Color [Natural Phenomenon or Process]
   748   C1550604:color [Indicator, Reagent, or Diagnostic Aid]
   748   C1705245:Color [Pharmacologic Substance]

Phrase: "(A3,"

Phrase: "B3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349968:B3+ [Element, Ion, or Isotope]

Phrase: "C3"

Phrase: ")."
Processing 00000000.tx.108: A large number of NFTs were detected only by thioflavin-S staining and Gallyas silver staining, but not by anti-NFT immunostaining. 

Phrase: "A large number of NFTs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "were"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "only by thioflavin-S staining"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205171:Only [Quantitative Concept]
   760   C0487602:Staining [Laboratory Procedure]
   760   C0950261:thioflavine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C1704680:Staining [Finding]
   760   C1720467:Only [Intellectual Product]

Phrase: "and"

Phrase: "Gallyas silver staining,"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   901   C1293950:Silver Staining [Laboratory Procedure]
   884 E C1318876:Silver stain [Indicator, Reagent, or Diagnostic Aid]
           Silver
   827   C0037125:Silver [Element, Ion, or Isotope]
   827   C0487602:Staining [Laboratory Procedure]
   827   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   827   C1305285:Silver [Qualitative Concept]
   827   C1704680:Staining [Finding]
   793 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   743 E C0079853:Moon [Geographic Area]
   734 E C0003782:Argyria [Injury or Poisoning]
   734 E C3463959:Argyria [Eukaryote]

Phrase: "but"

Phrase: "not by anti-NFT immunostaining."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0085400:NFT [Acquired Abnormality]
   760   C1518422:Not [Functional Concept]
Processing 00000000.tx.109: Arrows indicate examples of NFTs detected by all three methods. 

Phrase: "Arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: "indicate"

Phrase: "examples of NFTs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1707959:Example [Conceptual Entity]

Phrase: "detected by all three methods."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0025663:Methods [Intellectual Product]
   760   C0025664:methods [Intellectual Product]
   760   C0205449:Three [Quantitative Concept]
   760   C0442726:Detected [Finding]
   760   C0449851:Methods [Functional Concept]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   726 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.110: Bar = 100 m. 

Phrase: "Bar = 100 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.111: The monoclonal PHF-1 antibody, which recognizes tau protein phosphorylated at serine residues 396 and 404, detected NFTs in both the hippocampus and transentorhinal cortex (Fig 3). 

Phrase: "The monoclonal PHF-1 antibody,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "which"

Phrase: "recognizes"

Phrase: "tau protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0085401:tau Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2700455:Tau Protein [Amino Acid, Peptide, or Protein]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "phosphorylated at serine residues 396"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   726   C1709915:Residue [Conceptual Entity]
   726   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "and"

Phrase: "404,"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "NFTs in both"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   799 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "the hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "transentorhinal cortex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "(Fig 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.112: However, greater variations in PHF-1 immunoreactivity were observed among AD individuals. 

Phrase: "However,"

Phrase: "greater variations in PHF-1 immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205419:variations [Qualitative Concept]

Phrase: "were"

Phrase: "observed among AD individuals."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1441672:Observed [Functional Concept]
   737   C0027361:Individual [Population Group]
   737   C0237401:Individual [Human]
Processing 00000000.tx.113: Some AD cases showed very few PHF-1-positive NFTs but had a considerable number of NFTs detectable by thioflavin-S. 

Phrase: "Some AD cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "very few PHF-1-positive NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   818   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   785 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "but"

Phrase: "had"

Phrase: "a considerable number of NFTs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "detectable by thioflavin-S."
Processing 00000000.tx.114: This variation was also reflected in the quantitative comparisons as larger standard errors for PHF-1 staining compared with those for staining with polyclonal NFT antibody (see Table 1). 

Phrase: "This variation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205419:Variation [Qualitative Concept]

Phrase: "was"

Phrase: "also"

Phrase: "reflected in the quantitative comparisons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0392762:Quantitative [Quantitative Concept]
   760   C0558058:reflected [Mental Process]
   726   C1707455:Comparison [Activity]

Phrase: "as"

Phrase: "larger standard errors for PHF-1 staining"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   748   C0743559:errors [Qualitative Concept]
   748   C1442989:Standard [Qualitative Concept]
   748   C2828392:Standard [Intellectual Product]
   745   C1710181:Standard Error [Quantitative Concept]
   714 E C1608199:Error [Functional Concept]

Phrase: "compared with those for staining"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0487602:Staining [Laboratory Procedure]
   760   C1704680:Staining [Finding]
   760   C1707455:Compared [Activity]

Phrase: "with polyclonal NFT antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.115: Even in cases where abundant NFTs were stained with PHF-1 antibody (Fig 3), PHF-1 immunostaining still detected fewer NFTs than thioflavin-S. 

Phrase: "Even in cases where abundant NFTs"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   778   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   748   C0868928:Cases [Functional Concept]
   748   C1533148:Cases [Quantitative Concept]
   748   C2346714:Abundant [Qualitative Concept]
   745 E C3543859:neurofibrillary tangle [Cell Component]
   714 E C1706255:CASE [Medical Device]
   714 E C1706256:Case [Conceptual Entity]

Phrase: "were"

Phrase: "stained with PHF-1 antibody"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0597162:PHF [Cell or Molecular Dysfunction]
   760   C2986582:Stained [Qualitative Concept]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Fig 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "PHF-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597162:PHF [Cell or Molecular Dysfunction]

Phrase: "immunostaining"

Phrase: "still"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "fewer NFTs than thioflavin-S."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   756 E C3543859:neurofibrillary tangle [Cell Component]
Processing 00000000.tx.116: View larger version (30K): [in this window] [in a new window]  Figure 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(30K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413114:30K [Gene or Genome]

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 3."
Processing 00000000.tx.117: Comparison of PHF-1 immunostaining (red) and thioflavin-S staining (green) on the same sections of AD brains at CA1 (A1A3), subiculum/presubiculum (B1B3), and the pri- layer of the transentorhinal cortex (C1C3). 

Phrase: "Comparison of PHF-1 immunostaining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707455:Comparison [Activity]

Phrase: "(red)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332575:Red [Finding]
  1000   C1260956:Red [Qualitative Concept]

Phrase: "and"

Phrase: "thioflavin-S staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]

Phrase: "(green"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: ")"

Phrase: "on the same sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "of AD brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0006104:Brains [Body Part, Organ, or Organ Component]
   827 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "at CA1"

Phrase: "(A1A3"

Phrase: ")"

Phrase: ","

Phrase: "subiculum/presubiculum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0175194:Presubiculum [Body Location or Region]

Phrase: "(B1B3"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the pri- layer of the transentorhinal cortex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0934502:Layer [Body Part, Organ, or Organ Component]
   748   C1522408:Layer [Qualitative Concept]
   748   C1561599:Layer [Intellectual Product]

Phrase: "(C1C3"

Phrase: ")."
Processing 00000000.tx.118: Superimposed images (A3,B3,C3) were used to facilitate comparison. 

Phrase: "Superimposed images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1704254:Image [Intellectual Product]
   827   C1704922:Image [Entity]
   827   C3542466:Image [Intellectual Product]

Phrase: "(A3,"

Phrase: "B3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349968:B3+ [Element, Ion, or Isotope]

Phrase: "C3"

Phrase: ")"

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "facilitate"

Phrase: "comparison."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Comparison [Activity]
Processing 00000000.tx.119: Bar = 100 m.  

Phrase: "Bar = 100 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.120: View this table: [in this window] [in a new window]  Table 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.121: Numerical density of NFTs (mean  SE) in the AD hippocampus and transentorhinal cortex as detected by immunostaining, an improved thioflavin-S staining, and Gallyas silver staining methods on the same sectionsa,b Staining with Gallyas silver and thioflavin-S on the same fields revealed that these two methods detected the same NFTs (Fig 2C2D). 

Phrase: "Numerical density of NFTs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0178587:density [Quantitative Concept]

Phrase: "(mean"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444504:Mean [Quantitative Concept]
  1000   C2347634:Mean [Quantitative Concept]
  1000   C2348143:Mean [Quantitative Concept]

Phrase: "SE) in the AD hippocampus"

Phrase: "and"

Phrase: "transentorhinal cortex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "as"

Phrase: "detected by immunostaining,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "an improved thioflavin-S staining,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0487602:Staining [Laboratory Procedure]
   812   C1704680:Staining [Finding]

Phrase: "and"

Phrase: "Gallyas silver staining methods on the same sectionsa,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   789   C1293950:Silver Staining Method [Laboratory Procedure]
   767   C0487602:methods staining [Laboratory Procedure]
   744   C0025663:Methods [Intellectual Product]
   744   C0025664:methods [Intellectual Product]
   744   C0449851:Methods [Functional Concept]
   711 E C0871511:METHOD [Intellectual Product]

Phrase: "b Staining with Gallyas silver"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1293950:Silver Staining [Laboratory Procedure]
   760   C0487602:Staining [Laboratory Procedure]
   760   C1704680:Staining [Finding]

Phrase: "and"

Phrase: "thioflavin-S on the same fields"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "these two methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "the same NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   901   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   867 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "(Fig 2C2D"

Phrase: ")."
Processing 00000000.tx.122: Some NFTs displayed only very faint staining in 2/14 sections examined (Fig 4B, arrowhead) and in their adjacent sections stained with Gallyas silver alone (data not shown). 

Phrase: "Some NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "only very"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C0442824:Very [Qualitative Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "faint"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039070:Faint [Sign or Symptom]

Phrase: "staining in 2/14 sections"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0487602:Staining [Laboratory Procedure]
   760   C1704680:Staining [Finding]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   726   C0205155:Section [Spatial Concept]
   726   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   726   C1522472:Section [Substance]
   726   C1552923:Section [Quantitative Concept]
   726   C1705191:Section [Physical Object]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "(Fig 4B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: "arrowhead"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0453107:Arrowhead [Food]
  1000   C1080898:Arrowhead [Plant]

Phrase: ")"

Phrase: "and in their adjacent sections"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0205117:Adjacent [Spatial Concept]
   760   C1515981:And [Idea or Concept]
   726   C0205155:Section [Spatial Concept]
   726   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   726   C1522472:Section [Substance]
   726   C1552923:Section [Quantitative Concept]
   726   C1705191:Section [Physical Object]

Phrase: "stained with Gallyas silver alone"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   781   C1318876:Silver stain [Indicator, Reagent, or Diagnostic Aid]
           Silver
   760   C0037125:Silver [Element, Ion, or Isotope]
   760   C0205171:Alone [Quantitative Concept]
   760   C0439044:alone [Finding]
   760   C0679994:alone [Group Attribute]
   760   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   760   C1305285:Silver [Qualitative Concept]
   760   C2986582:Stained [Qualitative Concept]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.123: Gallyas silver staining appeared to detect more neuropil threads (Fig 4A and Fig 4B) but only weakly stained amyloid plaques. 

Phrase: "Gallyas silver staining"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   901   C1293950:Silver Staining [Laboratory Procedure]
   884 E C1318876:Silver stain [Indicator, Reagent, or Diagnostic Aid]
           Silver
   827   C0037125:Silver [Element, Ion, or Isotope]
   827   C0487602:Staining [Laboratory Procedure]
   827   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   827   C1305285:Silver [Qualitative Concept]
   827   C1704680:Staining [Finding]
   793 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   743 E C0079853:Moon [Geographic Area]
   734 E C0003782:Argyria [Injury or Poisoning]
   734 E C3463959:Argyria [Eukaryote]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "more neuropil threads"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0521175:Neuropil Threads [Acquired Abnormality]
   793   C1710394:Thread [Manufactured Object]
   793   C1882475:Thread [Intellectual Product]

Phrase: "(Fig 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: "and"

Phrase: "Fig 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")"

Phrase: "but"

Phrase: "only weakly stained amyloid plaques."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   840   C0333463:amyloid plaques [Acquired Abnormality]
           plaques
   840   C2936349:Plaques, Amyloid [Acquired Abnormality]
   771 E C0011389:Plaque [Disease or Syndrome]
   771 E C0332461:Plaque [Finding]
Processing 00000000.tx.124: In addition, our preliminary results using a recently developed intrinsic fluorescence induction method (Sun et al. 2001 ) showed that thioflavin-S and Gallyas silver staining methods failed to detect a subpopulation of plaque neurites (data not shown). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "our preliminary results"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1548161:Preliminary results [Idea or Concept]
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "developed"

Phrase: "intrinsic fluorescence induction method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025663:Method [Intellectual Product]
   812   C0449851:Method [Functional Concept]
   812   C0871511:METHOD [Intellectual Product]

Phrase: "(Sun et al. 2001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0038817:Sun [Natural Phenomenon or Process]
   812   C0376223:Sun [Geographic Area]

Phrase: ")"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that thioflavin-S"

Phrase: "and"

Phrase: "Gallyas silver staining methods"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   912   C1293950:Silver Staining Method [Laboratory Procedure]
   844   C0487602:Staining method [Laboratory Procedure]
   812   C0025663:Methods [Intellectual Product]
   812   C0025664:methods [Intellectual Product]
   812   C0449851:Methods [Functional Concept]
   779 E C0871511:METHOD [Intellectual Product]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "a subpopulation of plaque neurites"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1257890:Subpopulation [Population Group]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.125: View larger version (59K): [in this window] [in a new window]  Figure 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(59K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 4."
Processing 00000000.tx.126: Different effects of formic acid treatment on thioflavin-S staining or Gallyas silver staining. 

Phrase: "Different effects of formic acid treatment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   767   C1518681:Treatment Effect [Finding]
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "on thioflavin-S staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]

Phrase: "or"

Phrase: "Gallyas silver staining."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   901   C1293950:Silver Staining [Laboratory Procedure]
   884 E C1318876:Silver stain [Indicator, Reagent, or Diagnostic Aid]
           Silver
   827   C0037125:Silver [Element, Ion, or Isotope]
   827   C0487602:Staining [Laboratory Procedure]
   827   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   827   C1305285:Silver [Qualitative Concept]
   827   C1704680:Staining [Finding]
   793 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   743 E C0079853:Moon [Geographic Area]
   734 E C0003782:Argyria [Injury or Poisoning]
   734 E C3463959:Argyria [Eukaryote]
Processing 00000000.tx.127: Although thioflavin-S staining (A) and Gallyas silver staining (B) detected the same NFTs, faint NFT staining (B, arrowhead) was encountered in a small number of cases. 

Phrase: "Although"

Phrase: "thioflavin-S staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]

Phrase: "(A)"

Phrase: "and"

Phrase: "Gallyas silver staining"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   901   C1293950:Silver Staining [Laboratory Procedure]
   884 E C1318876:Silver stain [Indicator, Reagent, or Diagnostic Aid]
           Silver
   827   C0037125:Silver [Element, Ion, or Isotope]
   827   C0487602:Staining [Laboratory Procedure]
   827   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   827   C1305285:Silver [Qualitative Concept]
   827   C1704680:Staining [Finding]
   793 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   743 E C0079853:Moon [Geographic Area]
   734 E C0003782:Argyria [Injury or Poisoning]
   734 E C3463959:Argyria [Eukaryote]

Phrase: "(B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "the same NFTs,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   901   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   867 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "faint NFT staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]

Phrase: "(B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "arrowhead"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0453107:Arrowhead [Food]
  1000   C1080898:Arrowhead [Plant]

Phrase: ")"

Phrase: "was"

Phrase: "encountered in a small number of cases."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]
   748   C0700321:Small [Quantitative Concept]
   748   C0868928:Cases [Functional Concept]
   748   C1533148:Cases [Quantitative Concept]
   714   C0545082:Encounter [Behavior]
   714   C1512346:encounter [Health Care Activity]
   714 E C1706255:CASE [Medical Device]
   714 E C1706256:Case [Conceptual Entity]
   714   C1947978:Encounter [Behavior]
Processing 00000000.tx.128: Pretreatment with formic acid for 2 min prevented NFT staining by thioflavin-S on the AD hippocampal section (C). 

Phrase: "Pretreatment with formic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1550147:Pretreatment [Substance]
   770   C2709094:pre treatment [Temporal Concept]
   770   C3539075:Pretreatment [Temporal Concept]
   770   C3539076:Pretreatment [Activity]

Phrase: "for 2 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "prevented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "NFT staining by thioflavin-S"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0487602:Staining [Laboratory Procedure]
   760   C1704680:Staining [Finding]

Phrase: "on the AD hippocampal section"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "(C)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.129: In addition, in sections stained with thioflavin-S (D), treatment with formic acid for 2 min immediately eliminated the existing staining on NFTs (E). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "in sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "stained with thioflavin-S (D),"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0950261:thioflavine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C2986582:Stained [Qualitative Concept]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "treatment with formic acid"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "for 2 min immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0702093:/min [Temporal Concept]

Phrase: "eliminated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0849355:Eliminated [Qualitative Concept]

Phrase: "the existing staining on NFTs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0487602:Staining [Laboratory Procedure]
   753   C1704680:Staining [Finding]

Phrase: "(E"

Phrase: ")."
Processing 00000000.tx.130: However, Gallyas silver staining could still demonstrate NFTs (F) on this formic acid-treated section. 

Phrase: "However,"

Phrase: "Gallyas silver staining"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   901   C1293950:Silver Staining [Laboratory Procedure]
   884 E C1318876:Silver stain [Indicator, Reagent, or Diagnostic Aid]
           Silver
   827   C0037125:Silver [Element, Ion, or Isotope]
   827   C0487602:Staining [Laboratory Procedure]
   827   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   827   C1305285:Silver [Qualitative Concept]
   827   C1704680:Staining [Finding]
   793 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   743 E C0079853:Moon [Geographic Area]
   734 E C0003782:Argyria [Injury or Poisoning]
   734 E C3463959:Argyria [Eukaryote]

Phrase: "could"

Phrase: "still"

Phrase: "demonstrate"

Phrase: "NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "(F) on this formic acid-treated section."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   748   C0439133:(f) [Intellectual Product]
   748   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.131: Bar = 100 m. 

Phrase: "Bar = 100 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.132: Quantification of NFTs showed that the thioflavin-S and Gallyas silver stains identified the same number of NFTs in the three regions examined. 

Phrase: "Quantification of NFTs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709793:Quantification [Quantitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the thioflavin-S"

Phrase: "and"

Phrase: "Gallyas silver stains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C1318876:Silver stain [Indicator, Reagent, or Diagnostic Aid]
   827   C0038128:Stains [Indicator, Reagent, or Diagnostic Aid]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "the same number of NFTs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "in the three regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]

Phrase: "examined."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]
Processing 00000000.tx.133: In the CA1 and subiculum regions, polyclonal NFT antibody or PHF-1 antibody recognized approximately half of the NFTs detected by the other two methods (Table 1). 

Phrase: "In the CA1"

Phrase: "and"

Phrase: "subiculum regions,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]

Phrase: "polyclonal NFT antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "or"

Phrase: "PHF-1 antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "recognized"

Phrase: "approximately half of the NFTs"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   756 E C3543859:neurofibrillary tangle [Cell Component]
   753   C0332232:Approximately [Qualitative Concept]
   753   C2825407:Half [Quantitative Concept]

Phrase: "detected by the"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "other two methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.134: In the transentorhinal/entorhinal cortex, PHF-1 immunostaining detected more NFTs than the polyclonal NFT antibody (Table 1), although it still left out many NFTs that could be detected by thioflavin-S staining and Gallyas silver staining. 

Phrase: "In the transentorhinal/entorhinal cortex,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0175196:Entorhinal Cortex [Body Part, Organ, or Organ Component]
   901   C1289526:Entorhinal cortex [Body Part, Organ, or Organ Component]
   827   C0007776:Cortex [Body Part, Organ, or Organ Component]
   827   C1176472:Cortex [Body Part, Organ, or Organ Component]
   827   C2700441:Cortex [Plant]

Phrase: "PHF-1 immunostaining"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "more NFTs than the polyclonal NFT antibody"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   737 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "although"

Phrase: "it still"

Phrase: "left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "many NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "that"

Phrase: "could"

Phrase: "be"

Phrase: "detected by thioflavin-S staining"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0442726:Detected [Finding]
   760   C0487602:Staining [Laboratory Procedure]
   760   C0950261:thioflavine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C1704680:Staining [Finding]

Phrase: "and"

Phrase: "Gallyas silver staining."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   901   C1293950:Silver Staining [Laboratory Procedure]
   884 E C1318876:Silver stain [Indicator, Reagent, or Diagnostic Aid]
           Silver
   827   C0037125:Silver [Element, Ion, or Isotope]
   827   C0487602:Staining [Laboratory Procedure]
   827   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   827   C1305285:Silver [Qualitative Concept]
   827   C1704680:Staining [Finding]
   793 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   743 E C0079853:Moon [Geographic Area]
   734 E C0003782:Argyria [Injury or Poisoning]
   734 E C3463959:Argyria [Eukaryote]
Processing 00000000.tx.135: Dependence of Staining on Secondary Structure Because the thioflavin-S and Gallyas silver staining showed comparable sensitivity in demonstrating NFTs (Table 1), these two methods might share a similarity in staining mechanisms. 

Phrase: "Dependence of Staining"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0011546:Dependence [Mental Process]
   790   C0439857:Dependence [Mental or Behavioral Dysfunction]
   790   C2698668:DEPENDENCE [Regulation or Law]
   718 E C0851827:Dependent [Qualitative Concept]
   718 E C1701901:Dependent [Qualitative Concept]
   718 E C3244310:dependent [Functional Concept]

Phrase: "on Secondary Structure"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0162807:Secondary Structure [Spatial Concept]
   861   C0027627:secondary [Neoplastic Process]
   861   C0175668:Secondary [Temporal Concept]
   861   C0205436:Secondary [Quantitative Concept]
   861   C0678594:Structure [Spatial Concept]

Phrase: "Because"

Phrase: "the thioflavin-S"

Phrase: "and"

Phrase: "Gallyas silver staining"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   901   C1293950:Silver Staining [Laboratory Procedure]
   884 E C1318876:Silver stain [Indicator, Reagent, or Diagnostic Aid]
           Silver
   827   C0037125:Silver [Element, Ion, or Isotope]
   827   C0487602:Staining [Laboratory Procedure]
   827   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   827   C1305285:Silver [Qualitative Concept]
   827   C1704680:Staining [Finding]
   793 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   743 E C0079853:Moon [Geographic Area]
   734 E C0003782:Argyria [Injury or Poisoning]
   734 E C3463959:Argyria [Eukaryote]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "comparable sensitivity in"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   790   C0036667:Sensitivity [Quantitative Concept]
   790   C0312418:Sensitivity [Mental Process]
   790   C0427965:Sensitivity [Finding]
   790   C1511883:Sensitivity [Quantitative Concept]
   790   C1522640:Sensitivity [Qualitative Concept]
   790   C2346484:SENSITIVITY [Phenomenon or Process]
   790   C2349185:Sensitivity [Qualitative Concept]
   718 E C0332324:Sensitive [Functional Concept]
   718 E C1550474:sensitive [Idea or Concept]

Phrase: "demonstrating"

Phrase: "NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "these two methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]

Phrase: "might"

Phrase: "share"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "a similarity in staining mechanisms."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similarity [Qualitative Concept]
Processing 00000000.tx.136: To address this question, we investigated whether -pleated sheet secondary structure was necessary for both methods. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "this question,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522634:Question [Intellectual Product]

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "whether -"

Phrase: "pleated sheet secondary structure"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0162807:Secondary Structure [Spatial Concept]
   812   C0027627:secondary [Neoplastic Process]
   812   C0175668:Secondary [Temporal Concept]
   812   C0205436:Secondary [Quantitative Concept]
   812   C0678594:Structure [Spatial Concept]

Phrase: "was"

Phrase: "necessary for both methods."
Processing 00000000.tx.137: When applied after treatment with formic acid, which disrupts the structure of -pleated sheets without cleaving or removing the protein (Kitamoto et al. 1987 ), the thioflavin-S staining failed to detect NFTs (Fig 4C). 

Phrase: "When"

Phrase: "applied after treatment"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   882   C0001758:After-Treatment [Health Care Activity]
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C0185125:Applied [Health Care Activity]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]
   756 E C1632850:Apply [Functional Concept]
   756 E C1879355:Apply [Functional Concept]

Phrase: "with formic acid,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
  1000   C0885348:formic acid [Organic Chemical]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "which"

Phrase: "disrupts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "the structure of -pleated sheets without cleaving"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0439643:Sheets [Spatial Concept]
   714 E C2349187:Sheet [Quantitative Concept]

Phrase: "or"

Phrase: "removing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0849355:remove [Qualitative Concept]
   966   C1883720:Remove [Activity]
   966   C3244314:remove [Functional Concept]

Phrase: "the protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Kitamoto et al. 1987"

Phrase: ")"

Phrase: ","

Phrase: "the thioflavin-S staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "(Fig 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.138: Furthermore, addition of formic acid to thioflavin-S-stained sections immediately removed any fluorescence present (Fig 4D and Fig 4E). 

Phrase: "Furthermore,"

Phrase: "addition of formic acid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1883712:Addition [Functional Concept]

Phrase: "to thioflavin-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0950261:thioflavine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "S-"

Phrase: "stained sections immediately"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0205155:Section [Spatial Concept]
   793   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   793   C1522472:Section [Substance]
   793   C1552923:Section [Quantitative Concept]
   793   C1705191:Section [Physical Object]

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "any fluorescence present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]

Phrase: "(Fig"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]

Phrase: "4D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450377:4d [Intellectual Product]
  1000   C2986754:4D [Temporal Concept]

Phrase: "and"

Phrase: "Fig 4E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450378:4e [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.139: However, in formic acid-treated sections, the Gallyas silver staining was still able to stain NFTs (Fig 4F). 

Phrase: "However,"

Phrase: "in formic acid-treated sections,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   779   C0205155:Section [Spatial Concept]
   779   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   779   C1522472:Section [Substance]
   779   C1552923:Section [Quantitative Concept]
   779   C1705191:Section [Physical Object]

Phrase: "the Gallyas silver staining"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   901   C1293950:Silver Staining [Laboratory Procedure]
   884 E C1318876:Silver stain [Indicator, Reagent, or Diagnostic Aid]
           Silver
   827   C0037125:Silver [Element, Ion, or Isotope]
   827   C0487602:Staining [Laboratory Procedure]
   827   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   827   C1305285:Silver [Qualitative Concept]
   827   C1704680:Staining [Finding]
   793 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   743 E C0079853:Moon [Geographic Area]
   734 E C0003782:Argyria [Injury or Poisoning]
   734 E C3463959:Argyria [Eukaryote]

Phrase: "was"

Phrase: "still able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0085732:Able [Organism Attribute]
   827   C1299581:Able [Finding]

Phrase: "stain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "(Fig 4F"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450379:4f [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.140: These results indicate that the two methods stain NFTs through different mechanisms. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that"

Phrase: "the two methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]

Phrase: "stain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "NFTs through different mechanisms."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   806   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   773 E C3543859:neurofibrillary tangle [Cell Component]
Processing 00000000.tx.141: Discussion Top Summary Introduction Materials and Methods Results Discussion Literature Cited In this study we further improved the thioflavin-S staining method by introducing several technical modifications that result in overall reduction of tissue damage, photobleaching, and background autofluorescence, with no loss of sensitivity or selectivity. 

Phrase: "Discussion Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion Literature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0023866:Literature [Intellectual Product]
   812   C0034036:LITERATURE [Intellectual Product,Manufactured Object]

Phrase: "Cited In this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]

Phrase: "we further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "improved"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0184511:Improved [Qualitative Concept]
  1000   C0332272:Improved [Qualitative Concept]
  1000   C1561611:Improved [Intellectual Product]

Phrase: "the thioflavin-S"

Phrase: "staining"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "method by introducing several technical modifications"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0025663:Method [Intellectual Product]
   753   C0449851:Method [Functional Concept]
   753   C0871511:METHOD [Intellectual Product]

Phrase: "that"

Phrase: "result in overall reduction of tissue damage,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   778   C0010957:Tissue damage [Injury or Poisoning]
           Damage
   748   C0040300:Tissue [Tissue]
   748   C0282416:Overall [Intellectual Product]
   748   C0301630:Reduction [Natural Phenomenon or Process]
   748   C0392756:Reduction [Qualitative Concept]
   748   C0441610:Reduction [Therapeutic or Preventive Procedure]
   748   C1274040:Result [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C1547928:Tissue [Intellectual Product]
   748   C1561607:Overall [Qualitative Concept]
   748   C1883709:Damage [Functional Concept]
   748   C2825142:Result [Finding]

Phrase: "photobleaching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1138417:Photobleaching [Natural Phenomenon or Process]

Phrase: ","

Phrase: "and"

Phrase: "background autofluorescence,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0544711:Autofluorescence [Finding]

Phrase: "with no loss"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517945:Loss [Quantitative Concept]

Phrase: "of sensitivity"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0036667:Sensitivity [Quantitative Concept]
  1000   C0312418:Sensitivity [Mental Process]
  1000   C0427965:Sensitivity [Finding]
  1000   C1511883:Sensitivity [Quantitative Concept]
  1000   C1522640:Sensitivity [Qualitative Concept]
  1000   C2346484:SENSITIVITY [Phenomenon or Process]
  1000   C2349185:Sensitivity [Qualitative Concept]
   928 E C0332324:Sensitive [Functional Concept]
   928 E C1550474:sensitive [Idea or Concept]

Phrase: "or"

Phrase: "selectivity."
Processing 00000000.tx.142: Although the modification of the thioflavin-S technique by Vallet et al. 

Phrase: "Although"

Phrase: "the modification of the thioflavin-S technique"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392747:Modification [Functional Concept]
   748   C1554963:modification [Qualitative Concept]

Phrase: "by Vallet et al."
Processing 00000000.tx.143: 1992 greatly improved the signal-to-background ratio compared to the classical thioflavin-S method, it introduced some problems such as tissue damage, partial detachment, and photobleaching, as found by others (Cullen et al. 1996 ) and by our preliminary study. 

Phrase: "1992 greatly"

Phrase: "improved"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0184511:Improved [Qualitative Concept]
  1000   C0332272:Improved [Qualitative Concept]
  1000   C1561611:Improved [Intellectual Product]

Phrase: "the signal-to-background ratio"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0456603:Ratio [Quantitative Concept]
   812   C1547037:Ratio [Intellectual Product]
   812   C1706907:Background [Conceptual Entity]
   812   C1710082:Signal [Phenomenon or Process]

Phrase: "compared to the classical thioflavin-S method,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0025663:Method [Intellectual Product]
   748   C0439858:Classical [Qualitative Concept]
   748   C0443177:Classical [Functional Concept]
   748   C0449851:Method [Functional Concept]
   748   C0871511:METHOD [Intellectual Product]
   748   C0950261:thioflavine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C1707455:Compared [Activity]

Phrase: "it"

Phrase: "introduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1292748:introduce [Functional Concept]

Phrase: "some problems such as tissue damage,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1546466:Problems [Idea or Concept]
   719 E C0033213:Problem [Finding]

Phrase: "partial detachment,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0541879:detachment [Mental Process]
   861   C0595950:Detachment [Pathologic Function]
   789 E C0687118:Detached [Functional Concept]
   789 E C1561504:detached [Idea or Concept]

Phrase: "and"

Phrase: "photobleaching,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1138417:Photobleaching [Natural Phenomenon or Process]

Phrase: "as"

Phrase: "found by others"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0150312:Found [Quantitative Concept]
   790   C1955473:Others [Finding]
   756 E C0243095:Find [Finding]

Phrase: "(Cullen et al. 1996"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1051267:Cullen [Plant]

Phrase: ")"

Phrase: "and by our preliminary study."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439611:Preliminary [Temporal Concept]
   760   C0557651:Study [Manufactured Object]
   760   C1515981:And [Idea or Concept]
   760   C2603343:Study [Research Activity]
Processing 00000000.tx.144: Our proposed combination quenching method, using NaBH4 instead of NaOH, increases the efficacy of background quenching and alleviates tissue damage. 

Phrase: "Our proposed combination quenching method,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025663:Method [Intellectual Product]
   812   C0449851:Method [Functional Concept]
   812   C0871511:METHOD [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "NaBH4 instead of NaOH,"

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the efficacy of background quenching"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280519:Efficacy [Qualitative Concept]
   760   C1707887:EFFICACY [Research Activity]

Phrase: "and"

Phrase: "alleviates"

Phrase: "tissue damage."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0010957:Tissue damage [Injury or Poisoning]
           Damage
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]
   861   C1883709:Damage [Functional Concept]
Processing 00000000.tx.145: Treatment with a concentrated phosphate buffer significantly slows photobleaching, possibly by stabilizing critical secondary structural elements. 

Phrase: "Treatment with a concentrated phosphate buffer significantly"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0039798:treatment [Functional Concept]
   748   C0087111:Treatment [Therapeutic or Preventive Procedure]
   748   C1522326:Treatment [Functional Concept]
   748   C1533734:Treatment [Therapeutic or Preventive Procedure]
   748   C1705169:Treatment [Conceptual Entity]
   748   C3538994:TREATMENT [Research Activity]

Phrase: "slows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439834:Slow [Qualitative Concept]

Phrase: "photobleaching,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1138417:Photobleaching [Natural Phenomenon or Process]

Phrase: "possibly by stabilizing critical secondary structural elements."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   748   C0013879:Elements [Element, Ion, or Isotope]
   748   C0027627:secondary [Neoplastic Process]
   748   C0175668:Secondary [Temporal Concept]
   748   C0184512:stabilizing [Qualitative Concept]
   748   C0205436:Secondary [Quantitative Concept]
   748   C0678594:Structural [Spatial Concept]
   748   C1511545:Critical [Qualitative Concept]
   748   C2362652:Possibly [Qualitative Concept]
   714 E C1705248:Element [Conceptual Entity]
Processing 00000000.tx.146: Comparison of this improved thioflavin-S method with other common conventional staining methods on the same sections demonstrated that PHF-1 or NFT immunostaining is much less sensitive in detecting NFTs than the improved thioflavin-S staining and Gallyas silver staining, particularly in the transentorhinal cortex. 

Phrase: "Comparison of this improved thioflavin-S method"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1707455:Comparison [Activity]

Phrase: "with other common conventional staining methods"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   844   C0487602:Staining method [Laboratory Procedure]
   812   C0025663:Methods [Intellectual Product]
   812   C0025664:methods [Intellectual Product]
   812   C0449851:Methods [Functional Concept]
   779 E C0871511:METHOD [Intellectual Product]

Phrase: "on the same sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "demonstrated"

Phrase: "that PHF-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597162:PHF [Cell or Molecular Dysfunction]

Phrase: "or"

Phrase: "NFT immunostaining"

Phrase: "is"

Phrase: "much less sensitive in detecting NFTs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332324:Sensitive [Functional Concept]
   748   C1550474:sensitive [Idea or Concept]

Phrase: "than the improved thioflavin-S staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0487602:Staining [Laboratory Procedure]
   812   C1704680:Staining [Finding]

Phrase: "and"

Phrase: "Gallyas silver staining,"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   901   C1293950:Silver Staining [Laboratory Procedure]
   884 E C1318876:Silver stain [Indicator, Reagent, or Diagnostic Aid]
           Silver
   827   C0037125:Silver [Element, Ion, or Isotope]
   827   C0487602:Staining [Laboratory Procedure]
   827   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   827   C1305285:Silver [Qualitative Concept]
   827   C1704680:Staining [Finding]
   793 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   743 E C0079853:Moon [Geographic Area]
   734 E C0003782:Argyria [Injury or Poisoning]
   734 E C3463959:Argyria [Eukaryote]

Phrase: "particularly in the transentorhinal cortex."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0007776:Cortex [Body Part, Organ, or Organ Component]
   760   C1176472:Cortex [Body Part, Organ, or Organ Component]
   760   C2700441:Cortex [Plant]
Processing 00000000.tx.147: The similarity in sensitivity between the thioflavin-S and Gallyas silver methods is consistent with previous studies (Vallet et al. 1992 ; Cullen et al. 1996 ). 

Phrase: "The similarity in sensitivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similarity [Qualitative Concept]

Phrase: "between the thioflavin-S"

Phrase: "and"

Phrase: "Gallyas silver methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0025663:Methods [Intellectual Product]
   827   C0025664:methods [Intellectual Product]
   827   C0449851:Methods [Functional Concept]
   793 E C0871511:METHOD [Intellectual Product]

Phrase: "is"

Phrase: "consistent with previous studies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "(Vallet et al. 1992"

Phrase: "; Cullen et al. 1996"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1051267:Cullen [Plant]

Phrase: ")."
Processing 00000000.tx.148: The results of this study show that NFT or PHF-1 immunostaining is much less sensitive than thioflavin-S or Gallyas silver staining in detecting NFTs. 

Phrase: "The results of this study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0683954:results study [Finding]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that NFT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085400:NFT [Acquired Abnormality]

Phrase: "or"

Phrase: "PHF-1 immunostaining"

Phrase: "is"

Phrase: "much less sensitive than thioflavin-S"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332324:Sensitive [Functional Concept]
   753   C1550474:sensitive [Idea or Concept]

Phrase: "or"

Phrase: "Gallyas silver staining in detecting NFTs."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   778   C1293950:Silver Staining [Laboratory Procedure]
   762 E C1318876:Silver stain [Indicator, Reagent, or Diagnostic Aid]
           Silver
   748   C0037125:Silver [Element, Ion, or Isotope]
   748   C0487602:Staining [Laboratory Procedure]
   748   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   748   C1305285:Silver [Qualitative Concept]
   748   C1704680:Staining [Finding]
   714 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.149: The polyclonal anti-NFT antibody used in the present study was created by immunizing against a set of NFTs that were extracted in boiling SDS and purified by sucrose gradient centrifugation (Gorevic et al. 1986 ). 

Phrase: "The polyclonal anti-NFT antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "used in the present study"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   781   C0869040:study use [Research Activity]
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0557651:Study [Manufactured Object]
   760   C1273517:used [Finding]
   760   C2603343:Study [Research Activity]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "was"

Phrase: "created by immunizing"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   882   C1707531:Created By [Qualitative Concept]
   790   C1706214:Created [Activity]
   756 E C3244320:create [Functional Concept]

Phrase: "against a set"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036849:Set [Mental Process]
  1000   C1442518:Set [Functional Concept]
  1000   C1705195:Set [Conceptual Entity]

Phrase: "of NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "that"

Phrase: "were"

Phrase: "extracted in boiling SDS"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0185115:Extracted [Therapeutic or Preventive Procedure]
   770   C3541890:EXTRACTED [Finding]
   737   C0242301:Boil [Disease or Syndrome]
   737   C1546559:Boil [Intellectual Product]
   737 E C2828366:Extract [Substance]

Phrase: "and"

Phrase: "purified by sucrose gradient centrifugation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0007703:Centrifugation [Laboratory Procedure]
   760   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0439182:% gradient [Quantitative Concept]
   760   C0812409:Gradient [Quantitative Concept]
   760   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]
   760   C1998793:Purified [Functional Concept]

Phrase: "(Gorevic et al. 1986"

Phrase: ")."
Processing 00000000.tx.150: One study had identified at least two morphologically distinct fractions of PHF that can be separated on a sucrose density gradient (Ksiezak-Reding et al. 1994 ). 

Phrase: "One study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "had"

Phrase: "identified at least two morphologically distinct fractions of PHF"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   748   C1264633:Fraction of [Quantitative Concept]
           Fractions
   742   C0205396:Identified [Qualitative Concept]
   742   C0205448:Two [Quantitative Concept]
   742   C0597162:PHF [Cell or Molecular Dysfunction]
   742   C1550043:Identified [Finding]
   742   C1551388:Identified [Functional Concept]
   708 E C1554103:Fraction [Idea or Concept]

Phrase: "that"

Phrase: "can"

Phrase: "be"

Phrase: "separated on a sucrose density gradient"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0086972:Separated [Finding]
   753   C0178587:density [Quantitative Concept]
   753   C0439182:% gradient [Quantitative Concept]
   753   C0443299:separated [Spatial Concept]
   753   C0687118:Separated [Functional Concept]
   753   C0812409:Gradient [Quantitative Concept]
   753   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]

Phrase: "(Ksiezak-Reding et al. 1994"

Phrase: ")."
Processing 00000000.tx.151: Morphologically and immunochemically, NFTs are known to be highly heterogeneous (Schmidt et al. 1988 ; Uboga and Price 2000 ). 

Phrase: "Morphologically"

Phrase: "and"

Phrase: "immunochemically,"

Phrase: "NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "highly heterogeneous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019409:Heterogeneous [Qualitative Concept]

Phrase: "(Schmidt et al. 1988"

Phrase: "; Uboga"

Phrase: "and"

Phrase: "Price 2000"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0080045:Price [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.152: Intracellular neurofibrillary tangles (iNFTs) have distinct epitopes from extracellular neurofibrillary tangles (eNFTs, or ghost tangles), which are the insoluble cytoskeletal debris remaining when iNFT-containing neurons degenerate. 

Phrase: "Intracellular neurofibrillary tangles (iNFTs)"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   901   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   867 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "have"

Phrase: "distinct epitopes from extracellular neurofibrillary tangles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0003316:Epitopes [Immunologic Factor]

Phrase: "(eNFTs,"

Phrase: "or"

Phrase: "ghost tangles"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "are"

Phrase: "the insoluble cytoskeletal debris remaining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1527428:Remaining [Qualitative Concept]

Phrase: "when"

Phrase: "iNFT-containing neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "degenerate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011164:degenerate [Pathologic Function]
  1000   C1880269:Degenerate [Functional Concept]
Processing 00000000.tx.153: Using seven independent antibodies, various epitopes of tau, several investigators found that ghost tangles lack carboxy- and amino-terminal regions (Dickson et al. 1992 ; Endoh et al. 1993 ), suggesting that NFTs were extensively processed and that some tau-based epitopes can be lost from NFTs in situ. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "seven independent antibodies,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "various epitopes of tau,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0003316:Epitopes [Immunologic Factor]

Phrase: "several investigators"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035173:Investigators [Professional or Occupational Group]

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that ghost tangles"

Phrase: "lack"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "carboxy-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596260:Carboxy [Organic Chemical]

Phrase: "and"

Phrase: "amino-terminal regions"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0205088:Terminal [Temporal Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   793   C0017446:Region [Geographic Area]
   793   C0205147:Region [Spatial Concept]
   743 E C0205276:Regional [Spatial Concept]
   743 E C1947913:Regional [Spatial Concept]

Phrase: "(Dickson et al. 1992"

Phrase: "; Endoh et al. 1993"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "were"

Phrase: "extensively"

Phrase: "processed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522240:Processed [Phenomenon or Process]
   966 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "that"

Phrase: "some tau-based epitopes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003316:Epitopes [Immunologic Factor]

Phrase: "can"

Phrase: "be"

Phrase: "lost from NFTs"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   799 E C3543859:neurofibrillary tangle [Cell Component]
   770   C0745777:Lost [Functional Concept]

Phrase: "in situ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444498:In situ [Spatial Concept]
Processing 00000000.tx.154: In addition to the effects of proteolytic degradation on epitope availability, some tau epitopes may also be masked, as demonstrated by increased immunoreactivity of the C-terminal regions of tau in tissues after hydrated autoclaving (Dickson et al. 1992 ). 

Phrase: "In addition to the effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "of proteolytic degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "on epitope availability,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0470187:Availability [Functional Concept]

Phrase: "some tau epitopes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003316:Epitopes [Immunologic Factor]

Phrase: "may"

Phrase: "also"

Phrase: "be"

Phrase: "masked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0150108:masked [Research Activity]
  1000   C0150112:MASKED [Functional Concept]
  1000   C1555580:masked [Idea or Concept]
   966 E C0024861:Mask [Medical Device]
   966 E C1538279:MASK [Gene or Genome]
   966 E C1845191:MASK [Gene or Genome]

Phrase: ","

Phrase: "as"

Phrase: "demonstrated by increased immunoreactivity of the C-terminal regions of tau"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   756   C1707271:C-Terminal [Amino Acid Sequence]
   738   C0205088:Terminal [Temporal Concept]
   738   C0205217:Increased [Quantitative Concept]
   738   C0442805:Increased [Functional Concept]
   738   C0597879:immunoreactivity [Molecular Function]
   738   C1705314:Terminal [Manufactured Object]
   738   C1705315:Terminal [Spatial Concept]
   738   C1720655:Tau [Intellectual Product]
   738   C1947974:Tau [Research Activity]
   704   C0017446:Region [Geographic Area]
   704   C0205147:Region [Spatial Concept]

Phrase: "in tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]

Phrase: "after hydrated autoclaving"

Phrase: "(Dickson et al. 1992"

Phrase: ")."
Processing 00000000.tx.155: It should also be noted that the PHF-1 antibody used in the present study detects a specific phosphorylated epitope at serine residues 396 and 404, near the C-terminus, of the tau protein. 

Phrase: "It"

Phrase: "should"

Phrase: "also"

Phrase: "be"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "the PHF-1 antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "used in the present study"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   781   C0869040:study use [Research Activity]
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0557651:Study [Manufactured Object]
   760   C1273517:used [Finding]
   760   C2603343:Study [Research Activity]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "detects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "a specific phosphorylated epitope at serine residues 396"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0003316:Epitope [Immunologic Factor]

Phrase: "and"

Phrase: "404,"

Phrase: "near the C-terminus,"

Phrase: "of the tau protein."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0085401:tau Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2700455:Tau Protein [Amino Acid, Peptide, or Protein]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]
Processing 00000000.tx.156: Although the pathways and key phosphorylation events leading to tau hyperphosphorylation in vivo are poorly understood, in vitro studies show that hyperphosphorylation of tau is part of the mechanism of self-assembly into tangles of PHFs and straight filaments (Alonso et al. 2001 ). 

Phrase: "Although"

Phrase: "the pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathways [Molecular Function]
  1000   C1705987:Pathways [Conceptual Entity]

Phrase: "and"

Phrase: "key phosphorylation events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441471:Events [Event]
   827   C3541888:Events [Classification]

Phrase: "leading to tau hyperphosphorylation"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0332152:Leading [Temporal Concept]
   770   C1522538:Leading [Functional Concept]
   770   C1720655:Tau [Intellectual Product]
   770   C1947974:Tau [Research Activity]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "are"

Phrase: "poorly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205169:Poorly [Qualitative Concept]

Phrase: "understood"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0162340:Understand [Mental Process]

Phrase: ","

Phrase: "in vitro studies"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   983   C0681828:in vitro study [Research Activity]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that hyperphosphorylation of tau"

Phrase: "is"

Phrase: "part of the mechanism of self-assembly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1292711:Part of [Spatial Concept]
   748   C0449719:Part [Spatial Concept]
   748   C1709471:Part [Quantitative Concept]

Phrase: "into tangles"

Phrase: "of PHFs"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   966   C0597162:paired helical filament [Cell or Molecular Dysfunction]
   827   C1709450:Paired [Qualitative Concept]
   793   C0010851:Filament [Cell Component]
   743 E C1979891:Filamentous [Qualitative Concept]

Phrase: "and"

Phrase: "straight filaments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0010851:Filament [Cell Component]
   777 E C1979891:Filamentous [Qualitative Concept]

Phrase: "(Alonso et al. 2001"

Phrase: ")."
Processing 00000000.tx.157: However, iNFTs containing full-length tau do not demonstrate immunoreactivity to some phosphorylation-specific antibodies (Bondareff et al. 1995 ), which may account for the absence of PHF-1 immunoreactivity in a number of tangles observed in the present study. 

Phrase: "However,"

Phrase: "iNFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   901   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   867 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "full-length tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1720655:Tau [Intellectual Product]
   827   C1947974:Tau [Research Activity]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "demonstrate"

Phrase: "immunoreactivity to some phosphorylation-specific antibodies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0597879:immunoreactivity [Molecular Function]

Phrase: "(Bondareff et al. 1995"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "may"

Phrase: "account for the absence of PHF-1 immunoreactivity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0332197:absence [Quantitative Concept]
   744   C0597162:PHF [Cell or Molecular Dysfunction]
   744   C0597879:immunoreactivity [Molecular Function]
   744   C1551359:account [Idea or Concept]
   744   C1689985:Absence [Anatomical Abnormality]
   744   C2741673:Account # [Clinical Attribute]
   744   C2981730:Account [Classification]

Phrase: "in a number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237753:*Number [Quantitative Concept]
  1000   C0449788:Number [Quantitative Concept]

Phrase: "of tangles"

Phrase: "observed in the present study."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0557651:Study [Manufactured Object]
   760   C1441672:Observed [Functional Concept]
   760   C2603343:Study [Research Activity]
Processing 00000000.tx.158: Despite the relative specificity of this antibody in recognizing late-stage tangles over other forms of pathology, the activity of endogenous phosphatases and proteases may affect sensitivity and could account for part of the individual variability found in this study. 

Phrase: "Despite the relative specificity"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0037791:Specificity [Quantitative Concept]
   861   C1511884:Specificity [Quantitative Concept]
   789 E C0205369:Specific [Qualitative Concept]
   789 E C1552740:specific [Intellectual Product]

Phrase: "of this antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "in recognizing late-stage tangles"

Phrase: "over other forms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0348078:forms [Qualitative Concept]
  1000   C0376315:Forms [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: "of pathology,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030664:Pathology [Biomedical Occupation or Discipline]
  1000   C0205469:pathology [Functional Concept]
  1000   C0677042:pathology [Pathologic Function]
   928 E C1521733:Pathologic [Functional Concept]

Phrase: "the activity of endogenous phosphatases"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   781   C1149880:phosphatase activity [Molecular Function]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "proteases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1947941:Proteases [Enzyme]

Phrase: "may"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "sensitivity"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0036667:Sensitivity [Quantitative Concept]
  1000   C0312418:Sensitivity [Mental Process]
  1000   C0427965:Sensitivity [Finding]
  1000   C1511883:Sensitivity [Quantitative Concept]
  1000   C1522640:Sensitivity [Qualitative Concept]
  1000   C2346484:SENSITIVITY [Phenomenon or Process]
  1000   C2349185:Sensitivity [Qualitative Concept]
   928 E C0332324:Sensitive [Functional Concept]
   928 E C1550474:sensitive [Idea or Concept]

Phrase: "and"

Phrase: "could"

Phrase: "account for part of the individual variability"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C1292711:Part of [Spatial Concept]
   748   C0027361:Individual [Population Group]
   748   C0237401:Individual [Human]
   748   C0449719:Part [Spatial Concept]
   748   C1551359:account [Idea or Concept]
   748   C1709471:Part [Quantitative Concept]
   748   C2741673:Account # [Clinical Attribute]
   748   C2827666:Variability [Conceptual Entity]
   748   C2981730:Account [Classification]

Phrase: "found in this study."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0150312:Found [Quantitative Concept]
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]
   737 E C0243095:Find [Finding]
Processing 00000000.tx.159: The PHF-1 antibody has also been used in earlier studies (Gomez-Isla et al. 1997 ; Uboga and Price 2000 ), including a study in which neuronal loss was quantitatively demonstrated to exceed PHF-1 immunoreactivity in AD brains, leading to the conclusion that NFTs may not account for all neuronal loss in AD (Gomez-Isla et al. 1997 ). 

Phrase: "The PHF-1 antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "used in earlier studies"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   802   C0869040:Use studies [Research Activity]
   770   C0947630:studies [Laboratory Procedure]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C0557651:Study [Manufactured Object]
   737   C1279919:Early [Temporal Concept]
   737 E C1947944:Use [Intellectual Product]
   737 E C2603343:Study [Research Activity]

Phrase: "(Gomez-Isla et al. 1997"

Phrase: "; Uboga"

Phrase: "and"

Phrase: "Price 2000"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0080045:Price [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "a study in which neuronal loss"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0557651:Study [Manufactured Object]
   753   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "quantitatively"

Phrase: "demonstrated"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "exceed"

Phrase: "PHF-1 immunoreactivity in AD brains,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0597879:immunoreactivity [Molecular Function]

Phrase: "leading to the conclusion"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   770   C0332152:Leading [Temporal Concept]
   770   C1522538:Leading [Functional Concept]
   770   C1707478:Conclusion [Idea or Concept]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "that NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "may"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "account for all neuronal loss"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C1850496:Neuronal loss [Finding]
   770 E C0598940:neuron loss [Finding]
   760   C0521390:Neuronal [Immunologic Factor]
   760   C1517945:Loss [Quantitative Concept]
   760   C1551359:account [Idea or Concept]
   760   C2741673:Account # [Clinical Attribute]
   760   C2981730:Account [Classification]

Phrase: "in AD (Gomez-Isla et al. 1997"

Phrase: ")."
Processing 00000000.tx.160: However, the results of the present study suggest that caution should be exercised in utilizing PHF-1 immunoreactivity as a quantitative indicator of NFT abundance, particularly in the transentorhinal/entorhinal region, because some NFTs are undetected by PHF-1 immunohistochemistry. 

Phrase: "However,"

Phrase: "the results of the present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0683954:results study [Finding]
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that caution"

Phrase: "should"

Phrase: "be"

Phrase: "exercised in utilizing PHF-1 immunoreactivity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0597162:PHF [Cell or Molecular Dysfunction]
   753   C0597879:immunoreactivity [Molecular Function]
   719   C0015259:Exercise [Daily or Recreational Activity]
   719   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "as a quantitative indicator"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0021212:indicator [Indicator, Reagent, or Diagnostic Aid]
   861   C1235732:Indicator [Bird]
   861   C1522602:Indicator [Functional Concept]

Phrase: "of NFT abundance,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2346714:Abundance [Qualitative Concept]

Phrase: "particularly in the transentorhinal/entorhinal region,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0017446:Region [Geographic Area]
   753   C0205147:Region [Spatial Concept]

Phrase: "because"

Phrase: "some NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "are"

Phrase: "undetected by PHF-1 immunohistochemistry."
Processing 00000000.tx.161: Our study showed clear region-specific differences in NFT and PHF-1 immunoreactivity, with transentorhinal and entorhinal cortical areas yielding the fewest immunopositive tangles. 

Phrase: "Our study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "clear region-specific differences in NFT"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0682132:regional differences [Finding]
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "PHF-1 immunoreactivity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597879:immunoreactivity [Molecular Function]

Phrase: "with transentorhinal"

Phrase: "and"

Phrase: "entorhinal cortical areas"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   913   C0175196:Entorhinal Areas [Body Part, Organ, or Organ Component]
   827   C0001613:Cortical [Body Part, Organ, or Organ Component]
   827   C0007776:Cortical [Body Part, Organ, or Organ Component]
   827   C0022655:Cortical [Body Part, Organ, or Organ Component]
   827   C0205146:areas [Spatial Concept]
   793 E C0017446:Area [Geographic Area]
   771 E C0234875:bark [Organism Attribute]
   771 E C2700441:Bark [Plant]
   743 E C0205704:Cascara [Organic Chemical,Pharmacologic Substance]
   743 E C3486388:Cascara [Organic Chemical,Pharmacologic Substance]

Phrase: "yielding"

Phrase: "the fewest immunopositive tangles."
Processing 00000000.tx.162: Based on the known neuroanatomic distribution of NFTs as a function of AD progression (Braak and Braak 1991 ), it is likely that these differences reflect changes in available epitopes as the tangle evolves during the course of neuronal degeneration. 

Phrase: "Based on the known neuroanatomic distribution of NFTs"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   764   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   742   C0205309:Known [Qualitative Concept]
   742   C0520511:distribution [Idea or Concept]
   742   C1527178:Based [Functional Concept]
   742   C1704711:Distribution [Functional Concept]
   742   C1705938:Based [Idea or Concept]
   731 E C3543859:neurofibrillary tangle [Cell Component]
   708 E C0002055:base [Inorganic Chemical]
   708 E C0178499:Base [Chemical Viewed Functionally]
   708 E C1880279:Base [Biomedical or Dental Material]

Phrase: "as a function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]

Phrase: "of AD progression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0242656:progression [Pathologic Function]
   861   C0449258:Progression [Functional Concept]

Phrase: "(Braak"

Phrase: "and"

Phrase: "Braak 1991"

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that"

Phrase: "these differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "changes in available epitopes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "as the tangle"

Phrase: "evolves during the course of neuronal degeneration."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0011164:Degeneration [Pathologic Function]
   748   C0521390:Neuronal [Immunologic Factor]
   748   C0750729:Course [Temporal Concept]
   748   C1880269:Degeneration [Functional Concept]
   743   C0027746:Neuron Degeneration [Cell or Molecular Dysfunction]
Processing 00000000.tx.163: It has been inferred from neuropathological studies that the transentorhinal/entorhinal regions are the sites of appearance of the first NFTs in AD and that these changes spread in a predictable non-random manner across the hippocampus and neocortex (Braak and Braak 1991 ; Gertz et al. 1998 ; Delacourte et al. 1999 ). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "inferred from neuropathological"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0679201:Inferred [Mental Process]
   790   C3245504:inferred [Idea or Concept]
   718   C0876934:Neuropathology [Biomedical Occupation or Discipline]
   718   C1540677:neuropathology [Pathologic Function]
   718   C1555824:Neuropathology [Intellectual Product]

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "that"

Phrase: "the transentorhinal/entorhinal regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   793   C0017446:Region [Geographic Area]
   793   C0205147:Region [Spatial Concept]
   743 E C0205276:Regional [Spatial Concept]
   743 E C1947913:Regional [Spatial Concept]

Phrase: "are"

Phrase: "the sites of appearance of the first NFTs"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   748   C2945843:Site of [Qualitative Concept]
   742   C0205145:Sites [Spatial Concept]
   708 E C1515974:Site [Body Location or Region]
   708 E C2825164:Site [Spatial Concept]

Phrase: "in AD"

Phrase: "and"

Phrase: "that"

Phrase: "these changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "spread in a predictable non-random manner"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0034656:RANDOM [Research Activity]
   748   C0332261:Spread [Qualitative Concept]
   748   C0439605:Random [Qualitative Concept]
   748   C1518422:Non [Functional Concept]
   748   C1947932:Spread [Activity]

Phrase: "across the hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "neocortex"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0175173:Neocortex [Body Part, Organ, or Organ Component]

Phrase: "(Braak"

Phrase: "and"

Phrase: "Braak 1991"

Phrase: "; Gertz et al. 1998"

Phrase: "; Delacourte et al. 1999"

Phrase: ")."
Processing 00000000.tx.164: The loss of epitopes in the transentorhinal/entorhinal areas may be due to proteolytic processing of eNFTs over time, because eNFTs are only weakly reactive with antibodies to carboxy- or amino-terminal epitopes. 

Phrase: "The loss of epitopes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1517945:Loss [Quantitative Concept]

Phrase: "in the transentorhinal/entorhinal areas"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0175196:Entorhinal Areas [Body Part, Organ, or Organ Component]
   827   C0205146:areas [Spatial Concept]
   793 E C0017446:Area [Geographic Area]

Phrase: "may"

Phrase: "be due to proteolytic processing of eNFTs"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0678226:Due to [Functional Concept]
           due
   778   C1514570:Proteolytic Processing [Molecular Function]
   748   C0597304:Proteolytic [Molecular Function]
   748   C1709694:Processing [Activity]
   748   C1947941:proteolytic [Enzyme]
   748   C2987476:Be [Conceptual Entity]
   748   C3146286:Due [Idea or Concept]

Phrase: "over time,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "because"

Phrase: "eNFTs"

Phrase: "are"

Phrase: "only weakly reactive with antibodies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1264626:Weakly-reactive [Qualitative Concept]
   760   C0205332:Reactive [Qualitative Concept]

Phrase: "to carboxy-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596260:Carboxy [Organic Chemical]

Phrase: "or"

Phrase: "amino-terminal epitopes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003316:Epitopes [Immunologic Factor]
Processing 00000000.tx.165: Our results are also consistent with the observation that Layer II of the transentorhinal cortex and the subiculum contains a large proportion of eNFTs, especially in severe cases of long duration (Dickson et al. 1992 ). 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "also consistent with the observation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that Layer II of the transentorhinal cortex"

Phrase: "and"

Phrase: "the subiculum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0152316:Subiculum [Body Part, Organ, or Organ Component]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a large proportion of eNFTs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709707:Proportion [Quantitative Concept]

Phrase: "especially in severe cases of long duration"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   778   C0439591:Long duration [Qualitative Concept]
   748   C0205082:Severe [Qualitative Concept]
   748   C0205166:Long [Qualitative Concept]
   748   C0449238:Duration [Temporal Concept]
   748   C0868928:Cases [Functional Concept]
   748   C1533148:Cases [Quantitative Concept]
   748   C1706317:Long [Qualitative Concept]
   748   C2926735:Duration [Pharmacologic Substance]
   714 E C1706255:CASE [Medical Device]
   714 E C1706256:Case [Conceptual Entity]

Phrase: "(Dickson et al. 1992"

Phrase: ")."
Processing 00000000.tx.166: The greater sensitivity of the thioflavin-S and Gallyas silver staining methods compared to anti-tau immunohistochemistry warrants further inquiry into the mechanisms of these stains. 

Phrase: "The greater sensitivity of the thioflavin-S"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0036667:Sensitivity [Quantitative Concept]
   748   C0312418:Sensitivity [Mental Process]
   748   C0427965:Sensitivity [Finding]
   748   C1511883:Sensitivity [Quantitative Concept]
   748   C1522640:Sensitivity [Qualitative Concept]
   748   C2346484:SENSITIVITY [Phenomenon or Process]
   748   C2349185:Sensitivity [Qualitative Concept]

Phrase: "and"

Phrase: "Gallyas silver staining methods"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   912   C1293950:Silver Staining Method [Laboratory Procedure]
   844   C0487602:Staining method [Laboratory Procedure]
   812   C0025663:Methods [Intellectual Product]
   812   C0025664:methods [Intellectual Product]
   812   C0449851:Methods [Functional Concept]
   779 E C0871511:METHOD [Intellectual Product]

Phrase: "compared to anti-tau immunohistochemistry warrants further inquiry"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   744   C0021044:Immunohistochemistry [Laboratory Procedure]
   744   C0035168:inquiry [Research Activity]
   744   C1517331:Further [Spatial Concept]
   744   C1707455:Compared [Activity]
   744   C1720655:Tau [Intellectual Product]
   744   C1947974:Tau [Research Activity]
   744   C2987583:Inquiry [Activity]
   711 E C0205108:far [Spatial Concept]

Phrase: "into the mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "of these stains."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038128:Stains [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.167: The related benzothiazole dye thioflavin-T (ThT), a classical amyloid stain for senile plaques containing -amyloid peptide in AD brain, binds rapidly and specifically to anti-parallel -sheet fibrils. 

Phrase: "The related benzothiazole dye thioflavin-T (ThT"

Phrase: ")"

Phrase: ","

Phrase: "a classical amyloid stain for senile plaques"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "containing -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "amyloid peptide in AD brain,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "and"

Phrase: "specifically to anti-parallel -sheet fibrils."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0225328:fibrils [Cell Component]
   753   C2348042:Parallel [Qualitative Concept]
   753   C2349187:Sheet [Quantitative Concept]
   753   C2826345:PARALLEL [Research Activity]
   719 E C1948066:Fibril [Physical Object]
Processing 00000000.tx.168: The fibrillar -sheet-bound dye species undergoes a characteristic 120-nm red shift of its excitation spectrum that may be selectively excited at 450 nm, resulting in a fluorescence signal at 482 nm (LeVine H 1997 ). 

Phrase: "The fibrillar -sheet-bound dye species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1705920:Species [Conceptual Entity]

Phrase: "undergoes"

Phrase: "a characteristic 120-nm red shift of its excitation spectrum"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0332575:Red [Finding]
   739   C0333051:Shift [Functional Concept]
   739   C1260956:Red [Qualitative Concept]
   739   C2347509:Shift [Phenomenon or Process]

Phrase: "that"

Phrase: "may"

Phrase: "be"

Phrase: "selectively"

Phrase: "excited at 450 nm,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0312860:NM [Cell Function]
   770   C0549255:Excited [Activity]

Phrase: "resulting in a fluorescence signal"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   806   C0332294:Resulting in [Functional Concept]
   760   C0016315:Fluorescence [Natural Phenomenon or Process]
   760   C0678226:resulting [Functional Concept]
   760   C1710082:Signal [Phenomenon or Process]
   726 E C1274040:Result [Functional Concept]
   726 E C1546471:Result [Idea or Concept]
   726 E C2825142:Result [Finding]

Phrase: "at 482 nm (LeVine H 1997"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0033727:H+ [Element, Ion, or Isotope]
   804   C0312860:NM [Cell Function]
   804   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0441932:H+ [Classification]
   804   C0564385:/h [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.169: Thioflavin-S is likely to share a similar mechanism. 

Phrase: "Thioflavin-S is likely to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0332148:Likely [Qualitative Concept]
   804   C0750492:Likely [Idea or Concept]
   804   C0950261:thioflavine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "share"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "a similar mechanism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.170: In our in situ emission scan study, thioflavin-S-stained tissues, when post-treated with concentrated phosphate buffer, displayed a sharp emission peak at 525 nm when excited around 480 nm (data not shown). 

Phrase: "In our in situ emission scan study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0557651:Study [Manufactured Object]
   804   C2603343:Study [Research Activity]

Phrase: "thioflavin-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0950261:thioflavine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "S-"

Phrase: "stained tissues,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C0282157:stain tissue [Indicator, Reagent, or Diagnostic Aid]
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: "when"

Phrase: "post-"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0687676:Post [Temporal Concept]
  1000   C1704687:Post [Manufactured Object]
   928 E C1514253:Postal [Functional Concept]

Phrase: "treated with concentrated phosphate buffer,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   806   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C1522326:Treated [Functional Concept]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   760   C1880165:Concentrated [Biomedical or Dental Material]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "a sharp emission peak at 525 nm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0444505:Peak [Quantitative Concept]

Phrase: "when"

Phrase: "excited around 480 nm (data"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0312860:NM [Cell Function]
   760   C0549255:Excited [Activity]
   760   C1511726:Data [Idea or Concept]
   760   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.171: The emission spectrum of thioflavin-S staining might be wide or might have two peaks, because thioflavin-S staining is visible at both DAPI and FITC channels. 

Phrase: "The emission spectrum of thioflavin-S staining"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0233929:Emission [Body Substance]
   748   C1883073:Spectrum [Quantitative Concept]
   748   C2349995:Emission [Substance]
   748   C2827424:Spectrum [Conceptual Entity]

Phrase: "might"

Phrase: "be"

Phrase: "wide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332464:Wide [Spatial Concept]

Phrase: "or"

Phrase: "might"

Phrase: "have"

Phrase: "two peaks,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:peaks [Quantitative Concept]

Phrase: "because"

Phrase: "thioflavin-S staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]

Phrase: "is"

Phrase: "visible at both DAPI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205379:Visible [Qualitative Concept]

Phrase: "and"

Phrase: "FITC channels."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]
Processing 00000000.tx.172: Consistent with a binding interaction with fibrillar -sheet elements, treatment with formic acid immediately destroys thioflavin-S staining. 

Phrase: "Consistent with a binding interaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "with fibrillar -sheet elements,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0013879:Elements [Element, Ion, or Isotope]
   793 E C1705248:Element [Conceptual Entity]

Phrase: "treatment with formic acid immediately"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "destroys"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0681205:Destroy [Idea or Concept]

Phrase: "thioflavin-S staining."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]
Processing 00000000.tx.173: Although formic acid treatment can covalently modify the protein, it usually takes hours (t1/2=3.5 hr for -amyloid) (Klunk et al. 1994 ). 

Phrase: "Although"

Phrase: "formic acid treatment"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]
   734   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   734   C0885348:formic acid [Organic Chemical]

Phrase: "can"

Phrase: "covalently"

Phrase: "modify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "the protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "it usually"

Phrase: "takes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515187:Take [Health Care Activity]

Phrase: "hours"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0439227:hours [Temporal Concept]
   966 E C0564385:/hour [Quantitative Concept]

Phrase: "(t1/2=3.5 hr for -amyloid"

Phrase: ")"

Phrase: "(Klunk et al. 1994"

Phrase: ")."
Processing 00000000.tx.174: The low background staining indicates that a large array of -sheet structure is required for binding because thioflavin-S does not appear to stain native proteins that have only a few relatively isolated -strands. 

Phrase: "The low background staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]

Phrase: "indicates"

Phrase: "that"

Phrase: "a large array of -sheet structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0678594:Structure [Spatial Concept]

Phrase: "is"

Phrase: "required for binding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0243122:binding [Functional Concept]
   790   C1145667:Binding [Activity]
   790   C1167622:Binding [Molecular Function]
   790   C1514873:Required [Functional Concept]

Phrase: "because"

Phrase: "thioflavin-S"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "stain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "native proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0302891:Native [Functional Concept]

Phrase: "that"

Phrase: "have"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a few relatively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205388:Few [Quantitative Concept]

Phrase: "isolated -"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "strands."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1704972:Strand [Spatial Concept]
   966   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.175: Previously proposed models hypothesize that a minimum of five adjacent -sheet strands is necessary for Congo red (Klunk et al. 1989 ), and a similar requirement may apply to thioflavin-S. 

Phrase: "Previously proposed models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3161035:Models [Intellectual Product]

Phrase: "hypothesize"

Phrase: "that"

Phrase: "a minimum of five adjacent -sheet strands"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1524031:Minimum [Qualitative Concept]
   748   C1552614:minimum [Idea or Concept]
   748   C2826545:MINIMUM [Quantitative Concept]

Phrase: "is"

Phrase: "necessary for Congo red"

Phrase: "(Klunk et al. 1989"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "a similar requirement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1514873:Requirement [Functional Concept]

Phrase: "may"

Phrase: "apply"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0185125:Apply [Health Care Activity]
  1000   C1632850:Apply [Functional Concept]
  1000   C1879355:Apply [Functional Concept]

Phrase: "to thioflavin-S."
Processing 00000000.tx.176: The intense staining of AD pathology by thioflavin-S raises the question of whether it could identify pathological structures in other neurodegenerative diseases. 

Phrase: "The intense staining of AD pathology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0487602:Staining [Laboratory Procedure]
   753   C1704680:Staining [Finding]

Phrase: "by thioflavin-S"

Phrase: "raises"

Phrase: "the question of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1522634:Question [Intellectual Product]

Phrase: "whether"

Phrase: "it"

Phrase: "could"

Phrase: "identify"

Phrase: "pathological structures in other neurodegenerative diseases."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0678594:structures [Spatial Concept]
Processing 00000000.tx.177: The mechanisms of Gallyas silver staining of NFTs have not been fully elucidated. 

Phrase: "The mechanisms of Gallyas silver staining of NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0441712:Mechanisms [Functional Concept]
   708 E C1706376:Mechanism [Manufactured Object]

Phrase: "have"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "fully"

Phrase: "elucidated."
Processing 00000000.tx.178: It does not bear an absolute requirement for -sheet structures because it can stain NFTs in formic acid-pretreated sections. 

Phrase: "It"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "bear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004897:Bear [Mammal]

Phrase: "an absolute requirement for -sheet structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1514873:Requirement [Functional Concept]

Phrase: "because"

Phrase: "it"

Phrase: "can"

Phrase: "stain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "NFTs in formic acid-pretreated sections."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   778   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   745 E C3543859:neurofibrillary tangle [Cell Component]
Processing 00000000.tx.179: One possibility is that Gallyas silver staining may be related to the loss of the ability of NFTs to reduce silver ions in a manner similar to that of degenerative axons (Gallyas et al. 1980 ; Gallyas 1982 ). 

Phrase: "One possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   789   C0332149:Possible [Qualitative Concept]
   789   C1705910:Possible [Qualitative Concept]
   789   C2362652:Possible [Qualitative Concept]

Phrase: "is"

Phrase: "that Gallyas silver staining"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   901   C1293950:Silver Staining [Laboratory Procedure]
   884 E C1318876:Silver stain [Indicator, Reagent, or Diagnostic Aid]
           Silver
   827   C0037125:Silver [Element, Ion, or Isotope]
   827   C0487602:Staining [Laboratory Procedure]
   827   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   827   C1305285:Silver [Qualitative Concept]
   827   C1704680:Staining [Finding]
   793 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   743 E C0079853:Moon [Geographic Area]
   734 E C0003782:Argyria [Injury or Poisoning]
   734 E C3463959:Argyria [Eukaryote]

Phrase: "may"

Phrase: "be"

Phrase: "related to the loss of the ability of NFTs to"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   756   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   738   C0085732:Ability [Organism Attribute]
   738   C0439849:Related [Qualitative Concept]
   738   C0445223:Related [Finding]
   738   C1517945:Loss [Quantitative Concept]
   722 E C3543859:neurofibrillary tangle [Cell Component]
   704 E C0163712:Relate [Organic Chemical]

Phrase: "reduce"

Phrase: "silver ions in a manner"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0022023:Ions [Element, Ion, or Isotope]
   726 E C1700702:ION [Functional Concept]

Phrase: "similar to that of degenerative axons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348205:Similar [Qualitative Concept]

Phrase: "(Gallyas et al. 1980"

Phrase: "; Gallyas 1982"

Phrase: ")."
Processing 00000000.tx.180: In terms of applicability to routine neuropathological diagnosis, the general affinities of thioflavin-S for diverse AD pathologies can be viewed as a technical advantage because it can stain both plaque and tangle pathology with a single and simple technique. 

Phrase: "In terms of applicability"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   928   C1272460:applicable [Qualitative Concept]
   928   C1706839:Applicable [Qualitative Concept]

Phrase: "to routine neuropathological diagnosis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0011900:Diagnosis [Finding]
   827   C1704338:diagnosis [Qualitative Concept]
   827   C1704656:DIAGNOSIS [Research Activity]

Phrase: "the general affinities of thioflavin-S"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "for diverse AD pathologies"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0030664:Pathologies [Biomedical Occupation or Discipline]
   793 E C0205469:pathology [Functional Concept]
   793 E C0677042:pathology [Pathologic Function]
   743 E C1521733:Pathologic [Functional Concept]

Phrase: "can"

Phrase: "be"

Phrase: "viewed as a technical advantage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449851:Technical [Functional Concept]
   726   C0449911:View [Spatial Concept]

Phrase: "because"

Phrase: "it"

Phrase: "can"

Phrase: "stain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "both plaque"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011389:Plaque [Disease or Syndrome]
  1000   C0332461:Plaque [Finding]
  1000   C0333463:plaque [Acquired Abnormality]

Phrase: "and"

Phrase: "tangle pathology with a single"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0030664:Pathology [Biomedical Occupation or Discipline]
   760   C0205469:pathology [Functional Concept]
   760   C0677042:pathology [Pathologic Function]

Phrase: "and"

Phrase: "simple technique."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0449851:Technique [Functional Concept]
   777 E C0025664:techniques [Intellectual Product]
Processing 00000000.tx.181: Usually, difficulty in long-term preservation of thioflavin-S results limits its wide application in routine neuropathological diagnosis of AD, although the ability to digitally store photomicrographs may obviate this drawback. 

Phrase: "Usually,"

Phrase: "difficulty in long-term preservation of thioflavin-S results"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1299586:Difficulty [Finding]

Phrase: "limits"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439801:limit [Functional Concept]
  1000   C1549649:Limit [Idea or Concept]
  1000   C2349209:Limit [Conceptual Entity]

Phrase: "its wide application in routine neuropathological diagnosis of AD,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0185125:Application [Health Care Activity]
   742   C1947919:Application [Intellectual Product]
   742   C2347934:Application [Intellectual Product]
   742   C3539080:APPLICATION [Quantitative Concept]

Phrase: "although"

Phrase: "the ability to digitally"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0085732:Ability [Organism Attribute]

Phrase: "store"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1698986:Store [Functional Concept]

Phrase: "photomicrographs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   893   C0031753:Photomicrographies [Laboratory Procedure]

Phrase: "may"

Phrase: "obviate"

Phrase: "this drawback."
Processing 00000000.tx.182: Our modifications to the procedure, which enhance tissue quality and fluorescence photostability, may make the method more consistent and therefore more amenable to routine clinical use. 

Phrase: "Our modifications to the procedure,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0392747:Modification [Functional Concept]
   726   C1554963:modification [Qualitative Concept]

Phrase: "which"

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "tissue quality"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332306:Quality [Qualitative Concept]

Phrase: "and"

Phrase: "fluorescence photostability,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3272552:Photostability [Intellectual Product]

Phrase: "may"

Phrase: "make"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "the method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "more consistent"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0332290:Consistent [Idea or Concept]
   789 E C0332529:Consistencies [Qualitative Concept]
   789 E C1547017:Consistency [Quantitative Concept]

Phrase: "and"

Phrase: "therefore more amenable to routine clinical use."
Processing 00000000.tx.183: The Gallyas silver stain is another sensitive method for NFT demonstration but, like other silver stains, is often associated with higher variability than thioflavin-S. 

Phrase: "The Gallyas silver stain"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   901   C1318876:Silver stain [Indicator, Reagent, or Diagnostic Aid]
           Silver
   827   C0037125:Silver [Element, Ion, or Isotope]
   827   C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   827   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   827   C1305285:Silver [Qualitative Concept]
   743 E C0079853:Moon [Geographic Area]
   734 E C0003782:Argyria [Injury or Poisoning]
   734 E C3463959:Argyria [Eukaryote]

Phrase: "is"

Phrase: "another sensitive method for NFT demonstration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0025663:Method [Intellectual Product]
   753   C0449851:Method [Functional Concept]
   753   C0871511:METHOD [Intellectual Product]

Phrase: "but"

Phrase: ","

Phrase: "like other silver stains,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1318876:Silver stain [Indicator, Reagent, or Diagnostic Aid]
   861   C0038128:Stains [Indicator, Reagent, or Diagnostic Aid]

Phrase: "is"

Phrase: "often"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Often [Temporal Concept]

Phrase: "associated with higher variability"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C2827666:Variability [Conceptual Entity]
   737   C0205250:High [Qualitative Concept]
   737 E C0750490:Associate [Idea or Concept]
   737   C1299351:High [Qualitative Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   737   C2700149:HIGH [Intellectual Product]

Phrase: "than thioflavin-S."
Processing 00000000.tx.184: One drawback is that, unlike fluorescence-based methods, it lacks the capacity for multiple labeling. 

Phrase: "One drawback"

Phrase: "is"

Phrase: "that,"

Phrase: "unlike fluorescence-based methods,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0025663:Methods [Intellectual Product]
   827   C0025664:methods [Intellectual Product]
   827   C0449851:Methods [Functional Concept]
   793 E C0871511:METHOD [Intellectual Product]

Phrase: "it"

Phrase: "lacks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "the capacity for multiple labeling."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1516240:Capacity [Quantitative Concept]
Processing 00000000.tx.185: Our results with immunostaining suggest that tau immunoreactivity using the two antibodies examined may not be useful for quantitative staining of tangles, although they can be useful in differentiating specific NFT subpopulations. 

Phrase: "Our results with immunostaining"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that tau immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597879:immunoreactivity [Molecular Function]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the two antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "may"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "useful for quantitative staining of tangles,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1524063:Use of [Functional Concept]

Phrase: "although"

Phrase: "they"

Phrase: "can"

Phrase: "be"

Phrase: "useful in differentiating specific NFT subpopulations."
Processing 00000000.tx.186: Finally, our general approach to performing multiple stains on same sections may be useful in a number of research situations where individual tangles may need to be identified or categorized based on their affinities for certain antibodies. 

Phrase: "Finally,"

Phrase: "our general approach to performing multiple stains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449445:Approach [Spatial Concept]

Phrase: "on same sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "may"

Phrase: "be"

Phrase: "useful in a number of research situations where individual tangles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   722   C1524063:Use of [Functional Concept]

Phrase: "may"

Phrase: "need"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "or"

Phrase: "categorized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871968:categorized [Activity]

Phrase: "based on their affinities"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737   C1510827:Affinity [Natural Phenomenon or Process]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "for certain antibodies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.187: Acknowledgments Supported by NIH grant 3R01 NS39345-01 (to GB). 

Phrase: "Acknowledgments"

Phrase: "Supported by NIH grant 3R01 NS39345-01"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   748   C0018173:Grant [Quantitative Concept]
   748   C0027468:NIH [Health Care Related Organization]
   748   C1521721:Supported [Conceptual Entity]
   748   C1548284:Grant [Idea or Concept]
   714 E C0183683:Support [Medical Device]

Phrase: "("

Phrase: "to GB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041700:GB [Geographic Area]
  1000   C1551090:Gb [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.188: Human brain sections used in this study were kindly provided by the University of Kentucky Alzheimer's Disease Research Center, headed by Dr William R. 

Phrase: "Human brain sections"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   793   C0205155:Section [Spatial Concept]
   793   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   793   C1522472:Section [Substance]
   793   C1552923:Section [Quantitative Concept]
   793   C1705191:Section [Physical Object]

Phrase: "used in this study"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "were"

Phrase: "kindly"

Phrase: "provided by the University of Kentucky Alzheimer's Disease Research Center,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0002395:Alzheimer's Disease [Disease or Syndrome]
   760   C0683939:research center [Manufactured Object,Organization]
   760   C1521724:Alzheimer's Disease [Pathologic Function]
   739   C0012634:Disease [Disease or Syndrome]
   739   C0022557:Kentucky [Geographic Area]
   739   C0035168:research [Research Activity]
   739   C0041740:University [Manufactured Object,Organization]
   739   C0205099:Center [Spatial Concept]
   739   C0242481:Research [Research Activity]
   739   C1999230:Provided [Activity]

Phrase: "headed by Dr William R."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0031831:DR [Professional or Occupational Group]
   760   C0205090:R- [Spatial Concept]
   760   C0684010:R. [Professional or Occupational Group]
   760   C1707664:DR [Biomedical or Dental Material]
   760   C2348314:Dr. [Conceptual Entity]
   760   C2603358:R' [Clinical Attribute]
   760   C3540849:DR [Idea or Concept]
   726   C0018670:Head [Body Location or Region]
   726   C1281590:Head [Body Part, Organ, or Organ Component]
   726   C1706305:Head [Manufactured Object]
Processing 00000000.tx.189: Markesbery. 

Phrase: "Markesbery."
Processing 00000000.tx.190: Ann Tudor cut the sections for this study. 

Phrase: "Ann Tudor"

Phrase: "cut"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0000925:Cut [Injury or Poisoning]
  1000   C1883724:CUT [Phenomenon or Process]

Phrase: "the sections for this study."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   781   C1515004:Study Section [Professional or Occupational Group]
   726   C0205155:Section [Spatial Concept]
   726   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   726   C1522472:Section [Substance]
   726   C1552923:Section [Quantitative Concept]
   726   C1705191:Section [Physical Object]
Processing 00000000.tx.191: Received for publication July 11, 2001; 

Phrase: "Received for publication July 11,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0034036:Publication [Intellectual Product,Manufactured Object]
   760   C0034037:Publication [Occupational Activity]
   760   C1514756:Received [Qualitative Concept]
   760   C1704324:Publication [Intellectual Product]

Phrase: "2001"

Phrase: ";"
Processing 00000000.tx.192: accepted November 28, 2001. 

Phrase: "accepted November 28,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1272684:Accepted [Qualitative Concept]
   827   C1548435:Accepted [Idea or Concept]

Phrase: "2001."
Processing 00000000.tx.193: Literature Cited Top Summary Introduction Materials and Methods Results Discussion Literature Cited Alonso A, Zaidi T, Novak M, GrundkeIqbal I, Iqbal K (2001) Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments. 

Phrase: "Literature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0023866:Literature [Intellectual Product]
  1000   C0034036:LITERATURE [Intellectual Product,Manufactured Object]

Phrase: "Cited"

Phrase: "Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion Literature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0023866:Literature [Intellectual Product]
   812   C0034036:LITERATURE [Intellectual Product,Manufactured Object]

Phrase: "Cited"

Phrase: "Alonso A,"

Phrase: "Zaidi T,"

Phrase: "Novak M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "GrundkeIqbal I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Iqbal K (2001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1708601:K' [Quantitative Concept]

Phrase: ")"

Phrase: "Hyperphosphorylation"

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "self-assembly of tau"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0036588:Self [Idea or Concept]
   770   C1551994:self [Intellectual Product]
   770   C1706853:Assembly [Activity]
   770   C1879748:Assembly [Manufactured Object]
   770   C3244295:Self [Intellectual Product]

Phrase: "into tangles"

Phrase: "of paired helical filaments/straight filaments."
Processing 00000000.tx.194: Proc Natl Acad Sci USA 98:6923-6928[Abstract/Free FullText] Bondareff W, Harrington CR, Wischik CM, Hauser DL, Roth M (1995) Absence of abnormal hyperphosphorylation of tau in intracellular tangles in Alzheimer's disease. 

Phrase: "Proc Natl Acad Sci USA 98"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "6923-6928"

Phrase: "[Abstract/Free FullText"

Phrase: "] Bondareff W,"

Phrase: "Harrington CR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0201975:Cr [Laboratory Procedure]
   861   C3539604:CR [Gene or Genome]

Phrase: "Wischik CM,"

Phrase: "Hauser DL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642216:/dL [Quantitative Concept]

Phrase: "Roth"

Phrase: "M ("

Phrase: "1995"

Phrase: ")"

Phrase: "Absence of abnormal hyperphosphorylation of tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332197:absence [Quantitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]

Phrase: "in intracellular tangles"

Phrase: "in Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.195: J Neuropathol Exp Neurol 54:657-663[Medline] Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. 

Phrase: "J Neuropathol Exp Neurol 54"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1417055:EXP [Gene or Genome]

Phrase: ":"

Phrase: "657-663"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Braak H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Braak E (1991"

Phrase: ")"

Phrase: "Neuropathological stageing of Alzheimer-related changes."
Processing 00000000.tx.196: Neurobiol Aging 82:239-259 Braak H, Braak E (1992) The human entorhinal cortex: normal morphology and lamina-specific pathology in various diseases. 

Phrase: "Neurobiol"

Phrase: "Aging"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001811:Aging [Organism Function]
   966 E C0001779:Age [Organism Attribute]

Phrase: "82"

Phrase: ":"

Phrase: "239-259 Braak H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0033727:H+ [Element, Ion, or Isotope]
   812   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441932:H+ [Classification]
   812   C0564385:/h [Quantitative Concept]

Phrase: "Braak E (1992"

Phrase: ")"

Phrase: "The human entorhinal cortex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0175196:Entorhinal Cortex [Body Part, Organ, or Organ Component]
   901   C1289526:Entorhinal cortex [Body Part, Organ, or Organ Component]
   827   C0007776:Cortex [Body Part, Organ, or Organ Component]
   827   C1176472:Cortex [Body Part, Organ, or Organ Component]
   827   C2700441:Cortex [Plant]

Phrase: ":"

Phrase: "normal morphology"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0332437:Morphology [Qualitative Concept]
   861   C0543482:morphology [Spatial Concept]
   861   C0700329:Morphology, NOS [Finding]
   861   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "lamina-specific pathology in various diseases."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0030664:Pathology [Biomedical Occupation or Discipline]
   753   C0205469:pathology [Functional Concept]
   753   C0677042:pathology [Pathologic Function]
Processing 00000000.tx.197: Neurosci Res 15:6-31[Medline] Cammarata S, Mancardi G, Tabaton M (1990) Formic acid treatment exposes hidden neurofilament and tau epitopes in abnormal cytoskeletal filaments from patients with progressive supranuclear palsy and Alzheimer's disease. 

Phrase: "Neurosci Res 15"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "6-31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450355:31 [Intellectual Product]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Cammarata S,"

Phrase: "Mancardi G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Tabaton"

Phrase: "M ("

Phrase: "1990"

Phrase: ")"

Phrase: "Formic acid treatment"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]
   734   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   734   C0885348:formic acid [Organic Chemical]

Phrase: "exposes"

Phrase: "hidden neurofilament"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027834:Neurofilament [Cell Component]

Phrase: "and"

Phrase: "tau epitopes in abnormal cytoskeletal filaments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0003316:Epitopes [Immunologic Factor]

Phrase: "from patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with progressive supranuclear palsy"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   901   C0270920:Supranuclear palsy [Disease or Syndrome]
   885   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]
   827   C0205329:Progressive [Functional Concept]
   827   C0522224:Palsy [Finding]

Phrase: "and"

Phrase: "Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.198: Neurosci Lett 115:351-355[Medline] Cullen KM, Halliday GM, Cartwright H, Kril JJ (1996) Improved selectivity and sensitivity in the visualization of neurofibrillary tangles, plaques and neuropil threads. 

Phrase: "Neurosci Lett 115"

Phrase: ":"

Phrase: "351-355"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Cullen KM,"

Phrase: "Halliday GM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0546866:GM [Antibiotic,Carbohydrate]

Phrase: "Cartwright H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Kril JJ (1996"

Phrase: ")"

Phrase: "Improved selectivity"

Phrase: "and"

Phrase: "sensitivity in the visualization of neurofibrillary tangles,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0036667:Sensitivity [Quantitative Concept]
   748   C0312418:Sensitivity [Mental Process]
   748   C0427965:Sensitivity [Finding]
   748   C1511883:Sensitivity [Quantitative Concept]
   748   C1522640:Sensitivity [Qualitative Concept]
   748   C2346484:SENSITIVITY [Phenomenon or Process]
   748   C2349185:Sensitivity [Qualitative Concept]

Phrase: "plaques"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]

Phrase: "and"

Phrase: "neuropil threads."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521175:Neuropil Threads [Acquired Abnormality]
   827   C1710394:Thread [Manufactured Object]
   827   C1882475:Thread [Intellectual Product]
Processing 00000000.tx.199: Neurodegeneration 5:177-187[Medline] Delacourte A, David JP, Sergeant N, Buee L, Wattez A, Vermersch P, Ghozali F, FalletBianco C, Pasquier F, Lebert F, Petit H, Di Menza C (1999) The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease. 

Phrase: "Neurodegeneration 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]

Phrase: ":"

Phrase: "177-187"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Delacourte A,"

Phrase: "David JP,"

Phrase: "Sergeant N,"

Phrase: "Buee L,"

Phrase: "Wattez A,"

Phrase: "Vermersch P,"

Phrase: "Ghozali F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "FalletBianco C,"

Phrase: "Pasquier F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Lebert F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Petit H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Di Menza C (1999"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C3538902:DI [Gene or Genome]
   812   C3541881:DI [Idea or Concept]

Phrase: ")"

Phrase: "The biochemical pathway of neurofibrillary degeneration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1704259:Biochemical Pathway [Molecular Function]
           Pathway
   753   C0205474:Biochemical [Functional Concept]
   753   C1705987:Pathway [Conceptual Entity]

Phrase: "in aging"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]

Phrase: "and"

Phrase: "Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.200: Neurology 52:1158-1165[Abstract/Free FullText] Dickson DW, KsiezakReding H, Liu WK, Davies P, Crowe A, Yen SH (1992) Immunocytochemistry of neurofibrillary tangles with antibodies to subregions of tau protein: identification of hidden and cleaved tau epitopes and a new phosphorylation site. 

Phrase: "Neurology 52"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: ":"

Phrase: "1158-1165"

Phrase: "[Abstract/Free FullText"

Phrase: "] Dickson DW,"

Phrase: "KsiezakReding H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Liu WK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332174:/wk [Temporal Concept]
   861   C0439230:wk [Temporal Concept]

Phrase: "Davies P,"

Phrase: "Crowe A,"

Phrase: "Yen SH (1992"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0038108:SH [Geographic Area]
   827   C1555429:Yen [Quantitative Concept]

Phrase: ")"

Phrase: "Immunocytochemistry of neurofibrillary tangles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0242349:Immunocytochemistry [Laboratory Procedure]

Phrase: "with antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "to subregions"

Phrase: "of tau protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0085401:tau Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2700455:Tau Protein [Amino Acid, Peptide, or Protein]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: ":"

Phrase: "identification of hidden"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020792:Identification [Mental Process]
   790   C0205396:Identification [Qualitative Concept]

Phrase: "and"

Phrase: "cleaved tau epitopes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003316:Epitopes [Immunologic Factor]

Phrase: "and"

Phrase: "a new phosphorylation site."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C1519063:Phosphorylation Site [Amino Acid Sequence]
   827   C0031715:Phosphorylation [Molecular Function]
   827   C0205145:Site [Spatial Concept]
   827   C1158886:Phosphorylation [Molecular Function]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]
Processing 00000000.tx.201: Acta Neuropathol (Berl) 84:596-605[Medline] Endoh R, Ogawara M, Iwatsubo T, Nakano I, Mori H (1993) Lack of the carboxyl terminal sequence of tau in ghost tangles of Alzheimer's disease. 

Phrase: "Acta Neuropathol"

Phrase: "(Berl"

Phrase: ")"

Phrase: "84"

Phrase: ":"

Phrase: "596-605"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Endoh R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Ogawara M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Iwatsubo T,"

Phrase: "Nakano I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Mori H (1993"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: ")"

Phrase: "Lack of the carboxyl terminal sequence of tau"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   744   C0004793:Sequence [Nucleotide Sequence]
   744   C0162326:Sequence [Nucleotide Sequence]
   744   C0162327:Sequence [Nucleotide Sequence]
   744   C0205088:Terminal [Temporal Concept]
   744   C0332268:lack [Qualitative Concept]
   744   C0596260:Carboxyl [Organic Chemical]
   744   C1519249:Sequence [Functional Concept]
   744   C1705314:Terminal [Manufactured Object]
   744   C1705315:Terminal [Spatial Concept]
   744   C1720655:Tau [Intellectual Product]
   744   C1947974:Tau [Research Activity]

Phrase: "in ghost tangles"

Phrase: "of Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.202: Brain Res 601:164-172[Medline] Gallyas F (1971) Silver staining of Alzheimer's neurofibrillary changes by means of physical development. 

Phrase: "Brain Res 601"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "164-172"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gallyas F (1971"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]

Phrase: ")"

Phrase: "Silver staining of Alzheimer's neurofibrillary changes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1293950:Silver Staining [Laboratory Procedure]
   753   C0487602:Staining [Laboratory Procedure]
   753   C1704680:Staining [Finding]

Phrase: "by means of physical development."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0871079:physical development [Natural Phenomenon or Process]
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]
Processing 00000000.tx.203: Acta Morphol Acad Sci Hung 19:1-8[Medline] Gallyas F (1982) Physico-chemical mechanism of the argyrophil III reaction. 

Phrase: "Acta Morphol Acad Sci Hung 19"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0268596:ACAD [Disease or Syndrome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]
   766   C0544691:hang [Injury or Poisoning]
   766   C1823998:HANG [Gene or Genome]

Phrase: ":"

Phrase: "1-8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gallyas F (1982"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]

Phrase: ")"

Phrase: "Physico-chemical mechanism of the argyrophil III reaction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0441712:Mechanism [Functional Concept]
   744   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.204: Histochemistry 74:409-421[Medline] Gallyas F, Zaborszky L, Wolff JR (1980) Experimental studies of mechanisms involved in methods demonstrating axonal and terminal degeneration. 

Phrase: "Histochemistry 74"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019635:Histochemistry [Laboratory Procedure]

Phrase: ":"

Phrase: "409-421"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gallyas F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Zaborszky L,"

Phrase: "Wolff JR (1980"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1708595:Jr [Idea or Concept]
   827   C3280986:JR [Disease or Syndrome]

Phrase: ")"

Phrase: "Experimental studies of mechanisms"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0681814:experimental studies [Research Activity]
   777   C2698671:MECHANISTIC STUDIES [Regulation or Law]
   770   C0947630:studies [Laboratory Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "involved in methods"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0025663:Methods [Intellectual Product]
   790   C0025664:methods [Intellectual Product]
   790   C0449851:Methods [Functional Concept]
   790   C1314939:Involved [Functional Concept]
   756 E C0871511:METHOD [Intellectual Product]

Phrase: "demonstrating"

Phrase: "axonal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0004461:Axon [Cell Component]

Phrase: "and"

Phrase: "terminal degeneration."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011164:Degeneration [Pathologic Function]
   861   C1880269:Degeneration [Functional Concept]
Processing 00000000.tx.205: Stain Technol 55:281-290[Medline] Gertz HJ, Xuereb J, Huppert F, Brayne C, McGee MA, Paykel E, Harrington C, MukaetovaLadinska E, Arendt T, Wischik CM (1998) Examination of the validity of the hierarchical model of neuropathological staging in normal aging and Alzheimer's disease. 

Phrase: "Stain Technol 55"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   827   C0450382:55 [Intellectual Product]

Phrase: ":"

Phrase: "281-290"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gertz HJ,"

Phrase: "Xuereb J,"

Phrase: "Huppert F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Brayne C,"

Phrase: "McGee MA,"

Phrase: "Paykel E,"

Phrase: "Harrington C,"

Phrase: "MukaetovaLadinska E,"

Phrase: "Arendt T,"

Phrase: "Wischik CM (1998"

Phrase: ")"

Phrase: "Examination of the validity of the hierarchical model of neuropathological staging"

Phrase: "in normal aging"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001811:Ageing [Organism Function]

Phrase: "and"

Phrase: "Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.206: Acta Neuropathol (Berl) 95:154-158[Medline] Goedert M, Spillantini MG, Jakes R, Crowther RA, Vanmechelen E, Probst A, Gotz J, Burki K, Cohen P (1995) Molecular dissection of the paired helical filament. 

Phrase: "Acta Neuropathol"

Phrase: "(Berl"

Phrase: ")"

Phrase: "95"

Phrase: ":"

Phrase: "154-158"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Goedert M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Spillantini MG,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439269:mg% [Quantitative Concept]
   861   C1960952:mg % [Quantitative Concept]
   861   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "Jakes R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Crowther RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Vanmechelen E,"

Phrase: "Probst A,"

Phrase: "Gotz J,"

Phrase: "Burki K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Cohen P (1995"

Phrase: ")"

Phrase: "Molecular dissection of the paired helical filament."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0012737:Dissection [Therapeutic or Preventive Procedure]
Processing 00000000.tx.207: Neurobiol Aging 16:325-334[Medline] GomezIsla T, Hollister R, West H, Mui S, Growdon JH, Petersen RC, Parisi JE, Hyman BT (1997) Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. 

Phrase: "Neurobiol"

Phrase: "Aging"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001811:Aging [Organism Function]
   966 E C0001779:Age [Organism Attribute]

Phrase: "16"

Phrase: ":"

Phrase: "325-334"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] GomezIsla T,"

Phrase: "Hollister R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "West H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Mui S,"

Phrase: "Growdon JH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268060:JH [Disease or Syndrome]
   861   C1415529:JH [Gene or Genome]

Phrase: "Petersen RC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419366:RC [Gene or Genome]

Phrase: "Parisi JE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0454673:JE [Geographic Area]
   861   C1550752:JE [Temporal Concept]

Phrase: "Hyman BT (1997"

Phrase: ")"

Phrase: "Neuronal loss"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1850496:Neuronal loss [Finding]
   964 E C0598940:neuron loss [Finding]
   861   C1517945:Loss [Quantitative Concept]

Phrase: "correlates with"

Phrase: "but"

Phrase: "exceeds"

Phrase: "neurofibrillary tangles in Alzheimer's disease."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   806   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   773 E C3543859:neurofibrillary tangle [Cell Component]
Processing 00000000.tx.208: Ann Neurol 41:17-24[Medline] Gorevic PD, Goni F, PonsEstel B, Alvarez F, Peress NS, Frangione B (1986) Isolation and partial characterization of neurofibrillary tangles and amyloid plaque core in Alzheimer's disease: immunohistological studies. 

Phrase: "Ann Neurol 41"

Phrase: ":"

Phrase: "17-24"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gorevic PD,"

Phrase: "Goni F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "PonsEstel B,"

Phrase: "Alvarez F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Peress NS,"

Phrase: "Frangione B (1986"

Phrase: ")"

Phrase: "Isolation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0204727:Isolation [Therapeutic or Preventive Procedure]
  1000   C0205409:Isolation [Functional Concept]
  1000   C0220862:isolation [Laboratory Procedure]
   928 E C1548221:Isolated [Idea or Concept]

Phrase: "and"

Phrase: "partial characterization of neurofibrillary tangles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880022:Characterization [Activity]

Phrase: "and"

Phrase: "amyloid plaque core in Alzheimer's disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0444669:Core [Spatial Concept]
   753   C1167518:core [Cell Component]
   753   C1706352:Core [Medical Device]
   753   C1882467:Core [Manufactured Object]
   753   C3274653:Core [Body Substance]

Phrase: ":"

Phrase: "immunohistological studies."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]
Processing 00000000.tx.209: J Neuropathol Exp Neurol 45:647-664[Medline] Guntern R, Bouras C, Hof PR, Vallet PG (1992) An improved thioflavine S method for staining neurofibrillary tangles and senile plaques in Alzheimer's disease. 

Phrase: "J Neuropathol Exp Neurol 45"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1417055:EXP [Gene or Genome]

Phrase: ":"

Phrase: "647-664"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Guntern R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Bouras C,"

Phrase: "Hof PR,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0279759:PR+ [Laboratory or Test Result]
   861   C0279766:PR- [Laboratory or Test Result]
   861   C1418864:PR@ [Gene or Genome]
   861   C3538934:PR [Intellectual Product]
   861   C3538935:PR [Idea or Concept]

Phrase: "Vallet PG (1992"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1266240:PG [Laboratory Procedure]

Phrase: ")"

Phrase: "An improved thioflavine S method for staining neurofibrillary tangles"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0487602:Staining method [Laboratory Procedure]
   742   C0025663:Method [Intellectual Product]
   742   C0449851:Method [Functional Concept]
   742   C0871511:METHOD [Intellectual Product]

Phrase: "and"

Phrase: "senile plaques in Alzheimer's disease."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   806   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   760   C0392079:Senile [Finding]
   726 E C0011389:Plaque [Disease or Syndrome]
   726 E C0332461:Plaque [Finding]
   704 E C0231337:Old age [Finding]
   704 E C1999167:Old age [Population Group]
Processing 00000000.tx.210: Experientia 48:8-10[Medline] Iqbal K, Alonso ADC, Smith AJ, George L, Tung Y-C, Zaidi T (1989) Identification and localization of a tau peptide to paired helical filaments of Alzheimer disease. 

Phrase: "Experientia 48"

Phrase: ":"

Phrase: "8-10"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Iqbal K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Alonso ADC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0879593:ADC [Cell,Pharmacologic Substance]
   861   C1826409:ADC [Gene or Genome]
   861   C3539026:ADC [Intellectual Product]

Phrase: "Smith AJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0230613:AJ [Cell Component]

Phrase: "George L,"

Phrase: "Tung Y-C,"

Phrase: "Zaidi T (1989"

Phrase: ")"

Phrase: "Identification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020792:Identification [Mental Process]
  1000   C0205396:Identification [Qualitative Concept]

Phrase: "and"

Phrase: "localization of a tau peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "to paired helical filaments"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   966   C0597162:paired helical filament [Cell or Molecular Dysfunction]
   827   C1709450:Paired [Qualitative Concept]
   793   C0010851:Filament [Cell Component]
   743 E C1979891:Filamentous [Qualitative Concept]

Phrase: "of Alzheimer disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.211: Proc Natl Acad Sci USA 86:5646-5650[Abstract] Kitamoto T, Ogomori K, Tateishi J, Prusiner SB (1987) Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. 

Phrase: "Proc Natl Acad Sci USA 86"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "5646-5650"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Kitamoto T,"

Phrase: "Ogomori K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Tateishi J,"

Phrase: "Prusiner SB (1987"

Phrase: ")"

Phrase: "Formic acid pretreatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C1550147:Pretreatment [Substance]
   827   C2709094:pre treatment [Temporal Concept]
   827   C3539075:Pretreatment [Temporal Concept]
   827   C3539076:Pretreatment [Activity]
   734   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   734   C0885348:formic acid [Organic Chemical]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "immunostaining of cerebral"

Phrase: "and"

Phrase: "systemic amyloids."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0002716:amyloids [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827 E C0011560:Amyloid [Pathologic Function]
   827 E C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.212: Lab Invest 57:230-236[Medline] Klunk WE, Pettegrew JW, Abraham DJ (1989) Quantitative evaluation of congo red binding to amyloid-like proteins with a beta-pleated sheet conformation. 

Phrase: "Lab"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0022877:Lab [Manufactured Object,Organization]
   944 E C0035100:Rennin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   916 E C0587081:Labs [Finding]

Phrase: "Invest"

Phrase: "57"

Phrase: ":"

Phrase: "230-236"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Klunk"

Phrase: "WE,"

Phrase: "Pettegrew JW,"

Phrase: "Abraham DJ (1989"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0012836:DJ [Geographic Area]
   827   C0442982:Abraham [Intellectual Product]

Phrase: ")"

Phrase: "Quantitative evaluation of congo red binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0034384:Quantitative Evaluation [Quantitative Concept]
   753   C0220825:Evaluation [Functional Concept]
   753   C1261322:Evaluation [Health Care Activity]

Phrase: "to amyloid-like proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C1456454:Amyloid Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "with a beta-pleated sheet conformation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0026377:Conformation [Spatial Concept]
   717   C0599215:Beta Pleated Sheet [Cell Component]
Processing 00000000.tx.213: J Histochem Cytochem 37:1273-1281[Abstract] Klunk WE, Xu CJ, Pettegrew JW (1994) NMR identification of the formic acid-modified residue in Alzheimer's amyloid protein. 

Phrase: "J Histochem Cytochem 37"

Phrase: ":"

Phrase: "1273-1281"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Klunk"

Phrase: "WE,"

Phrase: "Xu CJ,"

Phrase: "Pettegrew JW"

Phrase: "(1994"

Phrase: ")"

Phrase: "NMR identification of the formic acid-modified residue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0020792:Identification [Mental Process]
   744   C0205396:Identification [Qualitative Concept]

Phrase: "in Alzheimer's amyloid protein."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.214: J Neurochem 62:349-354[Medline] Ksiezak-Reding H, Morgan K, Dickson DW (1994) Tau immunoreactivity and SDS solubility of two populations of paired helical filaments that differ in morphology. 

Phrase: "J Neurochem 62"

Phrase: ":"

Phrase: "349-354"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ksiezak-Reding H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "Morgan K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Dickson DW (1994"

Phrase: ")"

Phrase: "Tau immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597879:immunoreactivity [Molecular Function]

Phrase: "and"

Phrase: "SDS solubility of two populations of paired helical filaments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0037628:Solubility [Qualitative Concept]

Phrase: "that"

Phrase: "differ in morphology."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0332437:Morphology [Qualitative Concept]
   790   C0543482:morphology [Spatial Concept]
   790   C0700329:Morphology, NOS [Finding]
   790   C0700619:Morphology [Biomedical Occupation or Discipline]
Processing 00000000.tx.215: Brain Res 649:185-196[Medline] Lamy C, Duyckaerts C, Delaere P, Payan C, Fermanian J, Poulain V, Hauw JJ (1989) Comparison of seven staining methods for senile plaques and neurofibrillary tangles in a prospective series of 15 elderly patients. 

Phrase: "Brain Res 649"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "185-196"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lamy C,"

Phrase: "Duyckaerts C,"

Phrase: "Delaere P,"

Phrase: "Payan C,"

Phrase: "Fermanian J,"

Phrase: "Poulain V,"

Phrase: "Hauw JJ (1989"

Phrase: ")"

Phrase: "Comparison of seven staining methods"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707455:Comparison [Activity]

Phrase: "for senile plaques"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   861   C0392079:Senile [Finding]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   805 E C0231337:Old age [Finding]
   805 E C1999167:Old age [Population Group]

Phrase: "and"

Phrase: "neurofibrillary tangles in a prospective series of 15 elderly patients."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   726 E C3543859:neurofibrillary tangle [Cell Component]
Processing 00000000.tx.216: Neuropathol Appl Neurobiol 15:563-578[Medline] Lee VM, Balin BJ, Otvos L, Jr, Trojanowski JQ (1991) A68: a major subunit of paired helical filaments and derivatized forms of normal Tau. 

Phrase: "Neuropathol Appl Neurobiol 15"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1858559:APPL [Gene or Genome]

Phrase: ":"

Phrase: "563-578"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lee VM,"

Phrase: "Balin BJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005005:BJ [Geographic Area]

Phrase: "Otvos L,"

Phrase: "Jr,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "Trojanowski JQ"

Phrase: "(1991"

Phrase: ")"

Phrase: "A68"

Phrase: ":"

Phrase: "a major subunit of paired helical filaments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1711351:Subunit [Quantitative Concept]

Phrase: "and"

Phrase: "derivatized forms of normal Tau."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   797   C0439171:% normal forms [Quantitative Concept]
   760   C0348078:forms [Qualitative Concept]
   760   C0376315:Forms [Manufactured Object]
   726 E C1522492:Form [Functional Concept]
Processing 00000000.tx.217: Science 251:675-678[Medline] LeVine H, III (1997) Stopped-flow kinetics reveal multiple phases of thioflavin T binding to Alzheimer beta (1-40) amyloid fibrils. 

Phrase: "Science 251"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "675-678"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] LeVine H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: "(1997"

Phrase: ")"

Phrase: "Stopped-"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1272691:stopped [Qualitative Concept]
   966 E C1947925:Stop [Activity]
   966 E C2746065:Stop [Temporal Concept]

Phrase: "flow kinetics"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0022702:Kinetics [Natural Phenomenon or Process]
   861   C0220865:kinetics [Functional Concept]
   861   C2825046:Kinetics [Occupation or Discipline]

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "multiple phases of thioflavin T binding"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0585064:Phases [Temporal Concept]
   753   C1067936:Phasis [Eukaryote]
   719 E C0205390:Phase [Temporal Concept]

Phrase: "to Alzheimer beta"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0330390:Beta [Plant]
   861   C0439096:Beta [Intellectual Product]
   861   C2004068:Beta [Qualitative Concept]

Phrase: "(1-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439509:/40 [Temporal Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "amyloid fibrils."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1449651:Amyloid Fibrils [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0225328:fibrils [Cell Component]
   827 E C1948066:Fibril [Physical Object]
Processing 00000000.tx.218: Arch Biochem Biophys 342:306-316[Medline] Otvos L, Jr, Feiner L, Lang E, Szendrei GI, Goedert M, Lee VM (1994) Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404. 

Phrase: "Arch Biochem Biophys 342"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0230467:arch [Body Location or Region]
   812   C0741204:ARCH [Body Space or Junction]

Phrase: ":"

Phrase: "306-316"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Otvos L,"

Phrase: "Jr,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "Feiner L,"

Phrase: "Lang E,"

Phrase: "Szendrei GI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539617:GI [Idea or Concept]

Phrase: "Goedert M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Lee VM (1994"

Phrase: ")"

Phrase: "Monoclonal antibody PHF-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   812   C0597162:PHF [Cell or Molecular Dysfunction]
   812   C0746619:monoclonal [Finding]

Phrase: "recognizes"

Phrase: "tau protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0085401:tau Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2700455:Tau Protein [Amino Acid, Peptide, or Protein]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "phosphorylated at serine residues 396"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   726   C1709915:Residue [Conceptual Entity]
   726   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "and"

Phrase: "404."
Processing 00000000.tx.219: J Neurosci Res 39:669-673[Medline] Schmidt ML, Gur RE, Gur RC, Trojanowski JQ (1988) Intraneuronal and extracellular neurofibrillary tangles exhibit mutually exclusive cytoskeletal antigens. 

Phrase: "J Neurosci Res 39"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2347379:RES [Finding]

Phrase: ":"

Phrase: "669-673"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Schmidt ML,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "Gur RE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986904:RE [Idea or Concept]

Phrase: "Gur RC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419366:RC [Gene or Genome]

Phrase: "Trojanowski JQ"

Phrase: "(1988"

Phrase: ")"

Phrase: "Intraneuronal"

Phrase: "and"

Phrase: "extracellular neurofibrillary tangles"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   901   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   867 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "mutually exclusive cytoskeletal antigens."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0003320:Antigens [Immunologic Factor]
   706 E C2698667:ANTIGENICITY [Regulation or Law]
Processing 00000000.tx.220: Ann Neurol 23:184-189[Medline] Sun A, Nguyen XV, Bing G (2001) A novel fluorescent method for direct visualization of neurofibrillary pathology in Alzheimer's disease. 

Phrase: "Ann Neurol 23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0450348:23 [Quantitative Concept]

Phrase: ":"

Phrase: "184-189"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sun A,"

Phrase: "Nguyen XV,"

Phrase: "Bing G (2001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439267:g% [Quantitative Concept]
   827   C0596170:bing [Mental or Behavioral Dysfunction]

Phrase: ")"

Phrase: "A novel fluorescent method for direct visualization of neurofibrillary pathology"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C1704536:Direct Method [Therapeutic or Preventive Procedure]
   739   C0025663:Method [Intellectual Product]
   739   C0449851:Method [Functional Concept]
   739   C0871511:METHOD [Intellectual Product]

Phrase: "in Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.221: J Neurosci Methods 111:17-27[Medline] Uboga NV, Price JL (2000) Formation of diffuse and fibrillar tangles in aging and early Alzheimer's disease. 

Phrase: "J Neurosci Methods 111"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0025663:Methods [Intellectual Product]
   812   C0025664:methods [Intellectual Product]
   812   C0449851:Methods [Functional Concept]
   779 E C0871511:METHOD [Intellectual Product]

Phrase: ":"

Phrase: "17-27"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Uboga NV,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027951:NV [Geographic Area]
   861   C3540591:NV [Idea or Concept]

Phrase: "Price JL (2000"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0080045:Price [Quantitative Concept]

Phrase: ")"

Phrase: "Formation of diffuse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0220781:formation [Biologic Function]
   790   C0439634:formation [Spatial Concept]
   790   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "fibrillar tangles in aging"

Phrase: "and"

Phrase: "early Alzheimer's disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   913   C0679245:early disease [Temporal Concept]
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.222: Neurobiol Aging 21:1-10[Medline] Vallet PG, Guntern R, Hof PR, Golaz J, Delacourte A, Robakis NK, Bouras C (1992) A comparative study of histological and immunohistochemical methods for neurofibrillary tangles and senile plaques in Alzheimer's disease. 

Phrase: "Neurobiol"

Phrase: "Aging"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001811:Aging [Organism Function]
   966 E C0001779:Age [Organism Attribute]

Phrase: "21"

Phrase: ":"

Phrase: "1-10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Vallet PG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1266240:PG [Laboratory Procedure]

Phrase: "Guntern R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Hof PR,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0279759:PR+ [Laboratory or Test Result]
   861   C0279766:PR- [Laboratory or Test Result]
   861   C1418864:PR@ [Gene or Genome]
   861   C3538934:PR [Intellectual Product]
   861   C3538935:PR [Idea or Concept]

Phrase: "Golaz J,"

Phrase: "Delacourte A,"

Phrase: "Robakis NK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022688:NK [Cell]

Phrase: "Bouras C (1992"

Phrase: ")"

Phrase: "A comparative study of histological"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0009491:Comparative Study [Intellectual Product]
   806   C1579762:comparative study [Research Activity]
   762   C0019639:Histology, Comparative [Biomedical Occupation or Discipline]
   760   C0557651:Study [Manufactured Object]
   760   C2603343:Study [Research Activity]
   747   C0681853:histologic study [Research Activity]

Phrase: "and"

Phrase: "immunohistochemical methods for neurofibrillary tangles"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0025663:Methods [Intellectual Product]
   760   C0025664:methods [Intellectual Product]
   760   C0449851:Methods [Functional Concept]
   726 E C0871511:METHOD [Intellectual Product]

Phrase: "and"

Phrase: "senile plaques in Alzheimer's disease."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   806   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   760   C0392079:Senile [Finding]
   726 E C0011389:Plaque [Disease or Syndrome]
   726 E C0332461:Plaque [Finding]
   704 E C0231337:Old age [Finding]
   704 E C1999167:Old age [Population Group]
Processing 00000000.tx.223: Acta Neuropathol (Berl) 83:170-178[Medline]

Phrase: "Acta Neuropathol"

Phrase: "(Berl"

Phrase: ")"

Phrase: "83"

Phrase: ":"

Phrase: "170-178"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

